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THE METABOLISM AND MODE OF ACTION OF SOME 
AROMATIC AMINES IN RELATION TO CARCINOGENESIS 
-3-, 
"Das Wenige verschwindet leicht dem Blick, 
der vorw*ar-ts sieht, wie viel noch ubrig bleibt". 
J. W. von Goethe (1749-1832) 
lphigenie auf Tauris 
Acti. Scene 11. 
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ABSTRACT 
The clinical, epidemiological and experimental observations leading 
to the recognition of aromatic amines as carcinogens in man and experi- 
mental animals have been recorded. 
The metabolism of aromatic amines has been reviewed and current 
theories on the metabolic processes involved in the activation of aromatic 
amines to "proximate" carcinogens have been discussed and attention 
drawn to anomalies in both theories. 
The in vitro oxidative metabolism of 4-aminobiphenyl and 4-acetamido 
biphenyl has been examined and aH. P. L. C. method has been 
described for the determination of their hydroxylated metabolites. The 
in vitro deacetylation of some carcinogenic and non-carcinogenic acetamido 
compounds has been studied using a gas chromatographic technique in severai 
species. The acetylation of aromatic amines with various hepatic systems has 
been studied. 
The synthesis and biosynthesis of 4-aminobiphenylyi-3-glucosiduronate have 
been investigated and species differences in this metabolic reaction have been 
recorded. 
Examination for carcinogenic activity of 4-cminobiphenyl and three 
hydroxylated derivatives has been carried out using the mouse neonate 
technique. 
An examination of lysosomal damage caused by a series of aromatic amines 
and some of their hydroxylated derivatives has been carried out using a lyso- 
somai preparation obtained from dog urinary bladder epithelial cells. The 
-5- 
in vitro activation of a solubilised g-glucuronidase preparation by 
certain aromatic amines has been observed. 
The results obtained are discussed in relation to current concepts 
of the metabolism of aromatic amines and the role of these metabolites 
in carcinogenesis. 
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SECTION I INTRODUCTION 
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1 
.1 omatic Amines as Industrial Carcinogens in the 
Chemical Industry 
Whilst ancient civilizations were aware of certain health hazards associated 
with plant materials which could be used as systemic poisons, there seems to be 
no early record of the recognition of diseases specifically associated with in- 
dustry. This is despite the large scale miningý'of gold by the Egyptians and the 
widespread use of lead by the Romans. 
It was not until the establishment of silver mines in the Harz mountains in 
965 A. D., and the subsequent development of the industry over the following 
six hu. ndred years, that a really comprehensive 3tudy of an. industry was written. In 
"De Re Metallica" Agricola in 1556 included a chapter on the health of workers 
and clearly associated-the mining industry with diseases of joints, eyes and lungs 
occurring in the artisans. Eleven years after the treatise by Agricola, a mono- 
graph, specifically devoted to diseases associated with miners and smelters., was 
written by Paracelsus. This work, "Von der Bersucht und anderen Bergkrankheiten" 
clearly recognises the poisonous effects of various metals, and differentiates 
between acute and chronic effects. 
The publication "De Morbis Artificum" by Bernardino Ramazzini in 1700 
recognised that many other industries were implicated in the ill-health of workers. 
This classic work has had a tremendous influence on the recognition of industry 
as a potential hazard to healthand Hunter (1959) rightly describes Ramazzini 
as the Father of Occupational Medicine. 
il 
From these initial observations the discipline of Industrial Health has developed; 
obviously the advent of the Industrial Revolution resulted in more and more people 
becoming exposed to industrial situations where diseases could be induced. 
4-. 
The first description of cancer occurring as an industrial disease is 
attributed to Percival Pott (1775), who observed a high incidence of 
scrotal tumours in chimney sweeps, and suggested that this was due to 
intimate contact with soot. As industry developed it was soon realised 
thct many other materials., to which workers were exposed, were able 
to induce skin tumours. Volkmann (1875) observed skin tumours in workers 
exposed to paraffin, and Bell (1876) made a similar observation among 
workers in the shale oil industry in Scotland. 
The implication of aromatic amines as industrial carcinogenic hazards 
began with the observation by Rehn (1895), who reported the occurrence 
of cancer of the urinary bladder in three men employed in the manufacture 
of magenta. Rehn suggested that aniline, an aromatic amine used as an 
intermediate in the synthesis of magenta., was the causative agent. The 
German chemical industry, prior to the First World War (1914-1918), was 
paramount. Rehn's observation was soon followed by others, so that by 
1942 over three hundred cases of cancer of the urinary bladder had been 
found in workers in the German chemical industry and attributable to ex- 
posure to aromatic amines (Heuper, 1942). 
With the development of a chemical industry in other countries, either 
as a result of economic development or war, cancer of the urinary bladder 
became an international problem. In Switzerland tumours were observed 
in chemical workers by Schedler (1905) and in Great Britain the first cases 
were reported by Ross (1918). Henry, Kennaway and Kennaway (1931) 
observed that during the period 1921 to 1928 sixty-one fatalities due to 
cancer of the urinary bladder occurred in chemical workers in Great Britain. 
Heuper (1942) has documented a further thirty cases reported up to . 
1937. 
In other countries a similar situation exists. In Austria, Scheele (1926) 
and Schueller (1932) reported the occurrence of bladder tumours in chemi- 
cal workers, and in the Soviet Union bladder tumours have been reported in 
chemical workers by Rosenbaum and Gottlieb (1926) and Abramyan, 
Rothberg and Mayants (1933). 
In the United States of America, Ferguson, Gehrmann and Gay (1934) 
reported twenty five cases all originating from one chemical concern, and 
by 1942 Heuper estimated that about one hundred cases had been detected 
in thatcountry. In 1937 di Maio reported twelve bladder tumours occurring 
amongst eighty&-six workers in one Italian dye factory. Nagayo and Kinosita 
(1940) described three ur'inary bladder papillomas arising in workers in the 
Japanese chemical industry. 
With regard to the nature of the responsible agent in the etiology of this 
industrial disease.. little support can be found for the suggestion by Rehn 
(1895) that aniline may be involved. Walpole, Williams and Roberts (1952) 
suggested that bladder tumours were caused by naphthylamines and xenyl- 
amines occurring as impurities in the manufacture of dyestuffs. This idea 
received further support following the publication of an epidemiological 
survey of workers in the British chemical industry. In this report Case, 
Hosker, McDonald and Pearson (1954), Case and Pearson (1954), indicated 
that exposure to aniline was not responsible for the bladder tumours found 
in workers in the chemical industry, but that I- or 2-naphthylamine, 
-16- 
benzidine (414'-diaminobiphenYl) or magenta presented a very real risk to 
the workers engaged in their manufacture. 
Another potent industrial carcinogen, with an action on the urinary 
bladder, was recognised by Melick, Escue, Naryka, Mezera and Wheeler 
(1955) who reported that II% of workers exposed to xenylami ne (4-amino- 
biphenyl) developed bladder tumours. These workers have been subjected 
to extensive "follow up" and cytological studies (Koss, Melamed and Kelly, 
1965; Koss, Melamed, Ricci, Melick and Kelly, 1969; Melick, Naryka 
and Kelly, 1971) and some of their results are shown in Table II. These 
publications also indicate the value of exfoliative cytology in the detection 
of the disease, and Melamed (1972) has clearly shown that bladder cancer 
can develop even though exposure to the carcinogenic stimulus had ceased 
some years before the tumour was clinically recognised. During the fourteen 
years following the cessation of production of 4-aminobiphenyl, eighty-six 
workers developed a suspicious or positive cytology, and of these, forty-three 
subsequently had histologically confirmed cancer of the urinary bladder. 
Studies were also carried out on workers in the Italian chemical Industry 
where benzidine was still being produced (Maltoni and Ghetti, 1964) and 
a number of cases of carcinoma of the bladder were detected. 
Follow up studies by Forni, Ghetti and Armeli (1972) again indicated 
the value of cytologica; studies of urinary deposits because, of the sixteen 
new cases found, fourteen had been predicted by the technique described 
11 
by Crabbe (1952). 
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Table 1 .1 . 
1' Incidence of cancer of the urinary bladder found in men 
employed in two plants and exposed to 4-ctminobiphenyl 
(from Melick et al. 1971) 
Plant Year Men 
examined 
Men with 
bladder tumours 
% 
1 1953 71 12 16.9 
1958 186 23 12.4 
1970 261 42 16.1 
2 1953 44 1 2.3 
1958 45 2 4.4 
1970 
I- 
54 10 
I- 
18.5 
I-I 
-18- 
In recent reports the hazard from exposure to benzidine has again been 
emphasised. Zavon, Hoegg and Bingham (1973) found that of twenty-five 
men exposed to benzidine, thirteen had clinically defined cancer of the 
bladder and Wendel, Hoeg and Zavon (1974) reported on the relatively 
short induction time of the disease with this carcinogen in man. 
-19- 
1.2 atic Amines as a Carcinogenic Risk in othe-r 
Industries or Environments 
The evidence presented in the preceding section clearly implicates 
certain aromatic amines as causative factors in the etiology of bladder 
cancer observed amongst workers exposed to them in the chemical and 
dyestuff industry. Indeed the bulk of aromatic amines were originally 
specifically synthesised for use in the dyestuff industry as dyestuff inter- 
mediates, and generally they were transformed into harmless dyes (Case, 
1966a). 
In addition, small but significant amounts were purified and sold as 
fine chemicals for laboratory use. Later there developed a requirement 
for aromatic amines in other industries either as the parent amines or as 
specialised products. 
During the course of the survey carried out by Case and his colleagues 
(1954), a fortuitous observation was made in the general population, then 
being used as a control. An unexpected number of patients who suffered 
from bladder tumours had been employed in one large rubber works in 
Birmingham. Case and Hosker (1954) calculated that during the period 
1936-1950 only four cases of cancer of the urinary bladder would have been 
expected amongst all the skilled rubber-workers in Birmingham, if no 
industrial risk were involved; in practice twenty-two cases were discovered . 
Subsequent studies (Case, 1966b) continued to show that workers in the British 
rubber industry are "at risk". 
It was soon realised that the causative agents in the disease were probably 
the antioxidants, incorporated into the rubber to prevent perishing. These 
-20- 
antioxidants were produced from I-and 2-naphthylamine by condensation 
with acetaldehyde, and contained 2.5% free naphthylamines of which 4, 
0.25% was 2-naphthylamine. These antioxiclants were sold under the 
trade name "Nonox S" and "Nonox HP. Another antioxidant '. 'Santoflex 
BX" contained 4-aminobiphenyl (Anon. 1966a). 
similar situation has been observed in the United States of Americat 
where Guira (1971) examined the records of bladder cancer patients at 
four hospitals in Akron, Ohio. Of the 585 patients with bladder cancer, 
Guira found that 168 were employed in the rubber industry and 90% 
of these were employed by only three companies. Cole, Hoover and 
Friedel I (1972), in a survey of workers in Eastern Massachusetts, found a 
high incidence of bladder cancer amongst workers employed in the dyestuff, 
organic chemicals, rubber, paint and leather industries. Workers in these 
latter two industries could well be exposed to amines occurring as impurities 
in the pigments and dyes used. 
Perhaps not surprisingly another industry where rubber was extensively 
used soon became suspect as a source of industrial bladder tumours. In 1965 
Case and Davies reported on the high incidence of bladder tumours in 
workers in the electric cable industry which was apparently due to their 
exposure to aromatic amines occurring as impurities in the condensed anti- 
oxidant (Davies, 1965). 
As early as 1931 Henry, Kennaway and Kennaway indicated that workers 
in retort houses producing gas developed bladder tumours. This finding was 
substantiated in further surveys by Do II et aI. (1965,1977 T) who draw 
attention to the finding by Battye (1966) of 2-naphthylamine in tar fumes 
and condensate. 
-21- 
The compound a-naphthylthiourea (ANTU) was introduced into our 
environment as a potent rodenticide. The commercial compound con- 
tains approximately 1% free naphthylamines of which about one-fifth 
is the 2-isomer (Anon. 1966b). Two occurrences of bladder ca . ncer 
were reported in users of ANTU (Anon, 1966c). Veys (1969)described 
a further case reported to H. M. Coroners Notification Scheme. 
Aromatic amines are used in laboratories for many purposes; most 
chemists are exposed to them during their training due to their use as 
'spots' in order to gain expertise in chemical analysis or organic syn- 
thesis. Benzidine was routinely used in pathology laboratories for 
detection of blood in stools (Lehmann, 1967), and as a spray reagent 
for detection of sugars on paper chromatograms. Searle (1970) has drawn 
attention to the possible risk to laboratory workers of a whole variety of 
organic chemicals and The Department of Education (1970) issued a pam- 
phlet on the use of aromatic amines in schools and educational establish- 
ments. The only survey of chemists was carried out amongst members of 
The American Chemical Society by Li, Fraumeni, Mantel and Miller (1969). 
No higher incidence of cancer of the urinary tract was observed amongst 
this profession compared with a comparable group of professional men in 
general. 
Veys (1969) has indicated that workers in the textile and printing industries 
may also be "at risk" due to their exposure to dyestuffS which may contain 
aromatic amines or their derivatives. It should also be remembered that 
benzidine has been used to impregnate paper and is present in printing 
-22- 
materials for the manufacture of security papers. 
In addition to cancer of the pulmonary system cigarette smoking has 
been alleged to be a causal factor in a large number of other diseases. 
A number of reports indicate that cigarette smoking i's associated with 
cancer of the urinary bladder (see Gorrod, Jenner, Keysel I and Mikhael , 
1974, and references cited thereinand Armstrong and Dollf 1974). Smcl I 
amounts of naphthylamines and aminofluorene have been detected in 
cigarette smoke by Pailer, Hubsch, and Kb*hn (1967). More recently 
Masuda and Hoffmann (1969) have described quantitative methods for 
deten-nination of I -and 2-naphthylamine occurring in cigarette smoke. 
These authors reported a total of fifty nanograms of naphthylamines 
occurring in the smoke of one cigarette, about forty percent of which 
wds the 2- isomer. 
Naphthylamines could have been formed via reaction of ammonia with 
naphthalene or naphthol in the heated zone of the cigarette or by the 
pyrolysis of L-glutamic acid or L-leucine as described by Masuda, Mori 
and Kuratsune (1967). 
It is of interest that Wagle & Lee (1973) have recently claimed to 
induce bladder tumours by direct application of tobacco tar to the 
urinary bladders of rats. 
The majority of drugs used in clinical practice are nitrogenous com- 
pounds, although only few of them having the nitrogen atom directly 
attached to an aromatic system. At present two drugs., which could be 
converted into aromatic amines in vivo, have been demonstrated to be 
-23- 
bladder carcinogens in humans. 
The first indication that chlornaphazin (N, N-bis-( 2-chloroethyl)' -2- 
naphthylamine) was carcinogenic to man, came in the report by Chievitz and 
Thiede (1962) 
. These authors had used the drug in Denmark for the treatment 
of Hodgkiný disease and polycythaemiavera, and later found that three cases 
of cancer of the bladder occurred amongst twenty-six patients treated with 
this drug. Later, Videback (1964) reported a further nine cases which he 
attributed to the treatment of patients with chlornaphazin. 
Boyland & Monson (1963) have shown that chlornaphazin is converted 
in rats to metabolites which could have been derived from 2-naphthylamine, 
following initial dealkylation. 
The second drug which is clearly implicated in toxirity towards the human 
urothelial system is phenacetin. This drug was introduced as an analgesic- 
antipyretic in 1866, and throughout the ensuing years it has gained in popularity 
and, until recently, was widely used throughout the world. The toxicity 
associated with phenacetin and some related derivatives of p-aminophenol has 
recently been reviewed by Godfrey (1972) and Shelley (1967). The easy 
availability of this drug has lead to abuse in certain individuals. In many cases 
the individual first required the analgesic due to his employment. Thus watch- 
makers and others doing close work and workers in ordinance factories exposed 
to nitro- compounds, often take analgesics daily to treat headaches. 
Usually, phenacetin abuse is associated with nephrotoxicity leading to 
transitional-cell tumours of the renal pelvis (Bengtsson and Angervall, 1970; 
Begley, 1970), although tumours of the urinary bladder occur with a lower 
frequency (Bengtsson, Angervall, Ekman and Lehmann, 1968; Begley, Chadwick 
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and Jepson, 1970). More recently Manion and Susmano (1971) have described 
a further bladder tumour which they ascribe to phenacetin abuse. In all the 
cases of bladder cancer attributable to phenacetin, it should be noted that the 
individuals each had a yearly consumption in excess of one kg of the drug. 
Phenacetin is deacetylated in man to yield an aromatic amine, p-phene- 
tidine, although this appears to be a minor pathway of metabolism (Brodie and 
Axelrod, 1949). It may be that further metabolism of p-phenetidine occurs, 
as described by Buch, Hauser, Pf leýer and Rudl-ger (1966), and the true signi- 9 
ficance of this deacetylation route is more important than hitherto thought. 
The structures of compounds discussed in Sections 11 and 1 .2 are shown 
in Fig. ] . 2.1 . 
a 
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Fig. ] . 2.1 Structures of some aromatic amines and 
derivatives discussed in 
Sections I. I and 1 . 2. 
L 
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1 Production of Cancer-by Aromatic Amines in Experimental Animals 
The production of neoplastic disease is unlike many other toxic phenomena 4. 
in that, usually, a considerable time elapses from the first exposure to the 
chemical until the first appearance of a clinically recognisable tumour. This 
latent period varies very much with the animal species studied. In man, Case 
et al. (1954) reported a mean latent period of seventeen years for workers 
exposed to benzidine and naphthylamines. A similar figure is apparent from 
the work of Wendel et al. (1974) for workers involved in benzidine manufacture. ' 
Case and Pearson (1954) reported a similar late'nt period for workers exposed to 
aurami ne and magenta. 
The requirement to produce the disease in experimental animals was initiated 
with two specific aims in mind. Firstly there was the need to confirm which 
substances in our environment were really able to cause bladder cancer and 
which substances were ineffective. The second reason for reproducing the 
disease in experimental animals was the need to have a model system in which 
the initiation, development and the treatment of the disease could be studied. 
Animal species vary in their ability to utilise any specific metabolic path- 
way for foreign compounds (See Section 1 . 
4); they also vary in their sensitivity 
to a carcinogenic stimulus and in the latent period for any specific carcinogen. 
Therefore, only when the correct combination of species., together with the 
appropriate dosage schedule is used is it possible to produce the disease in 
experimental animals. 
The first reports of the production of tumours of the urinary bladder in 
rabbits, following subcutaneous administration of 2-naphthylamine 
(Schar 
1930; and Perlmann and Stachler, 1932,1933) have since been discredited 
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by Bonser (1913) and Heuper, Briggs and Wolfe (1938). In fact Berenblum 
and Bonser (1937) administered various amino compounds over long periods 
to tabbits and rats by injection, feeding or inhalation, but failed to pro- 
duce tumours of the urinary bladder or other organs. In the same year 
Heuper and Wolfe (1937) reported, in a preliminary communication, on 
the successful production of bladder neoplasms by administering commercial 
2-naphthylamine subcutaneously to female Beagle dogs. A full report of 
their experiments was published in 1938 (Heuper, Wiley and Wolfe) which 
showed that 2-naphthylamine was able to produce a whole spectrum of urinary 
bladder lesions ranging in severity from hyperplasia to carcinoma. These 
results were confirmed by Bonser (1943) who administered pure 2-naphthyl- 
9mine orally to mongrel dogs. In contrast, oral administration of 1-naphthyl- 
amine to dogs by Bionser, Clayson & Jul 1 (1958) indicated that this compound 
was virtually inactive. 
Conzelman and Moulton (1972) also administered 2-naphthylamine to 
Beagle dogs and found that the total amount of this compound required to 
produce bladder tumours was much less when small daily doses of 6.25 mg/Kg 
were given, compared to the animals receiving 25 or 50 mg/kg. This is in 
contrast to the findings of Saffiotti, Cefis, Montesano and Sellakumar (1967) 
who found that only high doses of 2-naphthylamine produced bladder cancer, 
after oral administration to Syrian hamsters. Bladder cancer was also produced 
by 2-naphthylamine when given to Rhesus Monkeys (Macaca mulatta) by Con- 
zelman, Moulton, Flanders, Springer and Crout (1969). It is of interest that 
of all the other adult animals treated with 2-naphthylamine, i. e. rats, mice, 
guinea pigs and rabbits only in mice was there a significant carcinogenic 
-28- 
.P 
response. In this species, Bonser, Clayson, Jul I and Pyrah (1952) reported 
the formation of hepatomas. 
4-Aminobiphenyl was reported by Walpole, Williams and Roberts (1954) 
to be carcinogenic to the bladder when fed to dogs; this result 
. 
was confirmed 
by Deichmann et al. (1956; 1965a; 1965b). ). The rabbit was also shown 
to develop bladder cancer after exposure to 4-aminobiphenyl (Bonser, 1962). 
When this amine was given by stomach tube to female mice, a remarkable 
strain difference in response was apparent. When Ab x I. F. mice were used 
the liver was resistant to the formation of hepatomas by this agent, whereas 
when C57 x I. F. mice were used a high incidence of hepatomas was observed. 
(Clayson, Lawson & Pringle, 1967). In the former strain a low incidence of 
bladder tumours was also observed (Clayson, Lawson, Santana and Bonser, 
1965). Walpole, Williams and Roberts (1952) showed that 4-aminobiphenyl 
produced 'Intestinal tumours when given subcutaneously to rats; in this same 
publication they also showed that the 3.2'-dimethyl derivative was much 
more potent than the parent amine. This latter compound is of special interest 
as again it indicates a genetic factor involved in determining the site of 
tumour formation upon exposure to an aromatic amine. Thus, this compound 
which produced early intestinal neoplasms in Wistar rats, elicited a high 
incidence of bladder tumours when administered to Slonaker rats. So and 
Wynder (1972) have reported a high incidence of bladder tumours in Syrian 
golden hamsters receiving 3, D-dimethyl-4-aminobiphenyl subcutaneously. 
Walpole and Williams (1958) also reported on the carcinogenicity of a 
variety of methyl derivatives of 4-aminobiphenyl: in nearly every case the 
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primary lesions seemed to be associated with the intestinal tract. The 
exception to this was 4-amino-2-methylbiphenyl which did not produce 
intestinal tumours but produced liver tumours instead. In other carcino- 
genesis experiments with 4-halogeno-4-aminobiphenyls, the 4'-fluoro 
compound was a powerful carcinogen, affecting the kidneys, liver and 
i intestines, whereas the chloro or bromo analogues were inactive even 
after two years of treatment. (Walpole & Williams, 1958). When the 
chloro substituent was in the 3-position the ability to produce intestinal 
neoplasms was retained. These authors also showed that 4-amino-3- 
methoxybiphenyl was able to produce bladder tumours after subcutaneous 
administration to rats. This result is very similar to that obtained by 
Hackmann (1956) who produced bladder tumours in rats after feeding 2- 
amino-3- methoxy-diphenylene oxide, a finding more recently confirmed 
by Radomski, Brill and Glass (1967). 
Benzidine is another compound implicated in the etiology of the human 
disease (Section 1 . 
1). This amine has also been tested in experimental 
animals and has produced bladder carcinoma when given to dogs (Spitz, 
quoted by Bonser, 1962), although in rats and mice hepatomas were 
produced (Sýitz, Maguigan and Dobriner, 1950; Pliss, 1964). Bonser, 
Clayson & Jull (1956) were unable to produce bladder tumours in mice with 
this compound, although hepatomas were again produced in this species. 
In rabbits only one of twelve animals developed a bladder carcinoma as a 
result of exposure to benzidine (Bonser, 1959). Benzidine was also shown 
to produce cholangiomas, hepatomas and liver cell carcinomas (Saffiotti, 
Cefis, Montesano & Sellakumar, 1967; Sellakumar, Montesano and 
Saffiottio, 1969). 
I 
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Deichmann et al. (1965) fed benzidine to pure-bred beagle dogs at a dose 
of 1 .0 mg/kg five times a week for approximately three years without the 
animals developing bladder tumours. At the same dose level 2-naphthylamine 
also failed to induce bladder neoplasms, whereas 4-aminobiphenyl was a 
potent bladder carcinogen at this dose level. 
Many other aromatic amines have been tested in experimental animals for 
their ability to produce neoplasms. In some cases these studies were conducted 
because of the use or proposed use of the compound either in the dyestuff 
industry or because of another specific use. of the compound. In other cases 
the amines were tested, because of structural similarity with known carcinogens, 
in the hope that a rational basis for the prediction of the chronic toxicity of 
aromatic amines would emerge. 
In the former category, 3,, 'ý-dimethylbenzidine (o-tolidine), a compound 
widely used as a dyestuff intermediate in the manufacture of more than ninety- 
five dyes, 3,31-dimethoxybenzidine (o-dianisidine) as intermediate for about 
ninety dyes, and 3, ý-dichloro benzidine have al I been tested. These amines 
seem to be weaker carcinogens than the mono-amines, producing a rather 
wider spectrum of tumours, but at a much lower incidence. Surprisingly, with 
rats, the liver seems resistant to these carcinogens and the predominant site 
of action is ZymbaN gland (Pliss and Zabezhinsky, 1970). In the hamster, 
3,3! -dimet[Lq; ýybenzidine and 3,3'-dichlorobenzidine caused a low yield 
of bladder tumours, whilst 3,3-dimethylbenzidine was inactive (Saffiotti et al. 
1970). This is in contrast to the activating effect of an adjacent methyi group 
seen during carcinogenicity studies on derivatives of 4-aminobiphenyl and 
2-naphthylamine. 3-Methyl-2-naphthylamine is a very potent carcinogen in 
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the rat, even producing tumours at the site of administration (Shenoy, 
Ambaye & Panse, 1964; Weisburger et al. 1967). 
As early as 1938, Shear had shown that 2-anthramine was a very potent 
hepatomarproducing agent when given to mice, a result confirmed by other 
workers, whereas Bielschowsky (1946,1949) showed that both I- and 9- 
anthromine were inactive. This specific structural requirement is similar 
to that observed with naphthylamines and aminobiphenyls, where I-naph- 
thylamine and 2-aminobiphenyl were virtually inactive compared with 2- 
naphthylamine and 4-aminobiphenyl. 
Work on what must be the most widely studied nitrogen-containing 
carcinogen started in 1941 when Wilson, De Eds and Cox reported that 
ý2-acetamidofluorene 
was a carcinogenic substance when fed to rats. This 
amide, which produced tumours in the liver as well as many other organs, 
was originally patented as an insecticide. Further studies showed that, 
with the exception of the quinea. pig, every species subjected to this 
material ultimately developed a tumour. The site and nature of the tumour 
depended upon the species, route of administration and hormonal status of 
the animal. So many studies have been carried out with this compound 
that it is impossible to cite them in detail. In 1958 Weisburger and Weis- 
burger reviewed all aspects of 2-acetamidofluorene carcinogenicity and 
this was subsequently updated by Arcos and Argus (1968) 
§ The nomenclature for compounds containing the group ArNHCOCH3 varies. 
They are described as acetamido, acetylamino or N-ary lacetam ides depend- 
ing upon the literature source, country of origin and the date of publication. 
Chemical Abstracts uses the latter system; however this can become clumsy 
in a descriptive text and the former type of nomenclature has been adopted 
throughout this thesis. 
J. 
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Unlike the other compounds discussed in this section, 2-acetamidofluorene 
is an amide and not an aromatic amine. However, amides can be hydrolysed 
biologically (see Section 3) to produce the corresponding amines and Arcos 
and Argus (1974) have called these amine-generating compounds Auxocarcinogens. 
In addition to acetyl groups, other acyl substituents can be enzymically cleaved 
to produce aromatic amines. Similarly, N-alkylated amines can be metabolised 
by an oxidative process to yield the corresponding amine. It is not surprising 
therefore that other amides were soon recognised as carcinogenic substances. 
These include a wide range of substituted derivatives of 2-acetamidofluorene 
(for details see Arcos and Argus, 1974), 4-acetamidobiphenyl (Jabra, 1963) 
and 2-acetamidophenanthrene. This latter amide is rather unusual in that it 
has the abi lity to produce leukaemia when given to rats (Mi I ler, Sandin, Mi I ler 
and Rus ch, 1955). 
In the same way as acetamides or other amides may be metabolic precursors 
of aromatic amines as discussed earlier, it is possible for aromatic nitro-compounds 
to be converted into aromatic amines by in vivo biological reduction (Mitchard, 
1971). It is not surprising therefore to find that some nitro-compounds are 
carcinogenic when administered to experimental animals. Deichmann et al. 
(1958) found bladder tumours were produced in dogs following the oral admini- 
stration of 4-nitrobiphenyl. Similarly, after 2-nitronaphthalene was fed to 
a monkey multiple papi I lomas were found in the urinary bladder by Conzeiman, 
Moulton and Flanders (1970), although frank carcinoma was not seen in this 
case. 
The nitro analogue of benzidine, 4,4'-dinitrobiphenyl has been tested in 
rats by Laham,, Grice & Sinclair (1964). This compound produced ear duct 
and mammary adenocarcinomas in female rats but was inactive in males. 
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From the foregoing it can be seen that the original idea that certain 
aromatic amines were etiological factors in the production of certain human 
tumours was well founded - Not only were the compounds suspected of being 
carcinogenic towards man, proven to be carcinogenic when given to 
experimental animals, but also a range of hitherto unsuspected compounds 
were shown to be carcinogenic and are therefore recognised as a hazard when 
allowed into our environment. 
In order to produce these tumours in experimental animals, it was generally 
necessary to expose the animal to multiple dosing for a large part of its life 
span. Often tumours were only produced when high doses were given and 
even then some species remained refractory to the stimulus. The many studies 
in this field show that no clear structure-activity relationship is apparent; 
usually if one isomer of an amine or amide is active, other isomers will be 
inactive or very weakly active. 
Additionally it has been shown that not only are aromatic amines active 
in their ability to produce tumours, but also, that compounds which are 
metabolised to aromatic amines have this property. It is not suggested that 
conversion to an aromatic amine is a prerequisite for activity in every case, 
and some compounds may have this property per se or after metabolic con- 
version via an alternative pathway. This concept will be discussed later 
in this thesis. The tumour producing activity of some aromatic amines, 
acetamido compounds and nitro compounds is summarised in Table 1 . 3.1 . 
This table is not comprehensive and for further details reference must be made 
to monographs by Clayson (1962), Arcos and Argus (1974), Boyland (1963), 
A. 
Scott (1962) and Temkin (1957). 
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The structures of some of the compounds discussed in this section are 
shown in Fig. ] . 3.1 . 
In view of the data presented in this section it would be easy to 
conclude that aromatic amines are so toxic that their use in human therapy 
is negated. However, this is not the case, and drugs such as p-amino- 
salicylic acid, the sulphonamides, Dapsone (4,4-d iam i nodi pheny Isu I phone), 
Procaine, Procainamide and Benzocaine have been widely used in human 
therapy for many years without being associated with a cancer-producing 
risk. Another aromatic amine 6-aminochrysene (Chrysenex) has been used 
both in the treatment of human mammary carcinoma and chronic myeloid 
leukaemia (Gelzer and Loustalot, 1967; Buu-Hoi, Huong, Ly and Tuong, 
1962). This compound was not carcinogenic when administered to adult 
rats or mice (Lambelin, Mees and Buu-Hoi, 1967). 
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Table 1 
. 
3.1 Sites of principal turnours produced by various amines or their 
metaboli 
ý-ompound I Site of Action 
i 
12-Naphthylamine man urinary bladder 
dog u, rinary bladder 
hamster urinary bladder 
mouse I iver 
monkey I urinary bladder 
4-Aminobiphenyi man u ri nary bladder 
dog urinary bladder 
rat intestine 
mouse liver 
rabbit urinary bladder 
4-Amino-4'-fluorobiphenyl rat kidney 
Benzidine man u ri nary bI adder 
dog urinary bladder 
mouse liver 
hamster I iver 
4-Amino-3-methylbiphenyl rat i ntest i ne 
4- Am i no- 3,2'-d imethy I- rat intestine 
biphenyl hamster urinary bladder 
4-Amino-3-methoxy- rat urinary bladder 
biphenyl 
4-Amino-3-methoxy- rat urinary bladder 
biphenylene oxide 
2-Anthramine mouse I iver 
contd. . 
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Table 1 
. 3.1 (continued) 
2-acetamidofluorene rat liver and mammary gland 
mouse liver and mammary gland 
hamster liver 
rabbit urinary bladder and kidney 
dog liver and urinary bladder 
cat I ung 
2-acetamidophenan- rat leukaemia 
thren 
4-acetamidobiphenyi dog urinary bladder 
4-nitrobiphenyi dog: urinary bladder 
4,4'-dinitrobiphenyl rat mammary gland 
F- nitronaphthalene monkey urinary bladder 
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F/k NH 
4-ami no-4'-f I uorobipheny I 
OCH 
3 
NH 
2 
4-am i no-3- methoxyb ipheny I 
2-acetamidofluorene 
Ir \\ 
4-nitrobiphenyl 
NHCOCH 
NO 
NH 
2-aminoanthracene 
CH CH 
3 
NH 
4- ami no-2'-3-dimethylbipheny I 
3 
H 
4- am i no-3- methoxyb ipheny leneoxide 
2- acetam idophenanthrene 
NHCOCH 
3 
0 
4,4'-dinitrobiphenyi 
2 
6-aminochrysene 
Fig. 1 . 3.1 . 
Structures of some compounds discussed in section 1 . 3. 
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1.4 Metabolism of Aromatic Amines 
When aromatic amines are given to experimental animals, the pharmacological 
or toxicological response, in the majority of cases, is at a site anatomically 
distant to that of the site of administration. This suggests that the amine may be 
acting via a metabolite rather than the parent compound, as otherwise local 
effects would have been expected. Other explanations, such as tissue suscept- 
ibility, tissue distribution or localisation are tenable for certain compounds, but 
in order to fully account for the toxicological or carcinogenic effects of aromatic 
amines the metabolism of these compounds appears a prerequisite. 
The aromatic amines discussed in the previous sections are composed of four 
distinct moieties, consisting of the essential amino group, and the aromatic 
nucleus (Ar) . In addition, some aromatic amines 
have nuclear substituents (RI) 
or substi tuents on the ni trogen atom (R2 and Rý. (Fi g. 1 . 4.1) . Each of these 
groups can be the site of a metabolic reaction. In many cases the initial re- 
action which is often oxidative, provides a functional group. This is usually 
followed by a conjugation reaction, thereby converting the molecule into a 
highly ionised water-soluble compound allowing excretion, via the kidney, into 
the urinary tract. This two-phase concept of foreign compound metabolism was 
originally proposed by Williams (1959) and is exemplified by the compound 
aniline. Aniline has been studied by many workers, originally by Schmiedeberg 
(1878) and Mul ler (1887), and more recently by Smith and Wi I liams (1949). 
Sch miqdeberg (1878) recognised that ani I ine was probably converted to p- 
aminophenol and then conjugated with sulphuric acid, but it was only with 
the systematic studies of Smith and Williams (1949) and of Parke 
(1960) who 
A 
used 
14 C-aniline that the true complexity of the metabolic picture emerged. 
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As aromatic amines already possess a functional group, some metabolic 
reactions involve the aromatic amino group without a prior oxidative reaction. I 
Thus aromatic amines are converted into N-giucosiduronic acids or N-sulphates 
(sulphamates) both in vitro and in vivo. The former metabolites were indicated 
from the work of Smith and Williams (1949a) in studies on the metabolism of 
aniline, pheneticline and anisidines. These N-glucosiduronates were first 
isolated by Bushby and Woiwod (1955,1956) from rabbit urine, following the 
-administration of 4.4-diami nodiphenyisu I phone (Dapsone). Boyland, Manson 
and Orr (1957) showed that th is was a Iso a route of metabo I ism for 2- naphthy I- 
amine. These authors also showed that aniline and 2-naphthylamine could be 
converted to sulphamic acids. Since then 3,4-dimethylani line (Boyland & Sims, 
1959), benzidine (Clayson, 1959), 4-aminobiphenyl (Bradshaw, 1959), 4-amino- 
2,43-dimethylbiphenyl and 4-amino-3-methyibiphenyl (Gorrod, 1960), have all 
been shown to form both N-glucosiduronates and sulphamates. 
Boyland, Manson and Orr (1957) showed that aromatic amines react spon- 
taneously with glucuronic acid to form N-glucosiduronates and it may be that 
some are formed by this mechanism. It seems likely however, that under 
physiological conditions, these compounds can be synthesised by transfer of the 
glucuronic acid moiety from uridine diphosphoglucuronic acid (UDPGA) under 
the influence of a microsomal glucuronyl transferase. This proposal would be 
in accord with the accepted mechanism for the formation of other glucosiduronates., 
including phenolic glucosiduronates. 
The biosynthesis of arylsulphamates has been studied by Roy (1960) who 
indicated that, in a similar manner to the formation of sulphates of phenols 
and alcohols, the sulphate was 
derived from adenosine-31-phosphate-5'-sulphato- 
phosphate (PAPS) via a specific arylamine sulphokinase. 
Roy (1960) also 
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OF 
indicated that this transferase was activated by the presence of certain 17-oxo 
steroids and suggested that the formation of a steroid enolsulphate, which may 
act as a sulphate donor, could occur under certain conditions in vivo. 
The other general metabolic conjugation reaction of arylamines is the 
formation of acyl derivatives, ArNHCOR. As will be discussed in Section 4 
the most common example of this type of conjugation is the formation of acetyl 
derivatives which involve the transfer of the acetyl group from acetyl Coenzyme A 
(acetylCoA) to the amino group. Although other acyl derivatives are commonplace 
in lipid biochemistry, few other acyl derivatives of aromatic amines have been 
reported as metabolites. Suiphanilamide is converted to a succinyl derivative in 
vitro by tissue extracts (cited by Williams, 1959) and 2-naphthylamine is excreted 
by rats and dogs as 2-formamido-l-naphthylsulphate (Boyland and Manson, 1966). 
The mechanism of these acylations has not been further investigated. 
The reverse reaction, that is the deacylation of acetamido compounds, has 
been reported, and occurs with both aromatic and aliphatic compounds. At least 
two different enzymes, depending upon the nature of the substrate , are capable 
1. 
/ 
of carrying out this reaction. This hydrolytic reaction will be discussed'in greater 
detail in Section 3. From the above it can be seen that when animals or man are 
exposed to aromatic amines both acetylation and subsequent, deacetylation can 
occur, leading to an equilibrium 
ArNH 2 W. 
*& ArNHAc 
As these two components have different physical properties, i. e. aromatic 
amines are basic whereas aromatic amides are not, it would not be surprising 
if 
they are substrates for different enzymes leading to different metabolic oxida- 
tion products. 
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R\ 
Fig. ] . 4.1 . Genera L structure of aromatic tLmines. 
a 
OH 
H2 HO 
I 
-C_ NHCOCH 
NH2 
Fig. 1 . 4.2. Possible 
involvement of acetylation in directing the site of hydroxylation 
NH2 ýo NHCOCH3 >HO 
9, 
of aromatic at-nines. 
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The nuclear parahydroxylation of aniline in vivo was recognised as a metabolic 
process (Schmiedeberg , 1878; Muller, 1887), and this site of hydroxylation was I 
confirmed by Smith and Williams (1949a). These latter authors fed aniline to 
rabbits and found that the major metabolite was the acid-labile N-glucosiduronate; 
but that in addition about one-third of the dose was excreted as the sulphate 
derivatives of ortho- and para- aminophenol and 4-aminoresorcinol., indicating 
that ortho-hydroxylation was also possible. This work showed that the &glucuronide 
fraction did not contain any conjugates of ortko-aminopheno'l although the glucuronide of 
para-aminophenol and para-acefami'dophenol were formed. As earlier work on 
acetanilide metabolism in the rabbit had indicated that only parahydroxylation 
occurs (Smith and Williams, 1948), it seems that hydroxylation in the ortho-position 
can only occur with free aromatic amines. In contrast to the experiments above 
Jaff; and Hi lb ert (1888) fed acetani lide to dogs and found conjugates of both 
ortho-and para-aminophenol in the urine. These results suggest that the dog possesses 
a deacylase enzyme, although this species lacks an arylamine acetylase system. 
As aniline is converted in vivo to acetanilide in most species, the possibility arose 
that the para-aminophenol formed from aniline by rabbits, was derived by hydroxyl- 
ation of acetanilide, and subsequent deacetylation) the ortho-aminophenol being 
formed by direct hydroxylation of the aniline (See Fig. ] . 4.2) 
However, when aniline was given to dogs, a species which cannot acetylate 
aromatic amines, both ortho- and para-aminophenols were found as metabolites 
(Parke, 1960). In agreement with these findings, Clayson (1950) reported that 
when 2-naphthylamine was given to dogs., between 30 and 70% was excreted as 
conjugates of 2-amino-1 -naphthol. Later studies using 8- 
14 
C-2-naphthylamine 
indicated that the true figure for this route is probably in excess of 90% (Radomski, 
Brill and Deichmann, 1967). 
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In contrast, when 2-acetamidonaphthalene was given to dogs, less than 5% 
of the dose was hydroxylated in the 2-position. Similar results were obtained 
using the cat, indicating that both cat and dog had a high ortho- hydroxy lase 
activity towards the parent amine, and a much lower activity towards the 
corresponding acetamido compound. With the latter compound hydroxylation 
to 2-acetamido-6-naphthol is the predominant route (Dobriner, Hofmann & 
Rhoads, 1941). 
A considerable step forward in our understanding of the molecular mechan- 
isms of aromatic amine metabolism come with the realisation that many of 
the metabolites which are formed in vivo, could be produced by suitably forti- 
fied tissue preparations in vitro. At first these preparations consisted of crude 
tissue minces or brei, but later tissue slices were used. Sato, Suzuki, Fukuyama 
and Yoshikawa (1955) studied the metabolism of aniline and acetanilide by liver 
slices prepared from rat, rabbit, dog and cat. In the same year Booth, Boyland 
and Monson showed that 2-naphthylamine was converted predominantly into 
2-amino-l-naphthylsulphate, together with some 2-acetamido-6-naphthyl- 
sulphate and 2-amino-6-naphthylsulphate. However, as this preparation was 
able to acetylate and deacetylate aromatic cmines and acetcmido compounds 
it was difficult to establish the exact sequence of reactions leading to each 
metabolite. 
Concurrent with this work, American scientists,, notably those associated 
with Brodie, Axelrod and Udenfriend., established that a wide variety of drug 
oxidations could be carried out by microsomal fractions prepared from various 
tissues (See Brodie, Axelrod, Cooper, Gaudette, La Du, Mitoma and Uden- 
friend, 1955). 
J. 
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Using a microsomal system prepared from male New Zealand White rabbits 
Mitoma, Posner, Reitz and Udenfriend (1956) investigated the metabolism of 
both aniline and acetanilide. These authors found that aniline was converted 
only , to para-aminophenol, whereas acetanilide was metabolised to all 
three isomers of acetamido-Phenol, although the meta- and ortho-isomers were 
formed in only trace amounts. Surprisingly, these authors claimed that acet- 
anilide was not hydrolysed to aniline by their preparation, whereas this process 
had been observed in the liver of many species,, including rabbit, by Michel, 
Bernheim and Bernheim as early as 1937, and was later shown to be localised 
in the microsomal fraction. 
These microsomal studies showed that the enzymes responsible for hydroxy- 
lating amines and amides required reduced nicotinamide adenine dinucleotide 
phosphate (NADPH) and molecular oxygen, and were inhibited by diethyl- 
aminoethyldiphenylpropylacetate hydrochloride (SKF 525A). A further study 
by Booth and Boyland (1957), using rat liver microsomes, showed that whereas 
acetanilide and 2-acetamidonaphthalene were hydroxylated at the carbon atoms 
furthest from the nitrogen substituent, the corresponding amines were hydroxyl- 
ated also on the carbon adjacent to the nitrogen. In 1961 Posner, Mitoma 
and Udenfriend re-examined the site of hydroxylation of aniline by cat liver 
microsomes, and found that about equal amounts of both para- and ortho- 
aminophenol were formed, whereas this ratio was reported to be "large" when 
rabbit liver was used. These authors reported that the rates of para- and 
ortho-hydroxylation of acetanilide, were equal using either dog or cat 
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microsomes, whereas two hundred times more of the para-isomer was formed 
using rabbit liver microsomes. Thus the wide range of in vivo ratios of para- 
to ortho-amino phenols, previously reported in various species by Parke and 
Wi I liams (1956), Parke (1960) and Piotrowski (1961), was to some extent 
verified in vitro. 
Parke and Williams (1956) suggested that the two hydroxylated derivatives 
of aniline were formed by two separate hydroxylating enzymes. This idea has 
received further support from the work of Bauer and Kiese (1964) who showed 
that the enzymespresent in rabbit liver microsomes, which produced para- or 
ortho-aminophenol from aniline, responded differently to the effects of in- 
hibitors incorporated into the incubation media. Thus, copper chLoride or semi- 
carbazide inhibited orthohydroxylation to a far greater extent than they did 
para-hydroxylation. In keeping with this greater sensitivity of the ortho- 
hydroxylase, it was found that storage of microsomes at 2-3 0C for two weeks 
virtually destroyed this enzyme without affecting the parahydroxy lase. 
Kiese (1959a, 1959b) reported the presence of nitrosobenzene in the blood 
of dogs receiving aniline. This report is of fundamental importance in the 
study of the metabolism of aromatic amines as it clearly indicates that Kiese 
recognised that the aromatic amino-group was vulnerable to metabolic oxidation. 
This N-oxidative ability was shown to be localised in the microsomal fraction 
of liver preparations (Kiese and Uehleke, 1961) and required NADPH and 
molecular oxygen. 
These observations led to a comparison of the processes involved in the 
metabolic N-oxidation and C-oxidation of aniline by liver microsomes, 
(Kampffmeyer and Kiese, 1963,1964), with the conclusion that different 
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enzymes were involved in these hydroxylations. These conclusions were based 
primarily on the different effects of certain substances incorporated into the 
incubation system, e. g. whereas 2,4-dichlorophenol had no effect on N-oxidation 
of aniline, it inhibited p-aminophenol formation by about 70%; a similar effect 
was observed after the incorporation of either D-penicillamine or a, al-dipyridyl. 
Conversely semicarbazide or adenosine triphosphate enhanced the N-oxidation 
whilst inhibiting C-oxidation. 
In these studies N-oxidation was only compared with the para- C- oxidation, 
whereas it was known that orthohydroxylation could occur. Bauer and Kiese 
(1964) concluded that not only are the ortho- and para-hydroxylation mechan- 
isms different., but that these are both differe6t from that involved in the N- 
oxidation of aniline. 
This suggestion of three different hydroxylating mechanisms for these three 
sites of hydroxylation of aniline is at variance with the proposal of Miller and 
Mi I ler (1960). These authors, after the observation that the carcinogen 2- 
acetamidofluorene was metabolised by attack on the amide nitrogen to yield 
the corresponding hydroxamic acid (Cramer, Miller and Miller, 1960) 
suggested that ortho-hydroxylation could arise via a rearrangement reaction. 
Such rearrangements are known to occur with ary1hydroxylamines and hydroxamic 
acids chemically (Hughes & Ingold, 1952) and metabolically (Booth and Boyland, 
1964; Gutmann and Erickson, 1969), but not under the conditions used by Bauer 
and Kiese (1964). This type of rearrangement has been invoked by Boyland, 
Manson and Nery (1963) to account for the metabolic formation of mercapturic 
acids from aromatic amines. 
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Further studies on the mechanism of these hydroxylations, became possible 
following the discovery by Klingenberg (1958) and Garfinkel (1958), of a new 
cytochrome in microsomal preparations. This cytochrome, which was designated 
cytochrome P-450 by Omura and Sato (1962), was later shown to have a central 
role in the oxidation of drugs and foreign compounds by the endoplasmic 
reticulum. These studies showed that cytochrome P-450 acted as a terminal 
oxidase to an electron transport system which consisted of several components, 
the initial one being NADPH: cytochrome C reductase which was linked to 
cytochrome P-450 by a non-haem iron protein (Omura, Sato, Cooper, Rosenthal, 
and Estabrook, 1965). The simplicity of this system has been challenged, and 
the possible involvement of cytochrome b5 in the transfer of a second electron 
has been proposed by Cohen and Estabrook (1971). 
These proposed schemes for the electron transport systems involved in the 
microsomal oxidation of foreign compounds are shown in Figure 1 . 4.3. 
From the above it can be seen that any procedure which interferes with any 
component of these chains could be expected to interfere with microsomal 
oxidations. Conversely any process which results in an increase in the rate- 
limiting component would be expected to enhance these oxidations. 
Thus, generally, oxidations involving an attack on a carbon atOm are 
inhibited by the Presence of carbon monoxide in the atmosphere and enhanced 
by pretreatment of the animal with certain agents,, e. g. phenobarbitone or 
3-methylcholanthrene. Carbon monoxide forms a complex with cytochrome 
P-450 and prevents it participating in oxygen activation, whilst both pheno- 
barbitone and 3-methylcholcnthrene enhance the synthesis of microsomal haem 
from 6-aminolaevulinic acid. 
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Kampffmeyer & Kiese (1965) investigated the metabolism of aniline in the 
presence of a carbon monoxide plus oxygen atmosphere and found that, whereas 
the formation of p-aminophenol was inhibited, the oxidation on the aromatic 
nitrogen was unimpaired. This observation gave rise to a generalisation that 
nitrogen oxidation was different to that of carbon oxidation., the latter utilizing 
the cytochome P-4k system, whilst the nitrogen oxidising system seemed to be 
able to function without cytochrome P-450. This theory was strengthened when 
Ziegler, McKee & Poulsen (1973) showed that a purified amine oxidase from pig liver 
was able to N-oxidise aromatic amines. This purified flavoprotein amine oxidase 
was devoid of cytochrome P-450. However., the situation is more complex. 
Uehleke and Brill (1968) have reported an increase in the excretion of N-oxidation 
products of aromatic amines in animals which were pretreated with phenobarbitone, 
thus implicating the cytochrome P-450 system (as the flavoprotein is non-inducible). 
In an attempt to rationalise these and many other observations, Gorrod (1973) 
proposed that basic amines were predominantly N-oxidised by Ziegler's flavo- 
protein enzyme, whilst the non-basic amides were N-oxidised by the cytochrome 
P-450 system. As aromatic amines have pKa values intermediate between 
aliphatic amines and amides it was further proposed that they may very well be 
substrates for both enzymes yielding the same products by different mechanisms. 
The actual enzyme involved would then depend upon the species distribution of 
the enzymes and the affinity of the aromatic amine towards the individual 
oxidases. 
Recently, Lotlikar, Wertman and Luha (1973) and Lotlikar, Luha and Zaleski 
(1974) have clearly shown that cytochrome P-450 is involved in the N-hydroxyla- 
tion of 2-acetamidofluorene. However, this molecular species of cytochrome 
P-450 
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must be different to that involved in the oxidation of the carbon sites of 2- 
acetmidofluorene as this latter N-oxidative process is lacking in the guinea 
pig, a species well able to hydroxylate the other sites on the molecule. 
In view of the foregoing discussion it seems peculiar that aniline p-hydroxylase 
is sti II used as a "marker" enzyme for studies on the mechanism of oxidation, or 
for investigating the influence of physiological or pathological parameters on drug 
metabolising enzymes. In these cases only the p-hydroxylase is measured, the 
other sites being completely ignored. 
A further complication arises in our understanding of the microsomcl mechan- 
ism of aromatic amine oxidation. It is known that substances capable of under- 
going oxidation are capable of interacting with microsomal cytochromes to give 
either a Type I or Type 11 spectra I change (Remmer, Schenkman, Estabrook, 
Sasame, Gillette, Narasimhulu, Cooper & Rosenthal, 1966) and that these 
changes are concentration dependent (Schenkman, Remmer & Estabrook, 1967). 
(Fig. 1 . 4.4. ). These 
latter authors have suggested that the Type I spectral 
change is caused by an interaction with the enzyme protein and/or lipid and 
results from a conformational change; the Type 11 change is thought to be the 
result of a direct interaction with microsomal haem at the same site as that 
normally occupied by oxygen. Primary aromatic amines all give a Type 11 
spectral interaction (Temple, 1971) and this is thought to occur by donation 
of the lone pair of electrons to allow the base to act as the sixth 
ligand of the 
iron in the protoporphyrin. Support for the involvement of these electrons 
comes from the observation of Gorrod, Temple and Disley 
(1971) who showed 
that as the pKa of para-substituted anilines was reduced, so the spectral 
ih microsomal cytochrome at a fixed concentration (I mM) of interaction wit 
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amine, decreased. 
If indeed, the nitrogen of aromatic amines is attached to the cytochrome 
iron, it is difficult to envisage how the oxygen is able to oxidise the molecule. 
A partia I explanation of this problem was offered by Gorrod and Temple- (1973), 
who, by the use of spectral modifierswere able to show that the observed 
spectra of anilines were in fact composite spectra with at least two components. 
These authors suggested that the Type I component was an indication of the 
binding site which allowed oxidation. This observation would also explain the 
finding (Sche, nkman et al, 1971) that whereas substances which gave a Type I 
interaction gave a good correlation between the Km and Ks values, aniline 
(which gives a Type 11 interaction) did not. 
It is also known that in vitro metabolism is greatly affected by the 
incorporation of certain other chemicals into the incubation media. Thus, 
acetone is known to enhance the parahydroxylation of aniline (Anders, 1968; 
Vainio & Hannineq 1972), whereas alcohols are known to inhibit this reaction 
in vitro (Cohen & Mannering, 1973). 
In aI ddition, the aniline parahydroxylase activity is dependent upon the 
nutritional status of the animal (Wade, Wu & Lee, 1975) and can be greatly 
increased by pretreatment of the animals with urethane (Schenkman, Ritchie, 
Cha & Sartorelli, 1974). 
At the present time, whilst a great deal of information has accrued regard- 
ing the metabolism of aromatic amines, there is still a paucity of knowledge 
regarding the molecular mechanism of their oxidation. 
The metabolism of certain specific carcinogenic amines will be discussed 
in Section 1 . 6. 
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1.5 der Cancer and Tryptophan 
In previous sections the relationship between exposure to aromatic amines 
and cancer production in various biological systems has been established. In 
man the clinically recognised condition, after exposure to certain of these 
substances, was cancer of the urinary tract. Aromatic amines are used in 
various industries, and therefore, a certain proportion of the tumours recog- 
nised in a population can be related to industrial exposure. However, the 
majority of a population are not employed in these industries, nor exposed to 
the compounds discussed earlier, yet tumours of the urinary tract still develop. 
This fact suggested that if cancer of the urinary tract was produced by a 
metabolite of an exogenous amine then the "spontaneous" disease might be 
caused via an analogous endogenous compound. 
In biological systems, few aromatic amines occur naturally; p-amino- 
benzoic acid is involved in the biosynthesis of folic acid and anthranilic acid 
is converted to tryptophan by some organisms. In man, urinary aromcrtic amines are 
derived mainly from the metabolic breakdown of tryptophan. 
Early studies had shown that the site and frequency of tumour development was 
often dependent on the protein content of the animal diet, and that in some cases 
riboflavin supplements exerted a protective effect. It was against this background 
that Dunning, Curtis and Mavn (1 950a) reported on the i nf I uence of D L- 
tryptophan added to a synthetic diet containing twenty-five percent tryptophan.. 
free casein hydrolysate, an the subsequent development of tumours in rats 
receiving diethylstilboestrol. These authors reported that supplementation of 
a diet with 1 . 
4% D, L-tryptophan increased the number and percentage of induced 
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mammary tumours, and significantly reduced the average latent period. When 
the tryptophan supplement was increased to 4% the reverse effect was observed, 
viz. a decreased number and percentage of tumours and a significantly pro- 
longed latent period. These same authors (1950b) extended their study to 
examine the influence of added tryptophan on the occurrence of liver and 
bladder cancer in rats, induced by 2-acetamidofluorene (0.06%) added to the 
diet. In this case, addition of 1 . 4% or 4.3% tryptophan to a tryptophan-free 
casein hydrolysate -containing diet, increased the number of liver tumours 
from 35% to about 70%. At the same time, al I the rats receiving 1 . 4% trypto- 
phan developed bladder tumours, as did 90% of those receiving 4.3% tryptophan 
supplement. The control rats which received equivalent casein, in addition to 
the 0.06% 2-acetamidofluorene,, never developed bladder tumours. 
In further experiments, Dunning & Curtis (1958) confirmed their earlier 
observations and showed that both indole and indoleacetic acid also had the 
ability to produce urinary bladder neoplasms in rats with diets containing 
2-acetamidofluorene. 
The effect of dietary tryptophan supplements on tumour production by 
nitrosamines has been studied by Japanese workers, and has given certain 
ambiguous results. Tryptophan appears to have a synergistic effect on the 
production of urinary bladder tumours in rats induced by N-butyl-N-(4- 
hydroxybutyl)-nitrosamine (Okajima, Hiasa, Imoto, Hiramatsu and Ito, 1968), 
and on the production of hepatomas in rats receiving N- ni trosodi ethyl ami ne 
(Kawachi, Hirata and Sugimura, 1968). In another study by the former group 
1, 
(Okaj ima et al. 1971), no synergistic effect was found between supplementary 
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tryptophan and bladder tumour production in rats which were also fed the 
bladder carcinogen N-nitrosodibutylamine. In these experiments the tTyp- 
tophan had a protective effect against the production of the liver tumours 
normally additionally found with N-nitrosodibutylamine. 
The idea that tryptophan may protect the liver and encourage dietary 
hepatocarcinogens to be excreted in the urine, and thus produce their 
carcinogenic effects in the bladder, is considered by Weisburger, Hadidian, 
Fredrickson and Weisburger (1967). 
More recently Radomski, Glass and Deichmann (1971) have shown that dogs 
fed a diet supplemented with six grams of D, L-tryptophan daily, developed 
marked focal hyperplasia of the transitional epithelium of the urinary bladder. 
This level of the amino acid increased the normal daily intake by about seven- 
fold, but did not produce carcinoma even though the diet was continued for 
seven years. 
The metabolism of tryptophan is rather more complex than the metabolism 
of simple aliphatic amino acids, as in addition to deamination and decarboxyl- 
ation, normally found with amino acids, ring hydroxylation and ring f ission of 
the indole nucleus can occur. 
These products can be further metabolised by a wide variety of reactions, 
as shown in the general scheme of Figure I . 5.1, to produce nicotinic acid and 
thence nicotinamide. This route, which is known as the tryptophan-nicotinamide 
pathway, produces several aromatic amines as intermediates. The first step in 
this pathway is the o; i dative fission of tryptophan to formylkynurenine which 
is mediated via the enzyme tryptophan pyrrolase. This compound is rarely 
I 
detected in biological systems since the formyl group is easily removed by 
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kynurenine formamidase to produce kynurenine. Kynurenine is hydroxylated 
to form 3-hydroxykynurenine which is cleaved by kynureninase to yield 
3-hydroxyanthranilic acid. This enzyme, which I 
requires pyridoxa 1-5- phosphate, is also able to split kynurenine to anthranilic 
acid, although this appears to be a minor pathway. 3-Hydroxyanthranilic acid 
is then enzymically cleaved to form cL-amino-g-carboxymuconic-E-semialdehyde, 
which either spontaneously cyclises to give quinolinic acid, or is enzymically 
converted to picolinic acid and carbon dioxide (Nishizuka, Ichiyama, Gholson 
and Hayaishi, 1965). 
In addition to this major pathway, tryptophan metabolites undergo many side 
reactions, thus kynurenine and 3-hydroxykynurenine are acetylated on the 
cL-amino group, and both are substrates for a pyridoxal-5- phosphate dependent 
transaminase converting them to the corresponding a-keto-acids. These keto- 
acids then spontaneously cyclise to kynurenic acid and xanthurenic acid 
respectively. From the foregoing it can be seen that several aromatic amines 
are formed as metabolites of tryptophan. Additionally, Dalgliesh (1955) 
has 
indicated that 2-amino-3-hydroxyacetophenone is another aromatic amine, 
derived from tryptophan, which is sometimes present in human urine. 
As early as 1941 some evidence indicated that this metoboiic pathway could 
be involved in certain pathological conditions. Lepkovsky and 
Nielsen (1942) 
showed that pyridoxine-deficient rats excreted 
large amounts of xanthurenic 
acid. Otani, Nishino and Imai (1941) found that about 
25% of patients with 
pulmonary tube rculosis excreted kynurenine when given 
0.5g of tryptophan, 
whereas this substance was not found in control subjects under 
the same dosage 
0 
regimen. However, it was not until the elucidation of 
the full metabolic 
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pathway and the development of a sensitive specific method for the analysis of 
these compounds that the role of tryptophan metabolism in certain conditions 
was established. 
In 1952 Musajo, Spada and Coppini re-investigated the excretion of trypto- 
phan metabolites in subjects with tuberculosis, and found that 11 out of 13 
patients excreted 3-hydroxyanthranilic acid even without any tryptophan supple- 
ment. This observation was really the forerunner of many experiments designed 
to implicate 3-hydroxyanthranilic acid and some other tryptophan metabolites 
in disease states. Because of the variations in analyticai techniques used (and 
other factors) some variation in the daily excretion of these compounds, in 
normal populations, was apparent (See Table 1 . 5.1). 
Because of the wide variation, both in amounts and type of metabolite 
excreted, it is now common practice to supplement the subjecA diet with 
tryptophan in this type of study. This is done with the intention of minimising 
dietary varictions and saturating the enzymes utilising tryptophan metabolites 
as substrates. Results obtained under these conditions therefore more correctly 
represent the potential of an individual to utilise a particular metabolic 
pathway. 
The earliest indication that endogenous aromatic amines could be involved 
in the etiology of non-industrial bladder cancer came from the observation of 
Ekman and Stro"mbeck (1947). These workers found unidentified diazotisable 
aromatic amines in the urines of bladder cancer patients. Later Boyland and 
Williams (1956) reported that urinary excretion of 3-hydroxyanthraniiic acid 
was elevated in patients with bladder cancer. This observation was confirmed 
by Quagliariello, Auricchio, Casale & Tancredi (1958) and Tompsett (1959), 
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Table 1.5.1. The urinary excretion of some tryptophan metabolites in control 
i J? 2p uIa fti o, n.!, 
_ 
TRYPTOPHAN METABOLITE Urinary excretion (mg/24 hr) 
kynurenine 
N,. -acetylkynurenine 
3-hydroxykynurenine 
3-hydroxykynureni. ne-o-sulphate 
kynurenic. acid 
xanthurenic acid 
gnthranilic acid, 
o- arninohippuric acid 
abcd f* 9h 
2.5 3.1 1.14 14.5 15 
3.0 ---- 
6.0 3.3 0.39 0.3-2.3 3.5 3 
7 
2.1 2.83 - 
2.1 - 0.66 - 
- 0.9 - 18 
4.7 0.62 
3-hydroxyanthranilic acid 5.2 0.3 0.3-0.9e 
3-hydroxyanthranilic acid-O-sulphate -- 
30 1-15 
12 - 
a) Price (1958) e) Watanabe & Hayashi (1972) 
b) Tompsett (1959) f) Fletcher (1966) 
c) Bennassi, Veronese & Scoffone g) Boyland & Williams (1956) 
(1963) 
d) Watanabe, Watanabe & Okada h) Rose & Toseland (1967) 
(1970) 
* After subjects received 2g. L-Tryptophan 
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but other authors were not able to substantiate these findings. In Italy, Bennassi, Per- 
issinotto and Allegri (1963) found that only 30% of bladder cancer patients 
excreted abnormal amounts of tryptophan metabolites. Kynurenine and 3-hydroxy- 
kynurenine were the most frequently elevated, whereas the 3-hydroxanthranilic 
acid level was abnormal in only 4 of the 201 cases studied. This finding is in 
contrast to that of Alifano, Papa, Tancredi, Elicio and Quagliariello (1964) who 
reported that 93% of their bladder cancer patients excreted elevated levels of 3- 
hydroxyanthranilic acid. 
Other studies by Brown, Price, Satter and Wear (1960) showed that only 
about half of the patients they examined had abnormal tryptophan metabolism. 
These patients excreted more kynurenine, 3-hydroxykynurenine and acetyl- 
kynurenine than did a control population. 3-Hydroxyanthranilic acid was not 
measured in this study. 
Treatment of these cancer patients with vitamin B6 (pyridoxine) virtually 
normalised the urinary excretion of these metabolites. As pyridoxal phosphate 
is known to be a cofcctor in both transaminase and kynureninase reactions, this 
result suggests that dietary deficiency may play a major role in the development 
of abnormalities of tryptophan metabolism. If this were so, it could account 
for the variations observed in subjects of different socio-economic backgrounds. 
However, it seems unlikely that vitamin B6 deficiency would account for Boyland 
and Williams' (1956) observations, as their patients were selected from a well 
developed society on a North European diet. 
The finding that certain of these tryptophan derivatives were carcinogenic 
or blastomagenic in certain systems, allowed the general concept that these 
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metabolites could be invoked in the induction of human bladder cancer. 
However, several observations are at variance with this idea. It is known 
that tryptophan metabolism is greatly influenced by the circulating levels of 
certain steroid hormones (Rose and McGinty, 1970) and hydrocortisone 
(Tenconi and Pasquariello, 1967). Therefore one might expect a correlation 
between physiological conditions which alter these levels and the production 
of bladder cancer. 
Such a situation arises in a comparison between the sexes, and in the 
development of the individual. Rose (1967) has shown that young women 
excrete significantly greater amounts of 3-hydroxyanthranilic acid and 3- 
hydroxykynurenine than do males, yet females tend to have a much lower 
frequency of cancer of the bladder. In other work, Rose and Toseland (1967) 
and Toseland and Price (1969) have clearly shown that women taking oestrogen- 
progestogen preparations,, as contraceptives, excrete between two and four 
times as much 3-hydroxyanthranilic acid as matched subjects not on these 
preparations. As yet there is no indication that women using oral steroid con- 
traceptives are at a greater risk than those not on the 'Pi 11. This aspect of 
tryptophan metabolism is further discussed in papers by Rose (1971) and Moursi, 
Abdel-Daim, Kelada, Abdel-Tawab and Girgis (1970). 
Fletcher (1966) reported that the elevated excretion of 3-hydroxykynurenine 
was a secondary feature of many pathological conditions and no real difference 
could be associated with those patients suffering from a neoplastic disease. 
Similarly the inherited metabolic disorder, hydroxykynureninuria (Komrower, 
Wilson/ Clamp and Westall, 1964) or the skin disease discoid lupus erythematos 
(Mandel and Appleton, 1964), in which high levels of 3-hydroxykynurenine are 
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excreted, are not considered premalignant states leading to bladder cancer. 
However, despite these objections there still remains substantial evidence i 
that aromatic amines derived from tryptophan play a role in human neoplastic 
disease. Studies in the Soviet Union by Raushenbach (1969) and I'vanova (1964) 
clearly implicate the involvement of 3-hydroxyanthranilic acid in adult leukaemia. 
In further studies on bladder cancer Yoshida, Brown and Bryan (1970) showed that 
bladder cancer patients with abnormal tryptophan metabolism develop recurrent 
neoplasms far more frequently than those patients with normal tryptophan meta- 
bo I ism. 
It may be that further metabolism of certain of these compounds occurs and 
that these processes mask the importance of a certain metabolic route in a 
particular disease. It is known that 3-hydroxyanthranilic acid is converted to 
cinnabarinic acid in the urine of patients with bladder cancer (Nishimura, 
Pipkin, Duke and Schlegel, '1969), and is also conjugated with glucuronic 
and sulphuric acids (Watanabe and Minegishi, 1972; Watana6e, Ohkubo and 
amura, 1972, Watanabe, Minegishi and Tsu tsui, 1972). 
In view of the structural similarity between these endogenous compounds 
and known carcinogenic metabolites of carcinogenic aromatic amines (see 
Section 1 . 6), it seems 
likely that they are implicated in the spontaneous 
production of urinary bladder tumours. The elucidation of their total role in 
this disease awaits the development and application of new specific analytical 
methods. 
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1.6 Nature of "Active" Metabolites 
Despite the early suggestions that hydroxylated metabolites of aromatic amines - 
may be responsible for initiating the carcinogenic process following exposure to 
aromatic amines (Leuenberger, 1912 and Engel, 1920) it was not until 1953 that 
Clayson put forward the " orthoami no- phenol" hypothesis of amine carcinogenesis. 
Clayson's hypothesis was based on his studies of 2-naphthylamine metabolism 
where he found that a good correlation existed between the percentage of admin- 
istered 2-naphthylamine excreted as 2-amino- I -naphthol derivatives and the 
susceptibility of the species towards bladder cancer. This hypothesis gained further 
support when a number of aromatic amines and some of their hydroxylated deriva- 
tives were tested for local carcinogenic activity by direct implantation of the 
compounds into the lumen of the urinary bladders of mice (Bonser, Clayson, Jull 
and Pyrah, 1952; Boyland & Watson, 1956; Allen, Boyland, Dukes, Horning 
and Watson, 1957; Bonser, Boyland, Busby, Clayson, Grover and Jul 1,1963; 
Boyland, Busby, Dukes, Grover and Manson, 1964). Essentially, these publica- 
tions showed that under these conditions of testing most parent aromatic amines 
were virtually inactive, whereas the ortho-hydroxylated derivatives produced 
high yields oF local tumours. 
In addition, compounds which could produce "orthoamino-phenols" in situ by 
enzymic hydrolysis, e. g. 2-amino-l-naphthylglucosiduronic acid, or by oxidative 
dealkylation, e. g. 2-amino-l-methoxynaphthalene were also active. Compounds 
hydroxylated at positions other than ortho- to the amino group were inactive. It 
was during these studies that the "orthoamino-phenols" 
derived from tryptophan 
were shown to be carcinogenic. 
-63- 
The early results cited above led Boyland (1958) to review the biochemistry 
of amine carcinogenesis and suggest that the following sequence of events led 
to the release of the local active agent either in or adjacent to the bladder 
epithelial cells: 
I. Amine absorbed and transported to liver 
2. Amine hydroxylated and conjugated in liver 
3. Aminophenol conjugate excreted in urine 
, 
4. Aminophenol conjugate enzymically hydrolysed. 
As Boyland, Manson, Sims and Williams(1956) had found that sulphate con- 
jugates of "orthoamino-phenals" were resistant to hydrolysis by various aryl- 
sulphatases, the glucosiduronic acid conjugates were considered to be the most 
likely precursor of the arninophenol. 
In the mouse bladder implantation experiments, 2-amino-1 -naphthol- 
glucosiduronate was even more active than 2-amino-I -naphthol hydrochloride 
in producing turnours. In 1958 Troll and Nelson detected a phosphate derivative 
of 2-naphthylamine in the urine of 2-naphthylamine treated dogs. This phosphate was 
subsequently synthesised and characterised as bis-2-amino-l-naphthylphosphate 
by Boyland, Kinder and Manson (1961) and later shown by bladder implantation 
to also be a carcinogen. Whilst both the glucosiduronic acid and phosphate 
derivatives of 2-amino-I -naphthol have been detected in those species susceptible 
to the carcinogenic effect of 2-naphthylamine, no phosphate conjugate has been 
detected which is derived from any other amine bladder carcinogen. 
Further studies on the metabolism of 2-naphthylamine in various species did 
not produce the complete correlation between structure and activity which was 
hoped for. For example, the rabbit which does generate bladder tumours after 
Pynnsure to 2-naphthylamine excretes very 
low levels of 2-amino-I -naphthol 
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conjugates; whereas the mouse which generates hepatomas and is resistant 
to bladder tumour formation excretes high levels of 2-amino- I -naphthol I 
conjugates. Urine from this species contains adequate levels ofg -glucuron- 
idase to release 2-amino-I -naphthol (Boyland and Williams, 1960). 
Another objection to the" ortho-ami nophenol "hypothesis is that I-naph- 
thylamine is usually considered a non-carcinogen in most species, and yet I- 
amino-2- naphthol conjugates are excreted. These would be expected to be 
hydrolysed to I-amino-2-naphthol, a compound which is carcinogenic upon 
bladder implantatic5n. 
Conversely, a number of ortho, -hy'droxylated derivatives of known carcin- 
ogenic compounds were found to be inactive in mouse bladder implantation 
tests and when incorporated into the diet of experimental animals. 
In 1960, Cramer, Miller and Miller discovered that the hepatocarcinogen, 
2-acetamidofluorene was metabolically N-hydroxylated to form the correspond- 
ing hydroxamic acid. This was reminiscent of the N-oxidation of aromatic amines 
earlier described by Kiese (1959) and when N-hydroxy-2-acetamidofluorene was 
shown to be a powerful carcinogen, ary1hydroxylamines became the logical 
candidates as the local carcinogen derived from aromatic amines. Indeed, 2- 
naphthy1hydroxylamine produced tumours in the mouse bladder implantation test 
and subsequently Boyland, Dukes and Grover (1963) showed that it produced 
abdominal tumours after intraperitoneal administration to rats. 
Since this time many N-hydroxyamides have been tested and shown to possess 
potent carcinogenic activity, but further work with ary1hydroxylamines has again 
failed to convince that they are an absolute prerequisite as an intermediate in 
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amine carcinogenesis. Clayson (1965) reported that 2-naphthy[hydroxylamine 
was inactive in skin painting experiments in mice and Boyland, Dukes and 
Grover (1964) showed that this compound failed to produce tumours when 
administered to quinea. pigs in high doses. When it is remembered that many 
non-carcinogenic aromatic amines are also excreted as ary1hydroxylamine 
metabolites, and that some of these have been shown to be highly carcinogenic 
or mutagenic in other systems., then their role in amine carcinogenesis is complex. 
The further metabolism or reactivity of either ortho-aminophenols or aryl 
hydroxylamines may be important factors in deciding whether a tumour wi II 
ultimately be produced. In the case of ortho-aminophenols it has been proposed 
that a quinoneimine, produced by oxidationis the reactive agent (Nagasawa 
and Gutmann, 1959). However, from 3-hydroxyanthranilic acid and 4-amino- 
3-hydroxybiphenyl, phenoxazones are easily formed by oxidation (Nagasawa, 
Gutmann and Morgan, 1959). Some phenoxazones have been tested and shown 
to possess carcinogenic activity. Aryl hydroxylamines can be oxidised in vivo 
to nitroso-compounds which in some cases are carcinogenic (Hecker, Traut and 
Hopp(] 968) orthey may rearrange to produce a reactive ary1carbonium ion 
(Boyland, Manson and Nery, 1963). Alternatively, nitrene (Rose, 1967) and 
nitroxide (Bartsch, Traut and Hecker, 1971) radicals have been suggested as 
being the local agent derived from aryl hydroxylamines. 
The reactivity of some of these metabolites and their oxidation products 
with cellular macromolecules, and the possible role of these reactions 
in amine 
carcinogenesis will be discussed further in 
Section 9. 
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1 
.7 Aims of the Present Investigation 
Although there have been many studies on the metabolism of aromatic amines 
and amides, few comparative studies of both an aromatic amine and its derived 
amide have been carried out using in vitro microsomal systems. One of the aims 
of the present investigation will be to examine the in vitro metabolism of the 
carcinogens 4-aminobiphenyl and 4-acetamidobiphenyl. 
As some evidence in the literature suggests that amines and amides may be 
metabolised at different sites on the molecule, it is considered desirable to 
examine the biological acetylation of some amines and the deacetylation of 
the corresponding amides. In view of the 'ortho-aminophenol hypothesis" of 
amine carcinogenesisand the resistance of the sulphate conjugates to enzymic 
hydrolysis, it is considered desirable to examine the species variation in 
glucuronyl transferase towards 4-amino-3-hydroxybiphenyl. This should give an 
indication of the potential amount of this glucuronide conjugate excreted in 
the urine of certain species, and may correlate with their susceptibility towards 
cancer of the urinary bladder, providing an active g-glucuronidase can be 
demonstrated in the urine . 
As the dog is unable to acetylate aromatic amines, and as this species is 
susceptible to the carcinogenic action of some amines, it is thought that a 
hydroxylated derivative of the amine (rather than the amide) is likely to be the 
local carcinogenic agent. In order to gain evidence for or against this view it 
is proposed to carry out tests of the carcinogenicity of some hydroxylated 
derivatives of 4-aminobiphenyl. 
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A recent view on the mechanism of action of amine metabolites in 
initiating the carcinogenic process implicates the interaction of the I 
metabolite with a specific cell organelle - the lysosome. As lysosomes 
vary in their properties, both from species to species and from organ to 
organ, any support for this idea would require the interaction of the active 
metabolite with lysosomes prepared from specific target organs. It is there- 
fore proposed to investigate this hypothesis by examining the interaction of 
a series of carcinogenic and non-carcinogenic amines, and some hydroxyl- 
ated derivatives, with a lysosomal preparation derived from the epithelial 
cells of the dog urinary bladder. 
The results obtained from proposed investigations will then be discussed 
in relation to the overall situation of the mechanism of amine carcinogenesis. 
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SECTION 2 THE "IN VITRO" HEPATIC OXIDATIVE METABOLISM OF 
4-AMINOBIPHENYL AND 4-ACETAMIDOBIPHENYL 
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2.1 INTRODUCTION 
4-Aminobiphenyl and 4-acetamidobiphenyl are both compounds which have 
been shown to be carcinogenic in a variety of animal species. The former 
compound has also been implicated as a factor in the etiology of certain 
human bladder tumours produced in specific industrial environments (see sections 
I and 6). Various animal species differ in their susceptibility towards the 
carcinogenic effects of these compounds, and even in sensitive species, the 
carcinogenic response may be elicited in different organs, depending upon 
whether the animal was exposed to the amine or amide (for fuller discussion 
and details see Sections I and 6). 
As these compounds produce their effects in organs anatomically distant 
from the site of administration J, it is probable that a metabolite., rather than 
the parent compound, is involved in initiating the carcinogenic process. It 
was with a view to understanding the role of their metabolites in amine, or 
amide carcinogenesis that previous studies on the metabolism of 4-aminobiphenyl 
and 4-acetamidobiphenyl were undertaken. 
Bradshaw and Clayson (1955) identified 4-amino-3-biphenylyl sulphate, 
as the only metabolite detected, in the urine of dogs fed 4-aminobiphenyl, 
indicating that hydroxylation of the nucleus ortho to the amino group had 
occurred. This metabolite was also detected in the urine of most other species 
fed 4-aminobiphenyl (Bradshaw 1955,1959). The percentage of the dose of 
4-aminobiphenyl, excreted as 4-amino-3-biphenylyl sulphate in the urine, 
varied according to the species examined. The dog, rat, hamster and mouse 
excreted 40,5,2 and I% of the dose respectively, as 4-amino-3-biphenylyl- 
sulphate, whereas in the urine of guinea pigs receiving 4-aminobiphenyl, no 
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4-amino-3-biphenylyisulphate 
was detected. The metabolism in vivo of 
4-aminobiphenyl (Bradshaw, 1957,1959) was further studied in the rabbit. 
This worker using paper chromatographic techniques, found no unconjugated 
4-amino-3-hydroxybiphenyl or 4-amino-2'-hydroxybiphenyl or their N- 
acetyl derivatives were present in urine, whereas the rabbit excreted both 
4-amino-4'-hydroxybiphenyl and 4-acetamido-41-hydroxybiphenyl. 
Whether 4'-hydroxylation preceded N-acetylation or vice-versa, or whether 
direct 4'-hydroxylation of 4-aminobiphenyl occurs, could not be established 
in this in vivo study. Elson, Goulden and Warren (1958) had observed a 
considerable rise in the urinary excretion of glucuronic acid following 
administration of 4-aminobiphenyl to rats, so the possibility arose that 4- 
aminobiphenyl was excreted as conjugates of glucuronic acid as well as the 
su I phate ester detected by Bradshaw and C layson (1955). 
Studies on the metabolism of 4-acetamidobiphenyl in vivo (Wyatt, Miller 
& Miller, 1961; Miller, Wyatt, Miller & Hartmann, 1961) showed that both 
rats and dogs excrete N-hydroxy-4-acetamidobiphenyl as a glucuronic acid 
conjugate. The same metabolite was found in the urine after administering 
4-aminobiphenyl to rats, but not when the amine was given to dogs. This 
latter finding is explicable in view of the inability of the dog to acetylate 
aromatic amines (see Section 4). In the urine of one dog fed 4-aminobiphenyl 
Mi I ler, Wyatt, Mi I ler and Hartmann (1961) detected a labi le co., -npound which 
they tentatively suggested was a conjugate of 4-hydi-oxylaminobiphenyl. These 
authors also report that the same metabolites were found in rat urine irrespective 
of whether 4-aminobiphenyl or 4-acetamidobiphenyl was fed to the animals, 
indicating to them the ease of acetylation of 4-aminobiphenyl by the rat. 
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The possible hydrolysis of 4-acetamidobiphenyl to 4-aminobiphenyl was not 
discussed. The metabolites detected were not fully characterised, but 
because of their reactivity with Folici-Ciocaltedweagent, and their ability 
to couple with diazonium reagents,, they were thought to be phenolic com- 
pounds. By analogy with the known sites of hydroxylation of 2-acetamido- 
fluorene it was suggested that hydroxylation had occurred at the 3,2' and 
position of 4-acetamidobiphenyl. 
The finding of N-hydroxylated metabolites of carcinogenic aromatic 
amides (Cramer, Miller & Miller, 1960 and discussion above) stimulated 
investigations as to whether carcinogenic amines could also be N-oxidised. 
Kiese (1959a & b) had previously shown that aniline was converted to 
nitrosobenze-ne by cats and dogs in vivo. Troll and Nelson (1961) found N- 
hydroxy derivatives of 2-naphthylamine in the urine of dogs and patients 
exposed to the amine. 4-Aminostilbene (Miller & Miller, 1962) and 
benzidine (Troll, Belman & Rinde, 1963) were also found to be excreted 
in several species as N-hydroxyiated metabolites. 
Uehleke (1961a) was able to carry out the N-hydroxylation of aniline and 
some N-alkylanilines in vitro using rat hepatic microsomal preparations 
fortified with NADPH and oxygen. Uehleke (1961b, 1961c) extended 
his 
study to the N-hydroxylation of 2-aminofluorene and 2-naphthylamine 
in 
vitro. Irving (1962a & b) examined the N-hydroxylation of 
2-acetamido- 
fluorene in vitro by rabbit liver microsomes. 
The N-hydroxylation of 4-aminobiphenyl in vitro was first observed by 
Uehleke (1963,1964 a& b) using rat liver microso: nes fortified with NADPH 
and oxygen, and in the same publications 
detected 4-nitrosobiphenyl in the 
blood oF cats receiving 
4-aminobiphenyl. 
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The first systematic study of the in vitro metabolism of 4-aminobiphenyl 
and 4-acetamidobiphenyl was reported by Booth and Boyland (1964) using 
rabbit liver preparations. In this species hydroxylation of both 4-amino- 
biphenyl and 4-acetamidobiphenyl was observed using the microso-Mal system 
as enzyme source, however the site of nuclear oxidation varied depending 
upon the substrate. Metabolic hydroxylation of the nitrogen atom was 
observed using the rabbit microsomal system with both substrates. Whereas 
4-aminobiphenyl was oxidised only on the carbon atom ortho to the 
nitrogen (3), in contrast 4-acetamidobiphenyl was only oxidised in the 
peri-para position (41). 
Booth and Boyland (1964) also showed that both rat and rabbit hepatic 
soluble preparations, free of microsomal hydroxylating activity, were able 
to enzymically isomerise the N-hydroxylated derivatives of both 4-amino- 
biphenyl and 4-acetamidobiphenyl to -yield the corresponding ortho-hydroxylated 
amine and amide respectively. Further, these authors were able to show that 
rabbit microsomal preparations were able to hydrolyse 4-acetamidobipkienyl as 
well as N, -3- and 4'-hydroxy-4-acetamidobiphenyl. This microsomal de- 
acetylating system was inhibited by the incorporation of potassium fluoride 
into the incubation medium. It became clear from this study that hydroxylation 
could appear to have. taken place at a certain position on the 4-aminobiphenyl 
nucleus, whereas in practice it had either been hydroxylated in the corres- 
ponding position in 4-acetamidobiphenyl and subsequently hydrolysed, or 
hydroxylation of the nitrogen atom in the molecule and subsequent isomerisation 
and, /or hydrolysis had occurred. 
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This work also showed that by the use of suitable precautions, such as 
using washed microsomal preparations, or by adding fluoride to the incubate, 
# 
these secondary metabolic processes could be eliminated. The metabo! ic 
reactions of 4-aminobiphenyl and 4-acetamidobiplhenyl observed by Booth 
and Boyland (1964) are shown in Figure 2.1 .1. 
The N-hydroxylation of 4-aminobiphenyl by hepatic rabbit microsomes 
in vitro was confirmed by Uehleke and Nestel (1967) who -also showed that 
this reaction was carried out by rat liver microsomes, although at a slower 
rate than in the rabbit liver preparations. The N-hydroxylating activity 
of rabbit liver microsomes towards 4-aminobiphenyl was shown by these authors 
to be greatly enhanced if the animal had been pretreated with phenobarbital. 
other sites oF oxidation of the 4-aminobiphenyl molecule were not studied 
by Uehleke and Nestel (1967). The early indication that 4-hydroxylamino- 
biphenyl was present in dog urine after the administration oF 4-aminobiphenyl 
(Miller, Wyatt, Miller and Hartmann, 1961) has been confirmed on several 
occasions (Fefer, Bri II and Radomski, 1967; Radomski and Bri 11,1970; Bri II 
and Radomski, 1971; Radomski and Bri I 1,1971). More recently Rado-. -nski, 
Conzelman, Rey and 3rill (1973) have shown that monkeys given 4-amino- 
biphenyl excrete 4-hydroxylaminobiphenyl as well as N-hydroxy-4-acetamido- 
biphenyl; in the dog the acetylated metabolite was not detected. In the 
; dog 4-hydroxylaminobiphenyl was excreted as an acid 
labile glucuronic acid 
conjugate (Radomski, Rey & Brill, 1973). 
A further minor metabolite of 4-acetamidobiphenyl has been recognised 
in which the acetamido group is oxidised to the cot-responding glycolamide 
(Fries, Kiese & Lenk 1971,1973). Further oxidation of this glycolamide to 
N- 
biphenylyloxamic acid has not been observ,. =., d (Lenk, 1972) 
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In view of the known differences in species susceptibility to carcinogenesis by 
4-aminobiphenyl and 4-acetamidobiphenyl, and the recognised differences of various 
species to hydroxylate compounds at different positions on a molecule, it is obviously 
desirable to extend the observations of Booth & Boyland (1964) to species other than the 
rabbit. In order to ascertain the relative importance of the various route of metabolism 
of 4-amino and 4-acetamidobiphenyl it is proposed to develop methods for the qua-, r%rrf4-. hon 
of thei r m- etabol i tes. 
Previous methods used for the determination of ary1hydroxylamines include reaction 
with salicylaldehyde plus potassium ferrocyanide or complexing with sodium pentacyano- 
ammine ferroate (Boyland & Nery, 1964) or diazotisation of the corresponding nitroso 
compound, formed by chemical oxidation, followed by coupling with a suitable amino 
(Herr & Kiese, 1959). Both and Boyland (1964) utilised the colour produced by the 
reaction between N-hydroxy-4-acetamido-biphenyl and ferric ions to measure the 
N-hydroxylation of 4-acetamidobiphenyl. In the proposed study, because of the 
desire to estimate the concentrations of individual metabolites in the presence of each 
other, it was decided to investigate the use of gas-liquid chromatographic methods as an 
analytical technique. Such techniques are known to have a high degree of specificity 
and sensitivity and are now widely used for drug metabolism and drug excretion studies. 
Recently a new chromatographic technique has been developed in which the 
eluting solvent is passed at high pressurethrough the column. This technique, which 
is 
known as either High Pressure Liquid Chromatography or High Performance 
Liquid 
Chromatography (HPLC), has recently been applied to the separation of aniline and its 
metabolites (Sternson and De Witte 1977,1978 and Sternson, De 
Witte and Stevens 1978) 
and a variety of nitrogen containing compounds and their 
N-oxidised derivatives (Nelson, 
Thorgeirsson and Wirth 1978). As thi s method is also sensitive, specific and non- 
destructive the use of this technique for the analysis of 4-aminobiphenyl and 
4-acetamidobiphenyl metabolites will be investigated. 
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2.2 EXPERIMENTAL 
2.2.1 Materiols 
2.2.1.1 Substrates, metabolites and related compounds 
* 
4-Aminobiph2gi was obtained from Koch-Light Laboratories and shown 
to contain several impurities when examined by T L. C or GLC (details 
of systems used are given later). Attempts at purification either by 
recrystallisation from benzene or aqueous ethanol in the presence of 
activated charcoal, or by sublimation at 100 0 under reduced pressure (15 mm), 
failed to completely remove the impurities. Pure 4-aminobiphenyl hydrochloride 
was obtained by hydrolysis of 4-acetamidobiphenyl with hydrochloric acid 
(2N) at 1000. The base was liberated from the salt by alkali, extracted into 
ether, the ethereal solution was washed, dried over sodium sulphate and 
evaporated to dryness at room temperature under reduced pressure. The 4-amino- 
biphenyl obtained gave a single discre-te spot on TLC and a single peak 
with GLC systems. The mp of the purified amine was 54 
0 in agreement 
with that found by Uehleke and Nestel (1967). 
4-Acetamido was prepared by acetylation of impure commercial 
4-aminobiphenyl with acetic anhydride in pyridine. The product was 
crystallised from ethanol and recrystallised from benzene-ethanol (95: 5 
by volume). 4-Acetamidobiphenyl was obtained as white needles, m. p. 
0 
171 , Hdbner and 
Osten (1881) record a m. p. of 1670 for this compound. 
4-Amino-3-hydroxZbiEhenXI was prepared by the reduction of 4-nitro- 
3-hydroxybiphenyl with hydrazine hydrate in absolute alcohol in the presence 
AO V, ýý avv., TXLNV% vs, 
it zo a4-tlt 1$7,10 t-ýPý r, jP_ I UkA 
t-ýIp. 
X 
LA44. Uk/ýN J" 
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of palladium on charcoal at 500 for fifteen hours, using the general techniquc-v 
described by Kuhn (1951). 4-Amino-3-hydroxybiphenyl was recrystallised 
fro, m aqeuous ethanol; m. p. 1820 in agreement with Bradshaw (1958) and 
Boyland and Sims (1954). 
4- Nitro- 3-hydroxZbi phenyl was obtained by treating 4-n - itrobiphenyl 
(Koch-Light Laboratories) with finely-divided potassium hydroxide in benzene 
under reflux for three hours as described by Dermer and Drucker (1942). 
4-Nitro-3-hydroxybiphenyl was recrystallised from ethanol; m. p. 103 0 in 
agreement with Colbert, Meigs and Jenkins (1937). 
4-Amino-4'-hydroxybiEtyl was prepared by reduction of 4-nitro-4'- 
hydroxybiphenyl using the hydrazine hydrate 11---chnique. 4-Amino-4'- 
hydroxybiphenyl was recrystallised from aqueous ethanol to give needles, 
m. p. 271 0. Bradshaw (1958) records a m. p. of 2690 for thiscomýc,, -- v% AL 
4-Nitro-4'-hydroxybiphenyl was prepared by the nitration of 4- 
biphenylyl benzoate followed by alkaline hydrolysis, as described by Jones 
and Chapman (1952). 4-Nitro-4-hydroxybiphenyl melted at 200 
0 in 
agreement with the literature. 
4-Amino-T-hydroxybiphe2ZI was prepared by reduction of 4-nitro-2'- 
hydroxybiphenyl in absolute alcohol using the hydrazine hydrate technique - 
4-amino-2'-hydroxybiphenyl was recrystallised from absolute alcohol to 
0 
give white needles, m. p. 191 . Despite being mentioned 
by Bradshaw (1958) 
its m. p. was not found in the literature. The analytical data is given in 
Table 2.2-1. 
4- Nitro- 2- hydroxybi phen yl The synthesis of this compound was attempted 
using the route described by Colbert and Denny 
(1959) and outlined in 
78 
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Fig. 2.2.1 (a). However, despite several attempts the yields remained poor, 
multiple products were formed and separation of the required compound was 
extremely difficult. 
4-Nitro-2'-hydroxybiphenyl was obtained via 4-nitro-2'-aminobiphenyl 
followed by diazotisation and reaction with hot dilute sulphuric. acid as 
described by Harris and Christiansen (1933), Fig. 2.2.1(b). Confirmation of 
the position of substitution of the nitro group on the nucleus was obtained by 
oxidation of the isomeric nitro-2'-hydroxybiphenyis and comparison of the 
products with authentic nitrobenzoic acids using thin layer chromatography. 
4- Nitro- 2'-hydroxybiphenyl was recrystallised from aqueous alcohol to 
form nearly white needles, m. p. 124 0 in agreement with Harris and 
Christiansen (1933). 
4-Hydroxylaminobiphenyl was prepared by reduction of 4-nitrobiphenyl 
by aluminium amalgam as described by Bell, Kenyon and Robinson (1926). The 
product was recrystallised from benzene as pale yellow glistening leaflets, 
m. po 152 
0 in agreement with the literature. 
4-Nitrosobip_henyl was prepared by the oxidation of 4-hydroxylamino- 
biphenyl with potassium permanganate, in ethanol - The reaction mixture was 
filtered and chromatographed using an alumina column. The bright green 
material was eluted using petroleum ether 
(bp 40 0- 60 0 ), which was removed 
by evaporation at 25 
0 under reduced pressure. The product was crystallised 
from absolute alcohol to give crystals of 4-nitrosobiphenyl, m. p. 
730. Mijs 
(1959) and Uehleke and Nestel (1967) have previously described this compound. 
Attempts at the Preparation of this compound by the direct oxidation of 
4- 
aminobiphenYl with hydrogen peroxide, as suggested 
by Hclmes and Bayer 
(1960), gave only 4-azoxybiphenyl, 
-80- 
0 
mp 208 . Bell, Kenyon and Robinson (1926) record a mp of 2120 for 
4-azoxybiphenyl. 
4-Acetamido-3-hydmxybipheqZl, 4-acetamido-2-_hydroxybiphenyl 
, 
4-acetamido-4'-hydroxybiphenyl, 4-acetamido-N-hydroxybiphenyl were 
obtained by treating the parent aminophenol with acetic anhydride in 
pyridine at 500 for 20 minutes, followed by pouring the reaction mixture 
onto crushed ice. The N, O-diacetyl derivatives which were obtained were 
extracted into diethyl ether which was subsequently washed with hydrochloric 
acid (2N) and water. The ethereal extract was dried with sodium sulphate. 
Evaporation of the ether at 25 0 under reduced pressure yielded the N, 0- 
diacetyl compounds which were recrystallised from aqueous ethanol as white 
crystals with the following melting points: - 
4-acetamido-3-acetoxybiphenyl 135 0 
4-acetamido-2'-acetoxybiphenyl 145 0 
4-acetami do-4'- acetoxybi phenyl 226 
0 
0 
4-acetami do- N-acetoxybi phenyl 120 
Bell Kenyon and Robinson (1926) record 119 
0 for the latter compound. The 
required compounds were prepared from the N, 0-diacetyl compounds by 
treatment with 1N sodium hydroxide in 50% aqueous ethanol at 60 
0 
until solution was effected. The solutions were filtered into the calculated 
amount of hydrochloric acid to neutralise the alkali, whereupon the 
corresponding 4-acetamido- N- or ring-hydroxy compounds were 
0a 
precipitated. The acetamido compounds were recrystallised 
from cqueous 
- 81 - 
alcohol to give white needles having the following melting points: 
4-acetamido-3-hydroxybiphenyl 1910, in agreement with Miller, 
Sandin, Miller and Rusch (1956); 4-acetamido-4'-hydroxybiphenyl 
224 0, in agreement with Raiford and Clark (1926); 4-acetamido-N- 
hydroxybiphenyl 1440, in agreement with Miller, Wyatt, Miller and 
Hartmann (1961). 
4-Acetamido-2'-hydroxybiphenyl, mp 145 0, and all the ring acetoxy 
compounds appear to be new compounds. The analytical data obtained 
from elemental analysis is shown in Table 2.2.1. 
N-(4-biphenylyi)-glycolamide and N-(4-biphenylyi)-oxamic acid 
were gifts from Dr. W. Lenk, Department of Pharmacology, University of 
M6nich, Germany. 
2.2.1.2. Cofactors 
Glucose 6-phosphate (G6P), isocitric acid (ICA), glucose 6- 
phosphate dehydrogenase (G6PDH), isocitrate dehydrogenase (ICDH), 
nicotinamide adenine dinucleotide phosphate (NADP), nicotinamide 
adenine dinucleotide (NAD) and their reduced forms (NADPH and 
NADH) were obtained from Boehringer Biochemicals Limited. 
2.2.1.3. Inhibitors, Inducers and miscellaneous chemicals 
Certain substances used as potential inhibitors, activators or inducers 
of microsomal oxidation were obtained from the following sources: 
2,4 dichloro-6-phenyi-phenoxyethylamine (DPEA) was a gift from Dr. 
R. E. McMahon, Lilly Research Laboratories, Indianapolis, Indiana; 
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7,8-benzoflavone (BF) from Dr. H. Gelboin, National Cancer Institute, 
Bethesda, Maryland; 1-methyl-2-mercapto-imidazole (methimazole, 
MMI) from. Dr. D. M. Zeigler, University of Austin, Texas; 1 j4- 
diazabicyclo (2,2,2)octane (DABCO) from Dr. U. Breyer., Institute of 
Toxicology, Ubingen, Germany. Arachlor 1254 was a gift from Monsanto 
Chemical Company, St. Lous, Missouri; and bromazepam from Dr. R. Long, 
Roche Products, Welwyn Garden City. 3-Mathylphenanthrene was a gifir 
from Dr. PSims, The Chester Beatty Research Institute, London; and 2-amino- 
3-hydroxyfluorene was purchased from Aldrich Chemical Company. 
Metyrapone was a gift from Ciba-Geigy Ltd., Horsham. 2-Diethylamino- 
ethyl -2,2-diphenyl valerate (SKF 525A) was a gift from Smith Kline and 
French Laboratories Ltd.; methylcholanthrene was obtained from Sigma 
Chemical Company; carbon monoxide and pýenobarbitone from British 
Drug Haises Ltd. Other chemicals used for the preparation of buffers or 
itolation media or during analytical procedures were obtained from either 
British Drug Houses Ltd. or Hopkin and Williams Ltd. or Fisons Laboratory 
Chemicals Ltd. 
2.2.1.4 Animals 
All animals used were mature males of the following species and strains: 
rats, Wistar (200-300 g); guinea pigs, Duncan Hartley (300-500g); 
rabbits., New Zealand White (2.5-3 kg); mice, C. B. R. I. stock or 
C57 (25-35g); 
hamsters, Syrian (80-100g); dogs, Alsatian or Greyhound. 
RA- 
%O-r 
2.2.2 Methods 
2.2.2.1 Tissue Preparations 
Animals used, with the exception of dogs, were stunned and 
decapitated and allowed to bleed until heartbeat was no longer detectable. 
The liver was removed and, where applicable, the gall bladder excised. 
Any fat or large amounts of connective tissue were removed and the 
hepatic lobes were rinsed with ice-cold isotonic potassium chloride 
buffered to pH 7.4 with tris (tris/Kcl). The I iver was blotted dry on fi I ter 
paper, weighed and cut into small pieces under ice-cold buffered tris/XCI 
(two ml per gram of liver). Homogenisation was effected using a glass 
homogeniser fitted with a teflon pestle (Arthur Thomasi Size B) driven 
by an electric motor at 2,800 rpm. In the case of dog and rabbit liver 
preliminary homogenisation was carried out using an overhead drive homogeniser 
for 3x 20 seconds with 5 second intervals at 0 0. The teflon-glass homogeniser 
was kept in ice whilst it was being used; the tissue suspension was made to 
pass the pestle three times during the preparation. The homogenate was 
centrifuged at 10,000 xg for twenty . minutes using a8x 
50 ml rotor in 
a refrigerated Sorvall RC 2B centrifuge in order to sediment any residual 
whole cells, cell debris, nuclei, mitochondria and lysosomes. The 
supernatant was carefully collected and the microsomal fraction prepared 
by further centrifugation at 140,000 xg for 60 minutes using an 8x 25 ml 
rotor in a M. S. E. Superspeed Model 40 or Model 50 centrifuge. The 
microsomal fraction was collected and resuspended in tris/I<Cl at a 
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concentration equivalent to 0.5 g of original tissue per ml of suspension. 
Dog liver was obtained from the Royal Postgraduate Medical School, 
Hammersmith, from dogs under general anaesthesia being used as donor 
animals in lung transplants. In these experiments the dog livers were 
placed in tris/KCI and surrounded by c*hed ice for transportation to 
the Hammersmith annexe of Chelsea College. 
2.2.3.2 Incubation Procedures 
Incubations were normally carried out in open 25 ml Ehrlenmeyer 
flasks at 37+ 10 in a shaking incubator (Gailenkamp). Incubates contained 
tissue equivalent to 0.5 g of liver in 1 .0 ml of tris//I<Cl, substrates 
(5 p1mol), 
glucose 6-phosphate (10 ýpol), glucose 6-phosphate dehydrogenase (3 units), 
magnesium chloride (60 I. Lmol) in a total volume of 3.5 mi. The subs-trates were 
added in 0.2 ml of methoxy-ethcnol., and incubates in which 4-acetamidobiphenyl 
was used as a substrate also contained sodium fluoride (100 LLmol) to inhibit 
deac, atylation (see Section 3). 
In experiments performed in conjunction with HPLC, incubations were 
carried out in 50 ml Ehrlenmeyer open-necked conical flasks in a shaking 
incubator at 370. Each incubate consisted of tissue equivalent to 250 mg 
of original isocitrate (10 mol) NAIDP (2. ý-) , mol) and isocitrate 
clehydrogenase (25 1). In these experiments the substrate 
(2.5 mol) was 
added in dimethylsulphoxide (25 ul). 
2.2.2.3. Pretreatment of Animals with Inducing Agents 
Animals were pretreated with potential inducing agents according to 
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the following dosage schedule. Phenobarbitone was given for three days at 
80 mgAg, methylcholanthrene for one day at 20 mgAg and Arachlor 1254 
for one day at 100 mgAg. All substances were given intraperitoneally. 
The animals were sacrificed on the fourth day after the first dose of 
phenobarbitone, the fifth day after the dose of Arachlor- and the third day 
after the dose of methylcholanthrene. 
2.2.2.4 Experiments Involving Potential Inhibitors or Activating Agents 
Potential inhibitors or activating agents were incorporated into the 
incubation medium at a final concentration of 10- 
3 M. In some cases 
solution or a suspension was obtained only after treatment in an ultrasonic 
bath prior to incorporation into the incubation medium. 
2.2.2.5 Protein Determination 
Microsomal protein was determined by the method of Lowry, Roseborough, 
Farr and R and-al 1 (1951) as modifi ed by Mi I ler (1959), using bovine serum 
albumin (BDH) as protein standards. 
2.2.2.6 C)jochrome b Determination 5-Z: w-- 
Microsomal suspension (1 ml) diluted with tris/KCI buffer (4 ml) was 
divided equally into two I cm glass cuvettes. Using a UniccmS P 
800 
spectrophotometer fitted with a scale expansion device a base 
line was 
established between 390 and 600 nm. The cytochrome b5 
in the sample 
cuvette was reduced with NADH (5 P& I of a2AM solution) and the 
difference spectrum obtained between 390 and 600 nm. 
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2.2.2.7 Cytochrome P-450 determination 
The cytochromes in both cuvettes., from the previous determination, were 
separately reduced by the addition of sodium dithionite (5 mg). One cuvette 
was then treated with a stream of carbon monoxide, delivered through a 
capillary tube to the bottom of the cuvette, for about 30 seconds. The 
difference spectrum of the reduced carbon monoxide- cytochrome complex 
against the reduced cytochrome was recorded between 390 and 600 nm. 
2.2.2.8 Chromatographic Methods 
2.2.2.8.1 Paper Chromatograehy 
Bradshaw (1959) reported that he had used the reversed phase technique 
of Gasparic, Petranek and Ve6efa (1955) for the successful separation of 
some hydroxy derivatives of 4-aminobiphenyl and 4-acetamidobiphenyl - 
Bradshaw pointed out that the method was associated with numerous difficulties 
which indicated that it may not be useful for routine use. 
Whatman No. 1 paper was impregnated with formamide by passing the 
paper through a solution of formamide (10%) in absolute ethanol and allowing 
the paper to air dry at room temperature. Chromatograms were run by the 
ascending technique in closed glass tanks at room temperature for a maximum 
of 15 cm. The solvents used were: ethylene dichloride; toluene., ethylene 
dichloride 3: 5 by vol. or toluene: ethylene - dichloride 1: 1 by vol. 
2.2.8.2 Thin Layer Chromatogahy (TLC) 
Thin layer chromatography was usually carried out using either Silica 
gel G or Silica gel G//UV254 (Machery Nagel) supported on glass plates 
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at a thickness of 0.25 mm. After speading, the plates were allowed to 
air dry, activated by heating to 100 0 for 45 minutes and cooled before 
use. In certain experiments aluminium oxide or cellulose was used spread 
on glass plates at a thid<ness of 0.25 mm. In these cases the alumina plates 
0 
were activated at 100 for 60 minutes and the cellulose plates were heated 
at 1009 for 10 minutes and cooled before use. All thin layer plates were 
stored in an air-tight cabinet over a desiýcant prior to use. 
2.2.2.8.2.1 Solvent systems for TLC 
During the course of this work numerous solvent systems were tried in 
an attempt to find one which would separate all the hydroxylated derivatives 
of both 4-aminobiphenyl and 4-acetamidobiphenyl from the parent 
compounds. Usually the solvents were prepared by mixing various 
proportions of a non-polar constituent such as benzene., petroleum ether or 
cyclohexane with a pcIar compound such as acetone or an aliphatic alcohol. 
The compositions of certain solvent systems used for TLC are shown in 
Table 2.3.1. 
The chromatographic properties of 4-aminobiphenyl and 4-acetamido- 
biphen yl together with compounds prepared as potential metabolites, using 
a number of solvent systems, are recorded in Table 2.3.2. 
2.2.2.8.2.2 Detection reagents used in conjunction with either paper or 
L. . thin layer chromatography 
With the exception of ultra-violet light the detection reagents used were 
chosen because of their ability to react with a specific function of a molecule. 
For example, diazonium compounds were used to detect phenols; conversely, 
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aromatic amines were converted to diazonium compounds in situ on the 
chromatograms and detected by reacting with phenols. Ary1hydroxylamines 
were detected by reagents which utilised the strong reducing properties of 
this group of compounds or their ability to form co-ordination complexes. 
The abbreviations used when arV detecting reagent is referred to later in the 
text are shown in brackets, e. g. ultra-violet light (UV 254). Ultra-violet 
light: Chromatograms were viewed under ultra-violet light produced by a 
Hanovia portable fluorescence lamp (model CHI/294 or model 16). The 
lamps were fitted with suitable filters such that light of principally 254 nm 
(UV 25. 
-. 
) or 366 nm (UV 366) respectively was emitted. Diazotisation and 
coupling in situ. chromatograms were lightly sprayed with hydrochloric acid 
(0.5 N), air dried for ten minutes and sprayed with sodium nitrite (0.5%). 
The diazonium compounds produced were coupled by spraying with an 
alkaline solution of one of the following phenols (0.5%) in sodium 
hydroxide (1 N) in aqueous ethanol (50%). The phenols used were 1 -naphthol 
(I-N), 2-naphthol (2-N), 4-hydroxybiphenyl (4-HB), 2-hydroxybiphenyl 
(2-HB) and hexylresorcinol (HR). E-Dimethylaminobenzaldehyde (DAB) and 
p-dimethylaminocinnamaidehyde (DAC) were used as a 0.5% solution in 
ethanol containing concentrated hydrochloric acid (I ml/100 ml). Diazotised 
sulphanilic acid (DSA) and diazotised 2-nitroaniline (DNA) were prepared 
immediately before use by treatment of the parent amine (0.2% in 0.5 N HCI 
The commercial ly-avai I able stable diazonium compound, 2-chloro-4- 
nitrobenzene diazonium naphtha I ene- 2-su I phonate (NNCD) 
(Hopkin and 
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Wi Iliams Limited) was used as a 0.2% aqueous solution. After treatment with 
the diazonium reagents the chromatograms, were sprayed with sodium carbonate 
(10 %). 
Ammoniacal Silver (AS) was prepared by treating silver nitrate (10%) 
with sodium hydroxide (2N) until precipitation was complete. The mixture 
was treated with ammonia (0.88 sp. gr. ) dropwise unti Ia clear solution was 
first obtained. 
Chlorimide reagents 2,6-, Ejichloroquinone chlorimide (DCQ) or 
2,6-dibromoqu i none chlorimide (DBQ) were used as a 0.2% ethanolic 
solution. The chromatograms were resprayed with sodium carbonate (10%) 
after the chlorimide reagent. 
Sodium amminoprusside (SAP) was used as a 0.05% solution in 20% 
aqueous ethanol containing 1% magnesium chloride. 
FerHc Chloride (FEC) was used as a methanolic solution (0.005%). 
Ferric Chloride - Ferricyanicle (FFCN) was prepared by mixing equal 
volumes of 0.03% aqueous solutions of ferric chloride and potassium ferricyanide 
immediately before use. 
Ferric Chloride/Bathophenanthroline (FBowas prepared by spraying the 
chromatogram with FEC and, after allowing to dry at room temperature for 
10 minutes, respraying with bathophenanthroline (4,7-diphenyl-1,10- 
phenanthroline ) 0.1 % in methanol. 
Alkaline Tetrazolium (AT) was prepared by dissolving 2,3,5-triphenyl- 
tetrazolium chloride (0.1 O/q) in ethanolic sodium hydroxide (0.5 N) 
immediately before use. 
Brentamine Fast_. Red (BFR) and Brentamine Fast Blue (BFB) were used as 
0.5% aqueous solution 
followed by spraying with sodium carbonate 
(100/0)- 
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2.2.2.8.3. Ga_s-Liquid Chromatographic Methods 
Gas-liquid chromatography was carried out using a Perkin-Elmer F. II 
gas chromatograph fitted with a flame ionisation detector. The-detector 
response was measured using a Hitachi 152 recorder with a full scale 
deflection of one millivolt. 
Initial experiments were carried out using a one metre metal column 
(0. D. 1/8") or a two metre glass column (0. D. 4"') packed with 2.5% SE-30 
on Chromosorb G (80-100 mesh, acid-washed, DMCS-treated). Later experi- 
ments utilised either 3% OV-1 on Chromosorb G (80-100 mesh, acid-washed 
DMCS-treated) or 3% OV-17 on C, hromosorb W(HP, 80-100 mesh). The gas 
pressures were adjusted to give optimal conditions as described in Section 4. 
2.2.2.8.3.1. Direct examinati on of 4-aminobiphenyl and 4-acetamido- 
. 
biphen yl and_ some potential metabolites b 
Solutions of 4-aminobiphenyl, 4-acetamidobiphenyl and various 
hydroxylated derivatives/ and 4-nitrobiphenyl and 4-nitrosobiphenyl in 
ether were separately injected onto the gas chromatograph and the retention 
times and peak shapes at different column temperatures recorded. 
2.2.2.8.3.2. Chromatography of acetyl derivatives 
Solutions of 4-aminobiphenyl, 4-acetamidobiphenyl and various 
hydroxylated derivatives were prepared in pyridine and treated with acetic 
anhydride at 50 
0 for up to three hours. Aliquots (2ul) were injected onto 
the gas chromatograph and the retention times and peak shapes recorded. 
2.2.2.8.3.3. Chromatography_pf trifluoracetyl (TFA) derivatives 
Solutions of 4-aminobiphenyl, 4-acetamidobiphenyl and various 
hydroxylated derivatives were prepared in pyridine and treated with 
trifluoroacetic anhydride at 
5' 0 Aliquots (2pl) were injected onto the 
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gas chromatograph and the retention times and peak shapes recorded. 
2.2.2.8.3.4 Chromatography of methyl derivatives 
Solutions of 4-aminobiphenyl, 4-acetamidobiphenyl and various 
hydroxylated derivatives were prepared in ether and treated with a solution 
of diazomethane. Aliquots of the reaction mixture were injected onto 
the gas chromatograph and the retention times and peak shapes recorded - 
2.2.2.8.3.5. Chromatography of tHmethylsilyl (TMS) 
Solutions of 4-aminobiphenyl, 4-acetamidobiphenyl and various 
hydroxylated derivatives were prepared in acetonitrile and treated 
with various "silylating" agents. The silylating agents were prepared by 
dissolving various proportions of hexamethyidichlorosi lane with trimethyl- 
chlorosilane in an organic basic solvent. Amongst the solvents tried were 
pyridine, pyrrolidine, thiethylamine and diethylamine. Latterly these 
were superceded by bis-silylacetamide or trimethylsilylimidazole. 
2.2.2.8.3.6. Choice of Intemal Standards 
A wide variety of aromatic hydrocarbons were examined as intemal 
standards as these were easily available pure, were easily extractable into 
organic solvents and were not affected by derivatizing reagents or mild 
oxidation conditions. Additionally, a number of 2-aminofluorenols and 
2-aminobiphenylylols were studied because of their structural similarities 
to potential 4-aminobiphenyl metabolites. These potential standards were 
examined by GLC and the retention times recorded. 
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2.2.2.8.3.7. Conversion of 4-hydroxylaminobiphenyl to 
4-njtýosobiphenyL 
., 
Solutions of 4-hydroxylaminobiphenyl were prepared in chloroform 
and treated with a variety of oxidising agents. Amongst the oxidants used 
were ferric chloride, potassium dichromate, nitric acid, perchloric acid 
and potassium ferricyanide. The organic phase was examined by GLC and 
the retention times of any products recorded. 
2.2.2.8.3.8. Determination of ring hydroxylated products by GLC 
Incubates (prepared as described in 2.2.2.2) which had been used to 
oxidise metabolically either 4-aminobiphenyl or 4-acetamidobiphenyl were 
transferred to screw-capped Sovirel tubes containing sodium chloride (1g) 
and internal standard. The incubctes were extracted with methylene 
dichloride (3 x5 ml) which was then concentrated under a stream of 
0 
n itrogen at 55 . The residue was dissolved in acetonitrile and a granule 
of anhydrous calcium chloride added. Bis-silylacetamide was added and 
the mixture heated at 50 0 for twenty minutes in a stoppered tube. The 
peak heights of the trimethylsilyl derivatives of the hydroxylated compounds 
were determined relative to the peak height of the internal standard. 
2.2.2.8.3.9 Determination of 4-hydroxylaminobiphenyl by GLC 
Incubates containing 4-hydroxylaminobiphenyl were treated with 
internal standard and transferred to screw-capped Sovirel tubes containing 
sodium chloride (1g) and potassium ferricyanide (0.2 ml 10%). The 
mixture was extracted with freshly-distilled petroleum ether (bp 40-60 
0 )/ 
v 
2x5 mi. The organic phase was concentrated by evaporation at 55 
0 
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under a stream of nitrogen. During the evaporation 20 41 of isopropanol 
was added to prevent volatilisation of 4-nitrosobiphenyl. The tubes were 
placed in crushed ice and stoppered, allowing the condensing vapour to 
wash the 4-nitrosobiphenyl and the internal standard into the collecting 
nipple. The peak height of the 4-nitrosobiphenyl relative to the peak 
height of the internal standard was determined. 
2.2.2.8.4 High Performance Liquid Chromat 
High performance I iqu id chromatograoiy was carried out usi ng an 
apparatus consisting of dual pumps in conjunction with a model 660 
solvent programmer and model 440 ultra-violet absorbance detector set 
at either 254 nm or 280 nm (Waters Co., Milford, Mass. ). 
The solvent programmer was set at curve 6 to give a linear solvent 
change. For the analysis of 4-aminobiphenyl and metabolites the. - initial 
solvent composition was phosphate buffer (0.03 M, pH 7.4) 65%; 
acetonitrile (U. V. grade, glass-distilled, Burdick and Jackson, Muskegon, 
Michigan) 35%. Solvents were filtered through a Millipore 5 micron 
solvent-proof disc prior to use. During the course of the run the solvent 
composition changed over three minutes to give a final composition of 
phosphate buffer 40% and acetonitrile 60%, the flow rate being maintained 
at 2 ml per minute - 
For the analysis of 4-acetamiclobiphenyl and metabolites the initial 
solvent composition was phosphate buffer 70%, acetonitrile 
30%. This 
was changed during seven minutes using 
linear programme number six to 
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give a final composition of phosphate buffer 25%, acetonitrile 75%. 
The column consisted of a stainless steel tube 20 cm long, having an 
intemal diameter of 4 mm, packed with VYDAC TM201 reverse phase C-18 
bonded to a silica support of 10 micron particle size (Applied Science 
Laboratories,. State College, Pennsylvania). The equipment was fitted 
with a Waters U6K injection system. 
2.2.8.4.1 Quantitative determination of hydroxXiated metabolites of 
4-aminobiphenyl and 4-acetamidobiphenyl using HPLC 
Following the incubations with 4-aminobiphenyl or 4-acetamidobiphenyl 
(as described in 2.2.2.2. ) the enzymic reaction was stopped by the addition 
of acetone (I ml), and the metabolites were extracted into ethyl acetate 
(5 ml) using a rotary shaker for thirty minutes. The ethyl acetate was 
removed after the mixture had been centrifuged, and evaporated under 
a stream of nitrogen at 40 0. The residue was dissolved in acetonitrile 
(0.5 ml), and an aliquot (10 pl) was injected onto the chromatograph. 
The metabolites were quantitated by use of factors obtained by carrying 
standard amounts of metabolites through the whole procedure. 
2.2.2.9 -ý'olorimetric Methods 
2.2.2.9.1 Determination of 4-hydroxylaminobiphenyl sing sodium 
amminoprusside (SAP) 
Standard amounts of 4-hydroxylaminobiphenyl were added to 
microsomal suspensions which were immediately mixed and treated with 
ethanol to precipitate protein. The mixtures were centrifuged at 2000 
rpm and aliquots were removed and treated with SAP reagent (SAP 0.25% 
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in 0.01 % magnesium chloride). The absorbance maximum was determined, 
using a Unicam SP 800 spectrophotometer, after the colour was allowed 
to develop maximally (30 min ). The absorbance equivalent to each 
concentration was determined. 
2.2.2.9.2. Determination of 4-(N-hZdroxyacetamido)-biphenyl using. 
ferric chloride 
Standard amounts of 4-(N-hydroxyacetamido)-biphenyl were added to 
a microsomal suspension which was then extracted with freshly-distil led 
diethyl ether. An aliquot of the extract was evaporated to dryness and 
redissolved in anhydrous methanol containing anhydrous ferric chloride 
(0.005%). The absorption maximum was determined using a Unicam 
SP 800 spectrophotometer and the absorbance equivalent to each 
concentration of hydroxamic acid was obtained. 
2.2.2.9.3. Determination of 4-amino-3-hydroxybiphenyl byconversion 
to 1,7-diphenyl-4-amino-3H-iso henoxazin-3-one 
Standard amounts of 4-amino-3-hydroxybiphenyl were added to 
microsomal suspensions which were then treated with trichloracetic acid. 
The mixtures were centifuged at 2000 rpm and aliquots of the supernatant 
were treated with potassium ferricyanide (20%) at room temperature with 
constant agitation for twenty minutes. The reaction mixtures were 
extracted with chloroform. which was subsequently dried using sodium 
sulphate. The absorption maximum was determined using a 
Unicam 
SP 800 spectrophotometer. A concentration versus absorbance relationship 
was established by determining the absorbance equivalent 
to each 
0 
concentration of 4-amino-3-hydroxybiphenyl added to the microsomes. 
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2.34, RESULTS AND DISCUSSIO . N' 
2.3.1 Paper Chromatography 
The reverse phase technique of Gasparic et al. (1955) for the 
separation of hydroxylated derivatives of 4-aminobiphenyl or 4-acetamido- 
biphenyl gave very poor results. In agreement with Bradshaw (1959) it 
was found that the substances gave irreproducible results varying from run 
to run and often streaked the whole length of the paper. Variation of 
solvent or of temperature or of support paper failed to stabi I ise the system and 
it was therefore abandoned. 
2.3.2 Thin Layer Chromatogrcehy (T LC) 
Thin layer chromatography has been widely used for the separation of 
aromatic amines and their metabolites (Smith, 1978, and references 
therein) and was used by Booth and Boyland (1964) in their study of 4- 
aminobiphenyl metabolism. In agreement with these authors it was found 
that the technique was quick, reproducible and when combined with specific 
detection reagents allowed the recognition of individual hydroxylated 
metabolites. The chromatographic properties of 4-aminobiphenyl and 
4-acetamidobiphenyl together with some potential metabolites are 
recorded in Table 2.3.2 and their responses to various detection reagents 
are recorded in Table 2.3.3. 
Compounds with free amino groups could readily be detected by 
dkmtisation followed by coupling with an alkaline phenol. Of the phenols 
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tested for this purpose, I- or 2- naphthol produced the best response. 
This reagent was not suitable for 4-amino-3-hydroxybiphenyl as 
diazotisation produced an internal diazo oxide which did not couple with 
alkaline phenols, but generally produced a green to yellow colour with 
the alkali alone. This substance could be recognised by the black 
color, 3tion produced with ammoniacal silver nit-rate, which formed faster 
than with the other aminophenols but slower than with the hydroxylamine. 
4-Hydroxylaminobiphenyl was easily detected by its specific response to 
SAP, FBP and AT. Compounds with free amino groups also gave an 
immediate reaction with either DAB or DAC; these reagents also gave 
positive reactions with acetamido and nitro compounds on being allowed 
to stand for several hours. In these cases the colours produced were of 
the parent amine,, presumably being produced by hydrolysis and reduction 
respectively. Phenolic compounds derived from either 4-aminobiphenyl 
or 4-acetamidobiphenyl could also be detected by their response to a range 
of diazonium compounds or chlorimide, reagents. The hydroxamic acid 
formed from 4-acetamidobiphenyl can readily be recognised by the 
characteristic colour produced in the presence of ferric lons. 
Amongst the solvent systems examined SI was the best for 
separating the hydroxylated derivatives of 4-aminobiphenyl whilst S4 was 
the best for 4-acetamido derivatives. 
It should be noted that no detection reagents were found which gave 
a response with either N-(4-biphenylyi)-glycolamide or N-(4-biphenylyl)- 
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oxamic acid. However,, the latter compound was unlikely to be formed in 
microsomal incubation systems. 
2.3.3. Gas-liquid Chromatography (GLC) 
The examination of the chromatographic properties of 4-aminobiphenyl 
and 4-acetamidobiphenyl in their derivatives revealed that whilst the parent 
compounds gave sharp symmetrical peaks using a number of different columns, 
the hydroxylated derivatives, that is the potential metabolites, did not. 
Generally the aminophenols gave very broad peaks and required a large amount 
of substance to be detected. The acetamidophenols also gave broad peaks with 
long retention times. The N-hydroxy derivatives of either 4-aminobiphenyl 
were unstable on all columns used; the ary1hydroxylamine gave rise to 
multiple peaks having chromatographic properties identical to 4-aminobiphenyl, 
4-nitrosobiphenyl and 4-nitrobiphenyl. The hydroxamic acid gave products which 
were identical to 4-acetamidobipýenyl, 4-nitrosobiphenyl and 4-aminobiphenyl 
when a metal column was used. When a glass column was used the principal 
product was identical with 4-acetamido-3-hydroxybiphenyl. 
Attempts at stabilisation or increasing the volatility of these compounds 
by use of derivatives was also associated with problems. The N, O-diacetyl 
derivatives of ring hydroxy derivatives of 4-aminz)biphenyl were stable and 
gave good peaks on the gas chrornatograph; however, the N, O-diacetyl 
derivative of 4-hydroxylaminobiphenyl (w'hich is the same compound as that 
produced by the acetylation of 4-acetamido-N-hydroxybiphenyl) was 
converted to the 3-acetoxy compound during GLC. The reactivity of the 
N, 0-diaceyl moiety appeared even greater when trifluoretic anhydride 
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Table 2.3.1 Composition of solvent Vstems used in conjunction with silica 
gel G plates for TLC 
SI Petroleum Ether (bp 600-80 0 ): Acetone 7-3 
S2 Chloroform: Methanol- Ammonia (SG 0.88) 95: 5: 1 
S3 Chloroform: Methanol: Water 95: 10: 1 
S4 Cyclohexane: t-Butanol: Acetic aýid: Water 16-4: 2-1 
S5 Carbon Tetrachloride- Ethyl Acetate: Dichloromethane- 
Formic Acid 35-25: 25: 5 
S6 Benzene: Methanol 9: 1 
S7 Benzene: Dioxane: Di ethyl ami n e: Water: Methanol 70: 17.5: 7.5: 1: 4 
S8 Cyclohexane: Ethyl Acetate 7: 3 
S9 Benzene: Methanol- Acetic Acid 45: 8: 4 
510 Chloroform: Ethyl Acetate: Acetic Acid: Water 12: 6: 2: 1 
- 101 - 
0 
M 
0 
C 
a, 
-C 
0- 
.0 
-0 
't 
a 
0 
C 
-o 
0 
0 
- 1.9 
-0 
-. i- 
ý 
(D 
. 
. 46- 
CL 
0 
OL 
-0 
m0 
a 
Ut E 
C114 
CII) 
C4 
0 
C 
I- 
52 
vi %c %0 
Co 
(> 
Co 
(> 
%0 
Co e Co r, 2 lý 00 %0 N LO 
NO 
c> 
C), C, 4 CN %0 LO LO 0 (N N %c %0 0 LO c> 0 0 CD 
CO 
vi 
('-4 
LO 
N 
CN 
to 
CN P- (N 
NO 
cn 
c:, 
CO (N 
0 
CN 
Co N 0-- 
p- 
(> C 
00 
N 
tn 
ý2 N 
to 
cn 
ý-0 
0 
to 
0 
00 
0 
Co 
C) 
ýo 
OD 
(N , 
N 
(n 
ýý Co Co 0 
Co 
,0 
vi 
(v) 
N 
c> 
e 
Co 
«nt 
C: ) 
e 
Co 
CD 
OD 
CD - VI 
N 
e M 
N 
CN 
No 
ýo 
0 
Co 
LO 
vi 
CN 
CN 
(> (> LO NO 
00 %0 00 
CN 
%o 
CD 
%c 
(> 
le 
(> 
le 
%0 
ne 
"0 
le 
Ilt r*4 
0- 
.e 0 0 LO ýe , ýe ;x N -e LO C'4 N --e c> vi LO C-) C'4 Co Co -e m CN %0 Int 
-- -CO 
cn m LO 0 Co ri - 0 0 0 to tn N (> (> N %0 %0 Co ý, 
C, q vi c), Co 0 LO Lo 0 Lo LO 0 Co -e 0, %0 N Co LO cl) 't 
C) e C) LO N C) 
7- LA LO C'4 
e 
cn 
Co 
CN 
Co 
N 
%0 
Co 
Co 
ci 
0 
Ce) 
-- (N 
C> 10 CN 
Cl> 
4c 
LU 
(A > _c OL 0- 0 
OL 
0 
c 41) 
X 
x x 
x C 
0 
-= CL 
X 
x 
x r- 
0 
_C OL 
X 
x 
0 
x c 
0 
_c CL 
X 
x 
Q) 
E 
o E 
l' 
1 
(A 7,2 
Z 
0 
_c 
0 
X 
0 
X 
_c 
0 
>, 
x 
0 
X 
-c 1 
JO X 
x 
e 
-c 1 
_c 12- 
m 
0 
09 
0 
- >, 
c 
_C 0 
- 
r 
9) 
-c 0 
0 
E 
0 
-0 
x 
--c 1 
cn 
0 
E 
2 
-0 
>, 
_C 1 
- CN 
0 
E 
L. -0 
>, 
_C 1 
0 
E 
2 -0 
X 
_C 1 
Z 
0 
E 
c3) 
1 
- X 
x 0 
1 
- x i 31 
c 
(L) 
0 0 0 0 x 2 
0 
* 0 9) 9) 0 
c3 
eLl 
0 0 c3 c3 -c 
F- 0 0 0 C) 0 1 1 
. Z: 
0- 
E 
- 102- 
oi 
E 
0 
a 
E 
0 
C 
0- 
.0 0 
c3 
c 
0- 
cm 
ol 
ce 
CY) 
Cý 
Cý 
3: 0 0 
Z c c 3: c 2 0 L 0 L t2 wo a-O 0 . 0 - M Z Z Z 0 Z Z Z Z 
Co 
O 0 
%- 
3 0 
L- 
Z 
L- 
Z 
L. 
:> 
Ce 
Z 
c2. 
Z 
01-0 CM-, c2 cle 
L - - 0- 92 Z Z Z Z Z 
9 
cim -2 -0 -0 -0 -0 -y e -? e < -0 _ID -0 -0 0 1) Z £2 Z 0: e Z tite Z Ce Z IM: e Z 
0) 
c x 
m 
c 3: m c - 19 0 0 a 
0 m 0 0 0 Z Z Z Z Z Z Z Z Z 
0 
0 W., ce ce- 
CN L- 
0 
0 0 JO Z Z Z Z Z Z Z Z Z 
0 3. » Co M c: 
c 
3ý c 0 
0 
0 4) - 
, KP c3) >, Z Z Z Z Z Z Z Z Z 
-3: c 0 -3: 1 -0 = -0 -0 0 ö-ý- a: c et 0-- Oec aý t2 ce- ce- 
(N 0 L- 0 X 0 L 0 L 
L- 
O 
Z Z Z Z Z Z Z Z Z 
. . J 
Z 
1 -0 0 M e- 2 & t2 0-. - in, -- aý cco ce aý 12 Z Z Z Z Z Z Z Z Z Z 
0 
> (DL) L- :: ) c3 Z L- 0 I- Z - c3 c3 c3 0 0 0 0 0 0 
ix 
CN 
1 0 0 _, Z 0 0 L - - 
x x 
c 0 0 0 -0 . 
x x 
0 
-c _c CL 
_c 2- _c 0- 
0- 
5 
-c -c X x X X 0 0 2 ý ' LU 0- 
-0 
-0 >, 
0 
>, _c rL - >, 
0 L- -0 
L. 
-0 
L- 
-0 -0 _ 
: 
C» 
x 
0 
>, X X r >, X X i X 0 0 m -c x _c O_ 1 Z x - 
x - 
c X C 2 -0 x x - _C _ CL 0 
0 0 0 
- 
0 
- c 0 Z 1 - - qt X - 0- 0 -0 -0 -0 0 0 0 - _c _c _c q 
1 x 0 
9 E 0- 0- 
0 0 0 0 2 V) 0 c3 0 0- 0- . r_ 0 r_ . r_ r .- 
2 
0 . 4- 0 jk- 0 -i- 0 0 
1 1 
E E E E X 
a c3 c3 0 
0 
C'14 
L. 
L. 2 
m c 
0- 
cý 
0 
vi 
4-ýN. 
x 
0) C» td) 
, Z: L- 0- 
4) 0 Z- 
E 
c3) -0 (1) 
0 _c 0 
.2 -4- > 
-4- 
Q -0 
a) Z- Q) 
70 0 -ý 
Li- C 0 
4- 00 
oz- uc 
o ý; !gD 
00 
E*2 
0 0: ý 0 Z 
-0 
IZ- 
c 
0 
U 
C,, 
. 
CV) 
a) 
-o 0 
I- 
0 
ce 0 0 
U- 
cc X 2 ce c): 4 z 
4) 
W ce ad 
z z z z z 
ý- Oao ce ce w -0 - cle ce . C., 4 
I: e cle ce CLO, WI 
z Z Z Z Z 0 z z z z z z z 
0 
cm C)-00 M! ý ce ne LL z z z z z z z Z Z 2 Z Z Z 0 
z 
u 
LL 
ID c LL 0 > 
LL. Z :5 0 CL -0 z z :5 :D a E 
Ce 
Z 
0: ý 
Z 
oe 
Z 0- 
U 
uj Cýe 2 0 2 ce r- C: C,: ý U- * > z z z z z z z 
3: 0 0 (D 
I 
0 0 - - 
V) 4) Q) - L. 11 2! 2- :) e- :) Cie 0: ý Cie - ce ce C)e ne %- X 0 z z z z z z z z 
C 
0 - Q x 3: 
C13 (3 0 :3 2 4) cg!: - ne 0 D 4) 0 cd M& ce a L. 
i0 
L.. 
0) 
m 
0) 
L- 
0) z z 5: :B 
L. 
0) 
L- 
-0 
z z z 
a 3: 'a) 4) >, o 0) a X 4) U 0 0 04 Cie w ce ce Z Z E -0 
Z Z Z 
U X X U x X >1 x a Q Q W- W- 0 V 0 (D 
C C Z Z C C L. L- Z Z Z 
U 0 0) 
a C3 --a - - c C3 C 0 ne 
C 
0 _0 -0 Ce 
0 
0 L2ý ce. L- 0 4) 2- 
L- z L. 4) 4) z 1- z z 0 C 0 0 0 
X x 
0 
-C -C X .- u 
z - X x C: 
x r -C CL a- 0- E a 
(D 
-a -C x -0 x x x 
- 0 
U . - 
-C a- 0- c X x x x x 0 
go- 0- .0 4- -0 0 C 0 
o C o L- 2 -?:, x LU ce -0 X x x x x - a- -0 
-0 
x 
-0 
x 
-0 
x 
0 0 
x 
o o 2 
. - S X I I 
Z X o x -c z C: (D co N X X C 
-C I I a 0- 0 0 0 0 0 C C a) 
co CN X X o- 
I f x o E E E E E C- a- 
0 0 c 
0 
c 
0 C 0 a 0 L. W 2 c 4- a . 6- C3 4- o 4- o 4- 0- 
9- 2 O -0 4) a) 4) a) Q) 
u 
E 4- 
C) 0 0 -C c a 0 0 0 0 c 
't "It 't "It qlt -It 
z z 
Cý 
03 
Cý 
clý 
CN 
c 
0 
4- 
u 
0. ) 
L'I 
$Z: (1) 
0 L- 
r 
-0. -0 
MO 
0 -4- 
00 
0 
.- OL 
0 
0 
c 
C) 
0 
LJ 
0- -Z 
0 
0-0: ý 
Ez 
0 
cý 
- 104- 
was used as an acylating agent, as in this case the product isolated from 
the reaction was identical in m. p. and chromatographic properties with 
that isolated from the acylation of 4-amino-3-hydroxybiphenyl.. 
Examination of the infra-red spectra of these compounds showed they were 
identical and possessed absorption bands at 1300 and 3400 nm, indicative 
of a secondary amide. 
A similar rearrangement and breakdown occurred during the 
chromatography of the products obtained by treating 4-hydroxylaminobiphenyl 
with either diazomethane or "silylating" agents. The retention times of 
4-aminobiphenyl and some related compounds and derivatives using an 
SE 30 column are recorded in Table 2.3.4. 
From this data it became clear that if the hydroxylamine could 
be quantitatively converted to 4-nitrosobiphenyl a method of assay 
might be developed. 4-Nitrosobiphenyl gives a peak on the chromatograph 
which is well separated from the solvent front., the parent amine and 
4-nitrobiphenyl -A number of oxidising agents were examined, 
but under 
conditions which may be useful for a routine assay they converted the 
hydroxylamine into 4-nitrosobiphenyl together with 4-nitro- and 
4-aminobiphenyl. The successful conversion of 4-hydroxylaminobiphenyl 
to 4- nitrosobiphenyl, without the formation of the other compounds, was 
achieved by the use of potassium ferricyanide as oxidising agent under 
slightly acid conditions. A number of compounds were examined as potential 
internal standards (Table 2.3.5) and from the results it was found that 
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either 3-methylphenanthrene or N-methyl-4-aminobiphenyl were suitable. 
The separation of 4-nitrosobiphenyl" from 4-aminobiphenyl and the internal 
standards is shown in Figure 2.3.1. Using this system it was possible to 
construct a calibration curve which was linear over the range 50 to 500 nano 
moles and which enabled the N-hydroxylation of 4-aminobiphenyl carried 
out by microsomal preparations to be studied quantitatively. 
The determination of the aminophenols and the hydroxylated products 
from 4-acetamidobiphenyl proved to be far more difficult cnd required 
that the metabolites be convertedto their trimethylsilyl derivatives. A 
number of "silylating" agents were tried under different conditions of 
solvent, basicity and reaction temperature. 
All the hydoxylated substances examined were converted to trimethyl- 
silyl derivatives by heating the substance with bis-silyl acetamide at 50' 
for twenty minutes in acetonitrile. The properties of these derivatives on 
OVI and OV 17 columns are recorded in Table 2.3.5. 
Unfortunately, whilst these derivatives had good peak shapes and 
convenient retention times it was very difficult to differentiate between the 
3-hydroxy and 2'-hydroxy compound derived from either 4-aminobiphenyl 
or 4-ace. tamidobiphenyl. Furthermore, the N-hydroxy derivative could only 
be quantitated as the rearranged 3-hydroxy compound, clearly undesirable 
when the possibility existed that metabolic hydroxylation could occur at 
both sites of the molecule. 4-(Biphenylyl)-glycolamide gave only a 
very poor response under the conditions used. 2-Amino-3-fluorenol (which is 
commercially available) was easily silylated and is a potentially useful 
internal standard. 
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A further complication arose in the fact that tissue preparations contained 
material which gave interfering peaks on the chromatograph. 
It is clear that GLC does not lend itself to the simultaneous determination 
of the products of hydroxylation at a number of sites on 4-aminobiphenyl 
and 4-acteamidobiphenyl. The number of samples to be analysed would 
make the development of a specific assay for each specific site of oxidation 
for too tedious and time-consuming. However, the techniques which were 
developed here were of considerable use in conjunction with TLC in 
confirming the identity of substances, following indications by R values f 
and response to detection reagents. 
2.3.4 Colorimetric Methods 
The reaction of ary1hydroxylamines with sodium amminoprusside to 
form coloured complexes reported by Boyland and Nery (1964) has been 
confirmed in this study with 4-hydroxylaminobiphenyl. The absorption 
spectrum and absorbance vs. concentration graph are shown in Figure 
2.3.2. The results obtained in aqueous solution indicate the sensitivity 
of the reaction; however, when the reaction was carried out in material 
derived from microsomal incubates the sensitivity was reduced by a factor 
of ten. 
The formation of a coloured complex between 4-acetamido-N- 
hydroxybiphenyl and ferric ions, which was used as a quantitative 
method by Booth and Boyland (1964), was also confirmed. Because of the 
need to carry out an extraction and yet gain information on only one site 
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B. Absorpticn spectra of complex formed between 4-hydroxylcminobiphenyl 
and sodiumamminaprusside 
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of oxidation, together with the risk of phenols being formed which may also 
give a positive reaction with ferric ions, the method was not used further. 
The oxidation of 4-amino-3-hydroxybiphenyl to 1,7-diph. enyl-4-amino- 
3H-isophenoxazin-3-one has previously been demonstrated by Nagasawa, 
Gutmann and Morgan (1959). As materials with structures of this type are 
often highly coloured it seemed that this reaction may be developed into a 
useful assay procedure for the determination of 4-amino-3-hydroxybiphenyl. 
The results obtained are shown in Figure 2.3.3; they show that whilst a 
coloured product is formed the low absorption of the product in the presence 
of microsomal constituents precluded this being developed into a useful 
assay. 
2.3.5 High Pressure Liquid Chromatography (HPLC) 
4-Aminobiphenyl, together with the possible metabolites discussed 
earlier, were examined by HPLC. The compounds gave characteristic 
peaks which were easily separated from each other by variation in the 
solvent composition. The RT values, which are recorded in Table 2.3.6, 
were reproducible under the solvent gradient systems developed, and they 
allowed the establishment of an assay method which not only permitted týe 
simultaneous determination of four sites of microsomal oxidation of 
4-aminobiphenyl but which also enabled the further oxidation of 4-hydroxy- 
laminobiphenyl to either 4-nitroso- or 4-nitrobiphenyl to be detected - 
The print-out for the standard compounds related to 4-aminobiphenyl 
6 
is shown in Figure 2.3.4. 
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Table 2.3.6. The chromatographic properties of 4-aminobiphenyl, 
4-acetamindibiphenyl__and some metabolites and some related 
compounds Using a HPLC system' 
Compound RT (sec) 
4-aminobiphenyl 300 
4-amino-3-hydroxybiphenyl 175 
4-ami no- 2'-hydroxybi phenyl 150 
4-amino-4'-hydroxybiphenyl 120 
4- N-hydroxyl am inobiphenyl 225 
4-nitrosobiphenyl 415 
4-nitrobiphenyl 480 
4,4-azobiphenyl 720 
4,4-azoxybiphenyl 560 
4-acetamidobiphenyl 335 
4- acetam ido-3- hydroxyb ipheny 1 255 
4-acetami do- 2'-hydroxybi phen yl 165 
4-acetamido-4-hydroxybiphenyl 122 
4-acetamido- N-hydroxybiphenyl 500 
4- N- (biphen ylyl)-91 ycol ami de 270 
4-N-(biphenylyi)-oxamic acid 125 
6 
The details of the chromatographic systems used are described in 
the text (Section 2.2.2.8.4). 
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Similar experience was obtained with 4-acetamidobiphenyl, although 
in this case the potential metabolites required a greater variation of solvent 
composition (see Section 2.2-2.8.4.1). The chromatogram (Figure 2.3.7) 
shows that oxidation on the 4'-, 2'- and 3- carbon atoms, and on the 
CH 
3 group of the acetamido 
function, can readily be detected, and the 
metabolites so formed can be distinguished from each other and from the 
parent amide and the hydroxamic acid. 
A single extraction of a microsomal incubate therefore allowed analysis 
of all the available potential hydroxylated metabolites of 4-aminobiphenyl, 
or 4-acetamidobiphenyl, respectively. 
2.3.6 Metabolism of 4-aminobiphenyl and 4-acetamidobi. phenyl, 
The results obtained from the qualitative studies have supported the 
early observations of Booth and Boyland (1964) in that, using rabbit tissue, 
the principal sites of microsomal oxidation of 4-aminobiphenyl were found 
to be either the nitrogen atom or the adjacent 3- position in the nucleus, 
whereas oxidation of 4-acetamido biphenyl occurred principally at the 
41- position. These observations have now been extended to rats, mice, 
hamsters and dogs. In the case of the amine two minor pathways of 
metabolism were detected using thin layer chromatography. 
These metabolites were first detected using tissue preparations from 
the guinea pig, a species which has a relatively low ability to hydroxylate 
4-aminobiphenyl in the 3- position. The technique used was to incubate 
six flasks, each containing 5 Umole of substrate, for thirty minutes, then 
- 115- 
extract the incubation mixture with diethyl ether as described earlier and 
bulk the ether extracts prior to examination by TLC. The areas of the 
chromatograms which corresponded in Rf to authentic compounds-were 
removed from the supporting plate and eluted with methanol, and this was 
again concentrated and an aliquot was re-examined by TLC. 
The remainder of the methanolic extract was evaporated to dryness, 
treated with bis-silylacetamide in acetonitrile and examined by GLC. 
The finding of metabolites which, as compared with authentic compounds, 
had identical chromatographic properties in several solvent systems and gave 
the some responses to detection reagents, and which gave si lyl derivatives 
with identical properties to those prepared from the authentic compounds, 
was considered very good evidence for the formation of both 4-amino-4- 
hydroxybiphenyl and 4-amino-2'-hydroxybiphenyl. These experiments were 
repeated using the above technique with hepatic microsomal preparations from 
rabbit, rats, mice and hamsters. In every case small amounts of the two new 
metabolites were detected. Using this technique, i. e. a combination of 
TLC and GLC, it was possible to find materials present on the TLC plates 
which had the properties of 4-nitrobiphenyl and 4-nitrcsoýiphenyl 
respectively. However, it is difficult to say whether 4-nitrobiphenyl was 
formed as a metabolite of 4-a minobiphenyl or whether it was caused by 
the on-column breakdown of either 4-hydroxylaminobiphenyl or 
4-nitroso- 
biphenyl. It is known that the former compound does break down to a number 
of substances when injected onto GLC systems (see earlier discussion 
in 
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this Section); however, the nitroso compound gave only one peak. It may 
have been that the microsomal extracts broke down during TLC due to the 
presence of ether-soluble material, perhaps peroxides formed during the 
incubation procedure. 
The metabolism of 4-acetamidobiphenyl was also examined using the 
above techniques, and again in agreement with the observations of Booth 
and Boyland (1964) it was found that hydroxylation at the 4-position was 
the major route of metabolism. 
Also in agreement with Booth and Boyland (1964) it was found that 
4-acetamidobiphenyl was hydroxylated at the nitrogen atom but not at the 
3- position in the nucleus. During metabolic studies with this compound 
a new minor metabolite was found which had the properties of 4-acetamido- 
2'-hydroxybiphenyl. Attempts at detecting N-(4-biphenylyl)-glycolamide, 
which would have been expected to have been formed as a metabolite 
(Fries, Kiese and Lenk, 1973) were unsuccessful - This may have been due 
to the lack of sensitivity of the methods used, as this material was detected 
using the HPLC system. 
The quantitative metabolism of 4-aminobiphenyl and 4-acetamido- 
biphenyl in various species was studied using the assay based on HPLC 
described earlier. The chromatograms of extracts of typical incubation 
mixtures containing 4-aminobiphenyl as substrate and rabbit or hamster 
hepatic microsomes as enzyme source are shown in Figures 2.3.5 and 2.3.6; 
and those obtained using 4-acetamidobiphenyl as substrate are shown in 
- 117- 
Figures 2.3.8 and 2.3.9. In these chromatograms the substances found in the 
qualitative study could be detected, together with N-(4-biphenyl)-glycolamide 
from 4-acetamidobiphenyl. Again a substance was formed from 4-amino- 
biphenyl which had the properties of 4-nitrobiphenyl. If the occurrence of 
this process - that is, the oxidation of an aromatic amine to an aromatic nitro 
compound - is substantiated then this will apparently be the first report of such 
a pathway in a mammalian system, although the process is known to occur in 
certain microbial systems. 
In order to gain further information about the enzymes involved in the 
metabolism of 4-aminobiphenyl and 4-acetamidobiphenyl a number of 
experiments were carried out establishing conditions for the comparative 
experiments using different species. 
The results obtained by varying the incubation time are shown in 
Table 2.3.7 and Figure 2.3.10. Production of all the metabolites from 4- 
aminobiphenyl increased with time up to twenty minutes of incubation. A 
similar result was obtained when 4-acetamido biphenyl was used as substrate, 
except that no change in the level of the 21-hydroxy compound was 
found 
after 5 minutes' incubation. A separate experiment was also carried out 
in 
which 4-aminobiphenyl was metabolised in the presence of fluoride 
ions. 
This was performed in order to establish whether fluoride had any 
inhibiting 
effect on microsomal oxidation, as it was routinely added to incubates 
in 
which 4-acetamidobiphenyl was a substrate. This was necessary 
in order to 
prevent deacetylation (see Section 3). The results show that no significant 
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a= 4-amino-4'-hydroxybiphenyl 
b= 4-amino-2'-hydroxybiphenyl 
c= 4-cimino-3-hydroxybiphenyl 
d= 4-hydroxylaminobiphenyl 
e= 4-aminobiphenyl 
f 4-nitrosobiphenyl 
g 4-nitrobiphenyl 
i 
f 
a 
4) 
a- 
b 
d 
g 
C 
\ 
11111filill -IIIIfII FT 1711111111 j7T TIIIýIIIIIII111111 time (sec. ) 
100 200 300 400 502 
Ei g 2.3.4. Computer printout showing standard compounds_ related to 
4-aminobiphen Z-11 
se crated y HPLC 
119- 
henyl 
henyl 
ienyl 
yl 
-0 
time (sec. ) 
122 222 322 422 520 
Fig. 2.3.5. Chromatogrcrn of extract from a microsomal incubate of 4-cminobiphenyl 
using rabbit hepatictissue 
- 120- 
phenyl 
pheryl 
)henyi 
nyl 
0 
CL 
0 
u 
(D 
time (sec. ) 
22 2 : 322 420 52 2 
Fig. 2.3.6. Chrornatogram of extract from a microsomal incubcte of 4-cminobiphenyl 
using harnster hepatic tissue 
- 121 - 
0 A 
0- 
time (sec. ) 
Fig 2.3.7. Computer printout showing standcrd compounds related to 4-ccetamidobiphenyl 
separated by H PLC A- 
102 2132 322 422 522 
- 122- 
time (sec. ) 
122 222 322 402 522 622 I Fig. 2.3.8. Chrornatogram of extract from a microsomal incubate of 4-acetamidobipheryl 
using rabbit hepatic tissue 
- 123- 
a= 4-acetcmid< 
b= 4-acetarnid( 
c= 4-acetamid< 
d= 4-N-(biphe 
e= 4-ccetcmid( 
f 4-cmincbipý 
g 4-acetcmid< 
a 
CL 
time (sec. ) 
-1 i0o 222 302 422 522 
2.3.9. Chrcmatograrn cf extract from a microsomal incubate of 4-acetamidobiphenyl 
using harnster hepatic tissue 
- 124- 
effect was caused by the inclusion of fluoride in the incubation media. 
was decided to use twenty minutes' incubation time for all further work. 
The influence of tissue and substrate concentration are recorded in 
Table 2.3.8. Increasing the tissue concentration caused an increase in 
metabolism at all sites of oxidation of both substrates; however,, this 
increase was not linear up to microsomes derived from 0.75g or original 
I 
liver, and it was therefore decided to use microsomes from 0.25g of liver 
for all further work. Increasing the apparent substrate concentration had 
little effect on any site of oxidation of either substrate (Table 2.3.8). 
This is perhaps not surprising as even at the lowest concentration the 
compounds are probably sufficient to saturate the solution and the oxidative 
enzymes. In all further work a substrate concentration of 5mM was used. 
Using the conditions established above, a comparative study on the 
ability of various sPecies to oxidise 4-aminobiphenyl and 4-acetamido- 
biphenyl was carried out. The results are recorded in Table 2.3.9. 
Considerable differences were observed, hamster tissue being the most 
active in i ts abi Ii ty to oxi dise vi rtua IIyaII the si tes on both substrates. 
In contrast , the dog general 
Iy had the poorest abi Ii ty to metabol ise -. the 
substrates. 
The guinea Pig, which possesses average ability to metabolise 
4-aminobiphenyl by metabolic attack on the N and 4'- position, has only 
one-third to a quarter of the average ability to hydroxylate in the 
3- 
position. In this species and the dog no evidence could be found to 
indicate 
that N-hydroxylation of 4-acetamidobiphenyl had occurred. 
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Fig. 2.3.10. The time course of N- and 4'-hydroxylation of 4-aminobiphenyl and 
4-acefamidobiphenyl 
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All species examined had the ability to metabolise 4-acetamidobiphenyl 
via an attack on the methyl constituent of the acetyl group, although 
considerable variation in activity was found; the rabbit and the mouse had 
about five times the abi I ity of the rat and the dog. 
The results obtained do not correlate very well with the carcinogenic 
activity of the substrates in a particular species. It is of interest that the 
hamster does have a very good ability to N-hydroxylate 4-aminobiphenyl 
and this compound is active in this species. However, the 'r. louse and the 
dog are also sensitive to 4-aminobiphenyl yet they produce much less N-hydroxy 
compound. 
The guinea pig, a species considered to be refractory to the effects 
of aromatic amines, is well able to N-oxidise 4-aminobiphenyl. It is 
clear that the further reaction of any compound formed (including reduction) 
will greatly influence the level of free compound actually available in any 
tissue, and it may be that further work is required to examine and 
quantitate these competing reactions. 
From the point of view of inter-species difference it is interesting 
that the ratio of ortho to peri-para, i. e. 3- to 4-, hydroxylation of an 
0 aromatic amine varies depending upon the species studied (see also 
Section 1.4), yet when the amine is acetylated ortho hydroxylation is 
completely abolished. 
The availability of an assay system which allowed two substrates to 
be examined for multiple oxidation products allowed some 
further 
experiments on the enzymology of the oxidative processes 
involved. 
- 130- 
Studies in which carbon mcnoxide was introduced into the incubation 
atmosphere were carried out and the results are shown in Table 2.3.10. In 
every case the presence of carbon monoxide inhibited the formation of 
products, suggesting the involvement of cytochrome P-450. However, the 
results were not uniform, and whilst increasing the ratio of carbon monoxide 
to oxygen caused a further decrease in the oxidation of 4- and CH 3- 
oxidation of 4-acetamidobiphenyl and N-oxidation of 4-aminobiphenyl, this 
did not occur at the other sites of oxidation of 4-aminobiphenyl. In these 
cases an increase in the CO: O 2 ratio to 
10: 1 did, however, produce a 
further fall in the oxidation products. It is also interesting that in these 
experiments performed using a low oxygen tension - that is, only 4% 
oxygen in the atmosphere instead of the normal 2 0%, 2'- and N-hydroxy- 
lation of 4-acetamidobiphenyl could not be detected. 
It was also of interest to pretreat animals with certain agents known 
to increase the activity of the microsomal enzymes. The results are 
presented in Table 2.3.11 . Contrary to the expected increase, 
3-methyl- 
cholanthrene caused a loss of enzyme activity at all sites of oxidation. This 
compound has previously been shown to increase the N-hydroxylation of 
4-chloroaniline when given to rats (Uehleke 1967). The effect of methyl- 
cholanthrene was virtually mimicked by pretreatment with Arachlor 1254, 
except that this agent did not produce decreased 4'-hydroxylase activity using 
4-acetamidobiphenyl as substrate. Phenobarbitone pretreatment did cause 
an increase in 4'-hydroxylation of both substrates and in N- and 3- hydroxy- 
lation of 4-aminobiphenyl; it was without effect on the N-hydroxylation 
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of 4-acetamidobiphenyl . The results give further support to the idea that 
differences exist in the enzymology of the N-hydroxylation of aromatic 
amines and amides (Gorrod, 1978a and b). The results are in agreement 
with those of Smith and Gorrod (1978) who reported that phenobarbitone 
pretreatment of rabbits caused an increase in the N-oxidation of aniline, 
4-toluidine and 4-chloroanifine, whereas 3-methylcholanthrene was 
without significant effect. Phenobarbitone pretreatment has also been 
reported to increase the N-oxidation of 2-naphthylamine when given to 
dogs (Uehleke and Mill, 1968) but it was without effect on the N- 
oxidation of 4-aminobiphenyl in rats (McMahon 1979, personal communi- 
cation). It seems that the response to an inducing agent is species-specific 
and extrapolation of data from one species to another is unwarranted. 
Certain experiments were carried out in which substances which were 
known to have an effect on microsomal oxidations were incorporated into 
the incubation mixtures. The results obtained in the presence of these 
compounds are recorded in Table 2.3.12. As was expected the well-known 
inhibitors SKF525A and DPEA (McMahon &Mills, 1961) both inhibited 
oxi dati on at aII si tes on both su bstrates stu di ed. Both SK F525A an dD PEA 
inhibited the N-oxidation of the amine and the amide to the same extent, 
although DPEA produced the greatest inhibition with each substrate. This 
result indicates that these N-oxidations are not carried out by the flavo- 
0 protein system described by Ziegler, Poulsen and McKee (1971), as this 
was activated by primary alkylamines. These authors found that the best 
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activator for this enzyme was n-octylamine, a substance which was also 
found to be a strong inhibitor of both aromatic amine and amide N- 
oxidation (Table 2.3.12). 
The flavoprotein N-oxidase was also reported to be inhibited by 
N- I-naphthyl thiourea (Ziegler & Mitchell, 1972) and strongly inhibited by 
meth imazole (Poulsen, Hyslop &Ziegler, 1974). The former compound did 
inhibit the N-hydroxylation of 4-aminobiphenyl; however, methimazole was 
without effect on this process. These latter results also suggest that the 
N-hydroxylation of 4-aminobiphenyl is not mediated via the flavoprotein 
amine oxidase. Recently it has been shown that bromazepam can activate 
a number of cytochrome P-450 dependent N-oxidations (Gorrod 1978a, 
Smith & Gorrod, 1978) and it was interesting to note that an activating 
influence was also found on both the 3- and N-oxidation of 4-aminobiphenyl 
and the conversion of 4-acetamidobiphenyl into the glycolamide. 
DABCO, a substance which has been used as a trapping agent for singlet 
oxygen (Ouannes & Wilson,, 1968) had virtually no effect on any site of 
oxidation of either substrate,. whereas adrenaline - which has the ability to 
react with superoxide anion (Ohnishi & Lieber, 1978) - virtually abolished 
the N- and 3- hydroxylation of 4-aminobiphenyl and the N- and 
CH3- 
oxidation of 4-acetamidobiphenyl. This could be interpreted as indicating 
the involvement of superoxide as the active form of oxygen produced by 
microsomes and utilised in the oxidation of xenobiotics. 
Perhaps the most 
surprising results were those where I -naphthyl thiourea and 
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i y -naphthoflavone were shown considerably to activate certain pathways. 
If these results can be substantiated in other species they may produce a 
useful tool to differentiate between the various forms of cytochrome P-450. 
At present it appears that all the oxidative pathways studied are mediated 
by cytochrome P-450. However, the different responses of each patý, way 
to potential inhibitors, activators,, inducing agents and change in oxygen 
tension suggest that more than one cytochrome P-450 is involved in the 
metabolism of these substrates. 
It is also interesting to note that N-acetylation abolishes hydroxylation 
of the 3-position; this could be explained by considering the orientation 
of the substrates within the microsomal matrix. 4-Aminobiphenyl gives 
a type II binding spectrum with cytochrome P-450, whereas 4-acetamido- 
biphenyl shows a very weak type I interaction (Gorrod & Disley, unpublished 
observations). If this indicates that 4-aminobiphenyl is forming a sixth 
ligand on the haem moiety, then this could be the orientating effect 
necessary to direct oxidation to the 3- position. In conjunction with Dr. M. 
Kibby, molecular orbital calculations were carried out on 4-cminobiphenyl 
and 4-acetamidobiphenyl in order to see if any correlation could be 
found between any electronic parameters of a site within the molecule and 
its susceptibility towards microsomal oxidation. The data generated 
by this 
study are recorded in the Addendum - 
In the present study no correlation could be found between the physico- 
chemical characteristics of a particular atom and its susceptibility to 
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microsomal oxidation. The calculations were carried -out assuming the 
molecules to be in the ground state. It may be that further calculations, 
in which the electronic characteristics of the substrates in the excited 
states are determined, may provide a correlation. 
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SECTION 3, THE "IN VITRO" HEPATIC DEACETYLATION OF 
AROMATIC ACETAMIDO COMPOUNDS 
- 139- 
3.1 INTRODUCTION 
The deacetylation of aromatic N-acetamido compounds has been observed 
in a variety of animal species in vivo, and in certain tissue preparations in 
vitro. The considerable variation in the ability of species to carry out this 
hydrolytic reaction, together with the variation of subcellular location of 
enzyme activity depending upon the substrate, has presently made it impossible 
to make any generalisations regarding the enzymes involved or their substrate 
specificity. 
The metabolism of aromatic a cetami do- compounds may be different from 
that of the corresponding amine (see previous section and section 1 . 4). For 
example, aniline is hydroxylated at both the ortho and para positions of the 
nucleus, depending upon the species studied, whereas acetanilide is pre- 
dominantly hydroxylated in the para position irrespective of the species studied 
(Parke, 1968). 
Similarly, 2-naphthylamine appears in animal urine hydroxylated in the 1- 
or 6-position depending upon the species, whereas with 2-acetamidcnaphthal, eak- 
the 6 position is the major site of nuclear hydroxylation. This change in the site 
of hydroxylation is particularly pronounced in the dog, a species which allegedly 
lacks the ability to acetylate aromatic amines. In this species 2-naphthylamine 
is excreted hydroxylated in the I position to an extent in excess of 90% of the 
dose administered. When 2-acetamidonaphthalene ls given to dogs less than 
5% hydroxylation occurs in the ortho position, it occurs predominantly in the 
6-(peri-para) position. ', section 1.4). 
When aromatic amines are administered to experimental animals, N-acetyl- 
ation occurs in most species; conversely when acetamido compoinds are given or 
formed, some hydrolysis occurs. For each substrate an equilibrium amine/amide 
ratio is observed depending upon the species. 
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As the carcinogenic response from aromatic amines appears to be elicited 
without the requirement for prior acetylation (e. g. dogs are susceptible to 
aromatic amines, but cannot acetylate them), it seems that the rates of 
acetylation, and subsequent deacetyiation, may be important not only in 
determining the site of metabolic hydroxyiation, but also in indicating whether 
a compound is likely to be carcinogenic in a given species. It was for these 
reasons that studies of deacetylation and acetylation of some aromatic amines 
(reported in Section 4) were carried out. , 
Elson, Goulden and Warren (1946) found that acetanilide and phenacetin were 
almost completely deacetylated when given to rats, whereas Smith and Williams 
(1948) failed to detect deacetylation when these compounds were administered 
to rabbits. Similarly, N 
4_ 
acetylsulphamethazine was deacetylated when given to 
pigeons, dogs and cats, but apparently not deacetylated when administered to 
either rabbit or man (Krebs, Sykes & Bartley, 1947), indicating a marked species 
difference. 
The in vitro hydrolysis of acetanilide was first reported by Michel, Bernheim 
and Bernheim (1937) who showed that this reaction was carried out by extracts 
of several rat tissues, the major activity being present in the liver and 
kidney. 
Acetanilide deacetylating activity was also present in hepatic extracts prepared 
from dog, cat, rabbit and ox. These authors compared results obtained 
from the 
hydrolysis of acetanilide with those from the hydrolysis of chloracetyl-l-tyrosine. 
They concluded that as the pH optima of these two enzyme activities were 
the 
same, and as the ratio of the activities 'ere the same in variois tissues, a 
common hydrolysing system was being utilised. This idea was not supported 
by Bray, 
James, Raffan, Ryman and Thorpe (1949), and Bray, James and Thorpe (I 949), who 
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studied the hydrolysis of N-acetylglycine and acetanilide in liver and kidney 
preparations from many species, and concluded that an enzyme was responsible 
for the hydrolysis of aliphatic acetamides different to that hydrolysing 
aromatic acetamides. Bray, James, Thorpe and Wasdell (1950) extended these 
observations to other aliphatic and aromatic acetamido compounds, and noted 
differences in the sensitivity of these substrate groups to hydrolysis with regard 
to acetone and heat treatment of the tissue preparation. These results supported 
the idea that more than one enzyme capable of deacetylating acetamido compounds 
was present in mammolian tissues. 
The first indication that deacetylation occurred during the metabolism of 
the carcinogen 2-acetamidofluorene came when it was observed that, following 
the administration of 
14 C-acetyl-2-acetamidofluorene to rats., 
14 C-carbon 
dioxide was detected in the expired air (Morris, Weisburger & Weisburger 1950; 
Weisburger, Weisburger & Morris, 1951). This was confirmed by Weisburger 
(1955) who showed that hydrolysis of 2-acetamidofluorene occurred in the presence 
of various tissue hornogenates derived from rats or mice. Weisburger (1955) also 
studied the hydrolysis of other isomers of acetamiclofluorene and found that, 
whereas the 2- and 4-isomers were hydrolysed at about the same rate., the 
and 3-isomers were deacetylated at only about one fifth of the rate of the 
2- and 
4-isomers. In these experiments the incubation times used were very 
long (two 
and twenty two hours), so that the initial rates of hydrolysis could not 
be measured. 
The deacetylation of 2-acetamidofluo: -ene by rat liver slices was confirmed 
by 
Peters and Gutmann (1955), who used radiochemical methods to 
follow the 
rates of hydrolysis. These authors also noted that rat 
liver slices were able to 
reacetylate the 2-aminofluorene formed, indicating that in the intact organ 
both 
- 142- 
reactions were possibie. 
Argus; and Ray (1959) examined the in vitro hydrolysis of a number of 
amide derivatives of 2-aminofluorene by 2N hydrochloric acid at 1000, 
and concluded that there was a relationship between the rate of hydrolysis 
of the amide linkage and the carcinogenicity of the compound, as those 
compounds which resisted hydrolysis were inactive in carcinogenicity tests. 
Studies on the intracellular localisation of aromatic amide deacetylating 
enzymes have produced conflicting results. Early studies by Hollinger (1960a) 
showed that an acetanilide deacetylase was present in a microsomal prepara- 
tion from rabbit liver. This enzyme was solubilised by treatment of the micro- 
somal preparation by freezing andthawing. Chromatography on a calcium 
phosphate column and elution by phosphate buffer resulted in the separation 
of thiý enzyme from another protein, which had the ability to hydrolyse the 
amide bond in monoethylglycinxylidide but not that in acetanilide. Hollinger 
and Niklasson (1962) found that the acetanilide hydrolysing activity of the 
solubilised enzyme was enhanced in the presence of albumin. 
In a series of publications on esterases Krisch and his colleagues described 
the hydrolytic properties of a number of proteins derived from various tissues. 
(Krisch, 1963a & b; Boguth, Krisch & Niemann, 1965; Benohr, Franz & Krisch, 1964- 
Benohr & Krisch, l 967a) . In these reports they showed 
that an enzyme with a 
v-., -ary high esterase activity could 
be isolated from the microsomal fraction of 
kidney and liver of the pig. Whilst this enzyme was able to 
hydrolyse aro-matic 
amides, the specific activity was very low compared to the specific activity 
obtained when aliphatic acetylamino : icids or amino acid esters were used as 
substrates. A similar protein was isolated from beef 
liver, (Benohr & Krisch 1967b), 
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but differences were noted in the substrate specificity of this enzyme compared 
with that obtained from pig liver and kidney esterase. The beef liver enzyme had 
the additional catalytic property of transferring the amino acid residues from amino 
acid esters to form dipeptides. Benohr and Krisch (1 967c) also showed that the 
enzyme from beef liver could be separated, using column chromatography, into 
two proteins, which were a monomer and dimer. These two forms of enzyme were 
interconvertible, the monomer having a molecular weight of 85,000, with one 
active centre, and the dimer 170,000, with two active centres. The enzymes 
were able to deacetylate a number of substituted anilides, but in no case did sub- 
stitution significantly enhance the rate of hydrolysis compared to that found with 
acetanilide. In all the cases studied para-substitution reduced the rates of 
hydrolysis compared to that found with acetanilide. Ortho-substituents generally 
increased the rates of hydrolysis compared with those found with the para-isomers. 
The acetanilide deacetylase activity was potently inhibited by organophosphate 
insecticides, sodium fluoride and SKF 525A. 
Bernhammer and Krisch (1965) investigated the hydrolysis of para-ethoxy- 
acetanilide (phenacetin) and para-carboxyacetanilide by the hog liver esterase. 
These authors found that whereas acetanilide was hydrolysed at about 391 n moles/ 
min/mg, para-ethoxy acetanilide averaged about 125 n moles/min/mg, and para- 
carboxy acetanilide was hydrolysed at only 0.45 n moles/min/mg protein. 
The 
low activity observed with the latter substrate was attributed to its 
being more 
polar and less lipid soluble than the other substrates studied. 
It is of interest that 
a deacetylase enzyme located in the cell cytoplasm 
has been isolated from 
kidneys of rats, rabbits, mice and guinea pigs 
(Franklin, Bridges &Williams, 1971). 
This enzyme has the ability to hydrolyse para-carboxyacetanilide 
but not 
acetanilide. 
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In view of the variations both in substrate specificity and enzyme distribution 
in various species it was decided to study the deacetylation of acetamidc 
compounds derived from carcinogenic and non-carcinogenic amines. The de- 
acetylation of acetamido compounds was followed by measurement of the parent 
amine by gas licluid chromatographic methods. The study was extended to 
various animal species in an attempt at correlation between rates of hydrolysis 
and carcinogenic activity of either the amine or its acetyl derivative in the 
species studied. 
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3.2 EXPERIMENTAL 
3.2.1 Materials 
I-Acetamidonaphthalene, 2-acetamidonaphthalene, 2-acetamidobiphenyl 
and 4-acetamidobiphenyl were all prepared by acetylation of the corresponding 
amine with acetic anhydride in pyridine. The acetamido compounds were re- 
crystallised to constant melting point from aqueous ethanol. All acetamido- 
compounds had melting points consistent with those recorded in the literature; 
they gave one detectable substance when examined by gas liquid chromatography 
or thin layer chromatography. 2-Acetamidofluorene and 1-thioacetamido- 
naphthalene were purchased from Koch-Light Laboratories Ltd. 
The corresponding aromatic amines were obtained and purified as described 
in Section 8.2. The ary I hydrocarbons used were gifts from Dr. P. Sims. Reagent 
grade diethylether (B. D. H) was distilled before use. Sodium fluoride was 
obtained from B. D. H., SKF525A from Smith Kline and French Laboratories and 
E600 was a gift from Dr. D. Temple, Universitat Frankfurt. 
3.2.2 Tissue preparations 
Hepatic tissue fractions were obtained as described in Section 2.2 from 
adult male animals. In one case tissue from a 75 yr old human male, who had 
died Four hours earlier from massive cerebral haernorrhage, was used. 
3.2.3 Assay of aromatic amines, 
3.2.3.1 Gas chromatographic system 
A Perkin-Elmer F11 gas chromatograph fatted with a two metre glass column 
o. d. z'", packed with Silicone gum rubber SE30 2.5% on AW/DMCS treated 
Chromasorb G (80-100 mesh'), was used throughout this work. The oven 
00 
temperature was maintained at 190 , the injection temperature was 210 
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3.2.3.2 Oetimum gas pressUre. 
The optimum gas pressures for the flame ionisation detector system were 
determined by injecting onto the column standard volumes of ethereal solutions 
of the amines using a glass micro-syringe fitted with a Cheney adaptor. A 
nitrogen pressure of 15 lbs/square inch was maintained during these measure- 
ments. After first determining the optimum hydrogen pressure, with the air 
pressure held constant, the air pressure was varied whilst the hydrogen pressure 
was held constant. 
3.2.3.3 Petermination of retention times for substrates and amines 
Using the optimum conditions established in 3.2.3.2, ethereal solutions of 
the acetamido compounds and the corresponding aromatic amines were chroma- 
tographed and the retention times were recorded. 
3.2.3.4 Choice of suitable internal marker 
A number of aromatic hydrocarbons were examined as potential internal 
marker. They were subjected to chromatography as described in 3.2.3.3 and 
their retention times were recorded. 
3.2.3.5 
_Linearity 
of detector response 
Solutions of the aromatic amines in ether, containing the internal marker 
established in 3.2.3.4, were injected onto the gas chromatograph. Volumes 
ranging from 0.5 to 2.0 4 litre were injected using a micro, -syringe fitted A th 
a Cheney adaptor. The peak heights of the amines and the internal marker 
were measured. 
3.2.4 Properties of arylacetamide deace se 
3.2.4.1 
_Incubation 
procedure 
All incubations were carried out in 50 ml conical flasks fitted with 
40 
ground glass stoppers in a Gallenkamp shaking incubator at 370. 
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3.2.4.2 Composition of incubate 
The incubate consisted of tissue., usually derived from 0.5 9 of liver 
suspended in 2 ml of tris/KCI, pH 7.4, and substrate, usually 10 ý4moles 
in 3 ml phosphate buffer, pH 7.4. 
3.2.4.3 Substrate specificity of deacetylase acti 
Acetamido compounds and N-1-naphthylthioacetamide were incubated 
with rabbit whole liver homogenates at pH 7.4 as described in 3.2.4.1 
and 3.2.4.2 for thirty minutes. The incubate was then extracted with ether, 
and the ethereal extract examined by chromatographic techniques'for the 
presence of the deacetylated compound,, as described in 3.2.3. 
3.2.4.4 Subcellular distribution of de. acetylase activity 
Acetamido compounds were incubated with various mouse hepatic cell 
fractions at pH 7.4, prepared as described in Section 2.2. The aromatic 0 
amines produced during a thirty minute in. cubation were determined by gas- 
liquid chromatography. 
3.2.4.5 Determination of pH optimum of deacetylase activity 
Acetamido compounds were incubated with a rat hepatic microso. mal 
preparation in the presence of phosphate buffers of differing composition 
in order to vary the final pH of the incubation system between pH 6.0 and 
pH 9.0. After thirty minutel incubation the pH was adjusted to 7.4 and 
the aromatic amines produced were determined by gas-liquid chro,, -natography. 
3.2.4.6 Influence of microsomal protein concentration on theedeacety-latio-n 
of arylacetamides. 
Arylacetamides were incubated with a rabbit hepatic microsomal prepara- 
tion. Flasks containing 10umoles ofsubstrate were incubated with microsornes 
equivalent to 0.125,0.25,0.5 and I Og of original liver tissue-, for twenty 
minutes. The arylamines produced were determined by gas-liquid chromatography. 
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3.2.4.7 Influence of incubation time on the deacetylation of arylacetamides 
Arylacetamides (IOpmoles)were incubated with hepatic microsomal preparations 
derived from various animal species as described in 3.2.4.1 and 3.2.4.2. The 
enzymic reactions were stopped at either 10,20,30., 45 or 60 minutes of incuba- 
tion, and the arylamine produced analysed by gas-liquid chromatography. 
3.2.4.8 Influence of certain inhibitors on deacetylase activity 
Arylacetamides (10 P-noles)were incubated with a rabbit liver microsomal 
preparation as described in 3.2.4.1 and 3.2.4.2. Control experiments were 
carried out in which no inhibitors were incorporated into the media. In other 
experiments various amounts of sodium fluoride, SKF 525A (diethylaminoethyl- 
dipheny I propy I acetate hydrochloride) or E600 (diethy I- p- ni tropheny I phosphate) 
were incorporated to investigate their possible inhibitory effects. 
3.2.4.9 The influence of some metal ions on deacetylase act-*v 
0 
The influence of some metal ions on deacetylase activity was examined 
by their incorporation into the incubation media at a final concentration of 
2gm, oles/ml. The metals were ail added as their chlorides. The substrate 
concentrations were 2; 1 -noles/ml. In this experiment rat liver microsomes 
were used and the incubation time was thirty minutes. 
3.2.5 Prol-ein determination 
Protein was determined by the Miller (1959) modification of the Lowry, 
Roseborough, Farr and Randall method as described in Section 7.2.3. 
3.2.6 Partition coefficients 
Partition coefficients of the arylacetamide substrates were determined by 
measuring their distribution between water and n-octanol. The solvents were 
saturated with the alternate phase prior to use, and equilibrium was established 
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by use of a bench rocking device for sixteen hours at room temperature. The 
initial and final concentrations of the acetamido compounds in the aqueous 
phase were determined using a Hilger ultraviolet spectrophotometer at the 
respective absorption maximum for each substan. ce. Concentratloos were deter- 
mined by comparison with a calibration curve constructed from serial dilutions 
of standard stock solutions of the acetamido compounds. 
a 
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3.3 RESULTS AND DISCUSSION 
3.3.1 Development of a gas chromatographic assaX for aromatic amines 
The results obtained after varying the gas pressures to the chromatographic 
detector are summarised in Table 3.3.1 . Increasing peak heights were observed 
upon decreasing the hydrogen pressure from 25 to 10 lbs/sq. inch. However, 
when hydrogen pressure below 10 lbs/sq. inch was used considerable instability 
of the detector response was observed. From these experiments it was decided 
to use a hydrogen pressure of 15 Ibs/sq. inch for further work. 
Under these conditions an increase in the pressure of air to the detector 
produced an increase in detector response. Instability of the instrument 
characteristics was observed at air pressures above 25 lbs/sq. inch, so that this 
pressure was used for subsequent work. The optimum hydrogen pressure was 
confirmed as 15 lbs/sq. inch in a further experiment when the air pressure was 
maintained at 25 lbs/sq. inch. 
Using the optimised gas pressures, the retention times of various substrates 
and the corresponding aromatic amines were determined. Preliminary experi - 
ments indicated that an oven temperature of 190 
0 was required in order to 
obtain sharp symmetrical peaks. The choice of this temperature allowed 
analysis of all the amines of interest as their retention times were short enough 
to be conveniently measured. 
The retention times of the acetamido compounds of interest and the corres- 
ponding aromatic amines are recorded in Table 3.3.2. 
Good separation of all the acetamido compounds from the corresponding 
aromatic amines was observed. Of the aromatic hydrocarbons examined for use 
as internal markers, only anthracene and phenanthrene had convenient retention 
times. Highly purified anthracene was commercially available and was chosen 
for further studies. 
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Table 3.3.1 . The effect on Ae detector response of varyin g the gas pressures 
during chromatography of some aromatic amines. 
Hydrogen 
Pressure* 
Detec or 
2ABP`+ 
response in 
4ABPI+' 
cm. 
I AN+ 2AN+ 2AFý 
25 17.3 8.5 15.1 11.9 4.6 
20 34.1 10.7 22.1 24.0 7.4 
15 48.0 16.0 35.0 32.5 13.0 
10 52.0 22.5 35.5 36.5 9.3 
keeping air at 15 lbs/sq. inch and nitrogen at 15lbs/sq . inch. 
Air 
Pressure* 
Detector 
2ABP +I 
response in 
4ABR+ I 
cm . I AN-+ 2AN+ 2AP+ 
20 65.0 31.8 46.8 56.7 12.0 
25 73.5 29.5 52.2 52.2 14.5 
30 79.0 25.8 53.5 49.0 17.0 
keeping hydrogen at 15 lbs/sq. inch and nitrogen at l5lbs/iq. inch, 
Hydrogen 
Pressure* 
Detector respons 
2A BP 4A B Fý 
in cm. 
IA N-- 2AN+ 2AF+ 
26 10.2 3.9 10.3 7.4 2.4 
22 12.3 7.6 11.5 12.0 3.6 
18 17.8 9.4 16.8 13.8 5.0 
14 18.8 10.3 17.8 17.0 5.9 
10 16.5 6.6 15.5 14.2 3.8 
keeping air at 25 lbs/sq. inch and nitrogen at 15 lbs/sq. inch 
* Al I pressures are recorded as I bs/sq. inch - 
2AB P 2-aminobiphenyl 
4ABP 4-aminobiphenyl 
IAN I-aminonaphthalene 
2AN 2---iminonaphthalene 
2AF 2-aminofluorene. 
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Table 3.3.2ý The retention times of some acetamido compounds, corresponding 
4 
aromatic amines and some potential internal markers. 
Compound Retention Time * 
min. and sec. 
1-acetamidonaphthalene 5 15 
1-aminonaphthylamine 2 03 
2-acetamidonaphthalene "5 30 
2-aminonaphthalene 2 10 
2-acetamidobiphenyl 4 45 
2-aminobiphenyl 2 20 
4-acetamidobiphenyl 10 30 
4-pminobiphenyl 3 32 
2-acetamidofluorene 18 30 
2-aminofluorene 6 58 
1 -th i oacetami donaphtha I ene 
7 00 
naphthalene 
1 00 
anthracene 
4 10 
phenanthrene 
4 20 
3-methylphenanthrene 6 
45 
11 30 
pyrene 
Using 2.5% SE30 on AW/DMCS treated Chromosorb 
G (80-100', mesh); 2 metre 
II A. glass column at 1900. xo, 
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2 
vo! ume of aromatic amine injected (41) 
Figure 3.3.1. The relationship between detector response to aromatic amines 
and volume of solution injected. 
0.5 1.0 2.0 
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The results of the experiments performed to check the linearity of 
detector response are shown in figures 3.3.1 and 3.3.2. When various 
volumes of standard solutions of aromatic amines are injected onto the 
chromatographic column a linear response was found up to 2.0 glitre 
injected. Similarly, when the standard solutions contained both the amine 
and the internal marker a linear relationship was found, irrespective of 
the volume injected. It was concluded that the chromatographic system 
was suitable for the analysis of aromatic amines derived from acetamido 
compounds. 
3.3.2 Final assay procedure used for the measurement of aromatic amines. 
The deacetylation reaction was stopped by the addition of ether (10 ml) 
and cooling in an ice bath. A solution of anthracene (5 ý. vnol, ýin ether (I ml) 
was added, and the aromatic amines extracted into the ether by multiple 
inversions during twenty minutes. An aliquot of the ethereal phase (1-2 41) 
was injected onto the gas chromatograph and the peak heights of the amine 
and the anthracene measured. The oven temperature was maintained at 
190 0 
0. "' o. d. glass and the injection block at 210 The column was 2 metre z 
containing SE30 2.5% on AW/DMCS treated Chromosorb G (80-100) with 
nitrogen as the carrier gas at 15 lb/sq. in. The gas pressure to the 
F. I. D were hydrogen 
15 lbs/sq. inch and air 25 lbs/sq. in. Using standard amounts of aromatic ami nes, 
a linear relationship between peak height ratio of amine to internal marker 
(anthracene) was obtained fro,. -n 0.1 to 10 gmoles of amine. 
The amount of amine produced by deacetylation was calculated 
by reference 
to standard curves constructed by the addition of known amounts of aromatic 
amines to microsornal suspensions and assayed as above. 
height of response to aromatic amine (cm. ) 
Figure 3.3.2. The relationship between detecto, response to aromatic amines 
and internal standard after injection of various volumes of 
solution. 
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3.3.3 Detection of aromatic amines derived from acetamido compounds 
Following the incubation of acetamido compounds with tissue preparations 
the mixture was extracted with ether and the extract examined using the gas 
chromatographic system developed above. The ether extract was also examined 
using thin layer chromatographic plates coated with si lica gel (0-. 25 mm) and 
developed with petroleum ether(b. pBO-10e) acetone mixture 4: 2 by volume. 
In both gas chromatographic and thin layer chromatographic systems only the 
presence of the corresponding aromatic amine was detected in addition to the 
unchanged substrate. The aromatic amines had identical properties to 
authentic material in these chromatographic systems, and gave the same 
response to detecting reagents as known compounds on thin layer plates. No 
other compounds derived from the acetamido substrates were detected. 
Using N-1-naphthylthioacetamide as a potential substrate, no evidence 1. 
could be obtained for hydrolysis even though the techniques used were 
capable of detecting 0.1 % of the substrate being hydrolysed. 
3.3.4 Intracellular distribution of mouse hepatic N-a! ylacetamide 
deacetylase 
The results obtained using four arylacetamides as substrates with various 
hepatic cell fractions are recorded in Table 3.3.3. Hydrolysis of all aryl- 
acetamides with al I cel I fractions was observed; however, the amounts of 
amines produced with the lysosome and mitochondrial fraction were small 
compared to that obtained using the microsomal fraction. Very little activity 
was found in the cell vipernatant. The activity found in the microsomal 
fraction was not removed when the microsomes were washed by resuspension 
and recentrifugation. In each case the highest specific activity, calculated 
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Table 3.3.3. Intracellular distribution of mouse hepatic N-arylacetamide 
deacetylase 
Substrate Fraction 14 pi mol ami ne 
31 Specific activity 
4 
liberated 
I 
2-Acetamidobiphenyl LM 5 1.12 0.11 
m 3.75 0.98 
wm 3.55 1.54 
s 1.12 0.06 
4-Acetamidobiphenyl LM 2.12 0.29 
m 4.38 1.14 
wm 4.06 1.77 
s 0.14 0.007 
1 -Acetamidonaphthalene LM 0.08 0.011 
m 0.56 0.15 
wm 0.50 0.22 
s 0.04 0.002 
2-Acetami donaphtha I ene LM 0.22 0.03 
m 1.12 0.29 
wm 1.23 0.53 
s 0.045 0.002 
6 
I. 10 ý4mo les 
2. LM = 7.3; M=3.84; WM = 2.3; 0S= 
18.7 mg protein 
3. During 20 mins' incubatioR at 37 C YA tiv tissup equivalent to 0.5g of origional 
liver 
4. A MOI ei/mg protein 
5. LM = lysosome and mitochondria 
M= microsomes 
WM= washed microsomes 
S= supernatant 
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qs, umoles/mg protein, was associated with the microsomal fraction and this 
was greatly increased using washed microsomes. 
It can be assumed that washing the microsomes removes a certain amount of 
extraneous protein. The results clearly show that N-arylacetamide deacetylase 
activity is associated with the endoplasmic reticulum and it is probable that the 
activity found with the other cell fractions is caused by contamination of the 
fractions with endoplasmic reticulum. The above observations are in line with 
those of Krisch and coworkers cited earlier., who found acetanilide hydrolysing 
activity associated with the microsomal fraction in the livers of various species. 
The lack of activity found in the cell supernatant is in contrast to the obser- 
vations of Franklin, Bridges and Williams (1971) using para-carboxy acetanilide 
as substrate, and show that at least two deacetylating systems must be present in 
0 
the liver. It appears that the soluble enzyme preferentially hydrolyses polar 
acetanilides, whilst the microsomal enzyme is responsible for the hydrolysis of 
the non-polar compounds. 
3.3.4 The pH optima of the microsomal deacetylating enzyme 
The pH vs. activity curves for four enzyme substrates are shown in Fig. 3.3.3. 
In all cases an increase in hydrolysing activity occurred between pH 6.0 and 8.5. 
At pH 9.0 a slight decrease in hydrolysing activity was found. Attempts to 
extend the pH range, in either the acid or alkali rangeTesulted in precipitation 
of the microsomal protein. The pH optimum for the enzyme activity was established 
as being in the region of 8.5, an observation in very good agreement with the 
data of Krisch (1963), who found that the microsomal acetanilide hydrolysing 
activity was maximal at p. 9 8.4and Hollinger (1960b) who found a pH optimum 
of 8.5 for both a particulate and solubilised microsomal ethylglycinexylidide 
hydrolysing enzyme. 
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3-0 
-0- 2-acetamidobiphenyl 
-Am'. 4-acetamidobiphenyl 
'l -acetamidonaphthalene 
2-acetamidonaphthalene 
_0 
2-0 6 
1.0 
6-0 6-5 7-0 7-5 8-0 8-5 9-0 
pH of incubate 
Fig. 3.3.3. The effect of pH on the m', crosomal hydrolysis of N-arylacetamides. 
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The pH optimum for the soluble paracarboxyacetanilide hydrolysing enzyme 
has not been reported. 
3.3.5 The influence of substrate concenlration on the deacetylation of 
aromatic acetamides 
The effect of increasing the substrate concentration on the hydrolysis of four acetamido 
compounds is shown in Fig. 3.3.4. In the case of 2-acetamidobiphenyl and 
2-acetamidonaphthalene increasing the concentration of the substrate, even 
up to 50, mmotes perflask, was accompanied by an increased amount of amine 
produced. I-Acetamidonaphthalene and 4-acetamidobiphenyl hydrolysis 
did not appreciably increase when the substrate concentration was increased 
beyond 10pioles per flask. 
Attempts to raise the substrate concentration of these latter two substances 
above- 10, Mmoles per f lask. resul. 
-fed 
in visible precipitation of the aryl acetamide 
from solution. In the light of this result it was decided to use 10 junojes of each 
substrate per flask in further experiments. 
3.3.6 The influence of incubation time on the course of hydrolysis of 
aromatic acetamido compounds by liver microsomes 
The time course of hydrolysis of four acetamido compounds is shown for 
rabbit microsomes in Figure 3.3.5. It can be seen that whereas the hydrolysis 
of 4-acetamidobiphenyl and 2-acetamidonaphthalene gave a linear relationship 
with time up to sixty minutes of incubation, 2-acetamidobiphenyl and I -aceta- 
midonaphthalene both deviated from linearity early. This phenomenon was 
seen in all the species studied and created difficulties when comparing a series 
of substrates in various species. This was overcome by using short incubation 
times (see 3.3.7). 
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Control experiments in which tissue preparations were excluded or the 
microsomes were denatured by prior heating at 950 for twenty minutes 
demonstrated that no aromatic amine was produced by a non-enzymic 
reaction. 
3.3.7 The influence of some_metal ions and some potential inhibitors on 
microsomal deacetylation. 
To clarify the situation with regard to the possible multiplicity of enzymic 
deacetylating systems, experiments were carried out in which the effects of 
metal ions on the cleacetylation of 2-acetamidobiphenyl and 4-acetamido- 
biphenyl were observed. The results are shown in Table 3.3.4. No effect 
of sodium, manganese, calcium or iron on the hydrolysis of either 2- or 4- 
acetamidobiphenyl was detected, neither was their rate of hydrolysis stimulated 
by the incorporation of manganese ions. This is in agreement with Franklin, 
Bridges & Williams (1971) who found stimulation of the rat kidney deacetylase 
but not rat hepatic deacetylase by this metal ion. The inhibition of deacetylase 
activity by copper, zinc and mercury is in agreement with Nimmo-Smith (1960), 
and Franklin, Bridges & Williams (1971). 
In contrast to the inhibition of hydrolysing activity found with SKF 525A 
by Hollinger (1960), no effect was observed when this compound was added 
to incubates containing either 2- or 4-acetamidobiphenyl (Table 3.3.5). 
Bernhammer and Krisch (1965) found only a slight inhibition of the 
deacetyla- 
tion of phenacetin by SKF 525A although acetanilide hydrolysis was 
inhibited 
at 10 -4 M (Benohr & Krisch, 1967b). Strong inhibition was observed 
in the 
presence of either sodium fluoride (Table 3.3.6) or E600 
(Table 3.3.7. ). 
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Table 3.3.4. The effect of metal ions on the deacetylation of 4-acetamidobiphenyl 
and 2-acetamidobiphenyl by rat liver microsomes. 
Addition 4-aminobiphenyl 
2.0 p-no I es/m formed* (prnoles) 
none 0.38 
Mn ++ 0.40 
Na + 0.39 
ca ++ 0.39 
Fe ++ 0.40 
Cu ++ 0.30 
Zn ++ 0.25 
Hg ++ 0.02 
2-aminobiphenyl 
formed* - (Wnoles) 
4.02 
3.94 
4.05 
3.95 
3.85 
2.98 
1.52 
0.05 
*During thirty minutes incubation at 37 
0. 
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Table 3.3.5. The effect of SKF 525A on the hydrolysis of 2- and 4- 
acetamidobiphenyl by rabbit liver microsornes. 
Addition A motes aromatic amine formed* 
2-aminobiphenyl 4-aminobiphenyl 
None 6.55 1.24 
SKF525A 2x 10-3 M 6.47 1.20 
1x 10-3 M 6.72 1.32 
2x 10-4 M 6.60 1.26 
I 
ýx 
10-4 M 6.70 1.20 
* During thirty minutes'incubation at 37 0 
Table 3.3.6. The effect of sodium fluoride on the hydrolysis of 2- and 4- 
acetamidobiphenyl_by rabbit liver microsomes 
Addition 2-aminobiphenyl 
formed*Wmoles) 
% inhibition 4-aminobiphenyl 
I% inhibitio 
formed * (A)molc-s): j 
TI 
none 4.27 0.90 
NaF 10 -4 M 1.87 56.2 0.28 ý 68.7 
NaF 10-3 m 0.50 
1 88.3 1 0.02 ý 97.6 
NaF 10 -2 M10.06 
1 98.7 1 0.01 1 98.8 
* During twenty minutes incubation at 370 
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Table 3.3.7. The effect of_ di ethy I- p- nitropheny I phosphate (E600) on th-e 
hydroiysis of 2- and 4-acetamidobiphenyl by rabbit liver 
mi crosomes. 
Addition pmoles amine formed 
2-aminobiphenyl 4-aminobiphenyl 
none 6.27 1.12 
E600 10 M 0 0 
E600 10- 
3M 0 0 
E600 10 -4 M 0 0 
E600 10 -5 M 0 0 
E600 10-6 M 0.24 0.12 
0 
During 20 minutes"incubation at 37 
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The inhibition observed in the presence of fluoride substantiates the 
work of others. Seal and Gutmann (1959) used fluoride as an inhibitor 
in their studies on the hydrolysis of 2-acetamidof luoren% as did Grantham, 
Weisburger and Weisburger (1965). Booth and Boyland (1964) had previously 
shown that the hydrolysis of 4-acetamidobiphenyl by rabbit hepatic micro- 
somes was inhibited by fluoride. The complete inhibition of týýe microsomal 
deacetylating system observed in the presence of E600, even at low concen- 
trations, is in agreement with the studies of Benohr and Krisch (1967b), who 
found no hydrolysis of acetanilide by a beef microsomal enzyme in the 
presence of 10- 
5 
molar E600. This organophosphate also inhibits the de- 
acetylation of N-hydroxy-2-acetamidofluorene (Irving, 1966). 
3.3.8 Species differences in the deacetylation of aromatic acetamides 
The results obtained for the comparative deacetylating ability of hepatic 
microsomes derived from common laboratory species and man are shown in 
Table 3.3.8. In the comparison of the isomeric acetamido biphenyls, in all 
cases except the mouse, the 2-isomer was deacetylated at a far greater rate 
than the 4-isomer. This is of particular interest as this would mean that 
animals exposed to 2-acetamidobiphenyl are likely to be exposed to high 
concentrations of -2-aminobiphenyl metabolically derived from it, with the 
a concorr, ittant risk of amine toxicity. Conversely, animals treated with 
4-acetamidobiphenyl would be expected tobe exposed'only to lower concen- 
trations of 4-aminobiphenyl with a lower risk of amine toxicity. In the 
mouse, a species in which liver tumours are produced following exposure 
to 
4-aminobiphenyl, the high deacetylating activity observed towards 4- 
acetamidobiphenyl indicates that this compound might also be carcinogenic 
as a result of its conversion to 4-aminobiphenyl . 
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Tabie 3.3.8. Species differences in the deacetYlation of arylacetamides by 
hepatic microsomes 
Species 4-acetamido- 
biphenyl 
2-acetamido- 
biphenyl 
2-acetamido- 
naphthalene 
I-acetamido- 
naphthalene 
Rat o. 4o 4.50 0.45 o. 4o 
Rabbit 0.54 3.20 0.62 1.45 
Guinea Pig o. 4o 3.64 0.75 4.75 
Mouse 2.90 2.45 0.40 0.25 
Dog 0.35 1.92 0.05 0.12 
Cat 0.21 3.68 0.63 0.44 
Human 0.39 1.05 0.54 0.12 
ThE results are expressed-aspmoles-substrate hydrolysed per gram of liver during 
#. 0 
ten minutes incubation at 37f from lOpmoles of. substrate. The results are 
derived from duplicate experiments from at least two animals. The cat and 
human data are from duplicate experiments on only a single sample of tissue. 
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Exposure of dogs to 4-acetamidobiphenyl is known to produce tumours 
of the urinary bladder (a process which does not require an acetamido group), 
so that it is tempting to suggest that the rate of deacetylation of this com- 
pound, in this species, is high enough to produce carcinogenic levels of 
4-aminobiphenyl. However, if this were so then as the rates of -deacetyla- 
tion observed in the other species were comparable, bladder tumours might 
also have been expected upon exposure to 4-acetamidobiphenyl. 
The fact that this is not the case suggests that the dog is unique in 
either possessing a further metabolic pathway to the active carcinogen, or 
that it lacks a detoxication pcthway, so that the 4-aminobiphenyl levels 
remain high. The results obtained from investigations of these possibilities 
are discussed in sections 2 and 4. 
Comparison of the rates of enzymic hydrolysis of the isomeric acetamido. 
naphthalenes shows that generally the non-carcinogenic I-isomer is 
hydrolysed faster than the carcinogenic 2-isomer. The very low deacetylase 
activity found for 2-acetamidonaphthalene in the dog is consistent with the 
finding that dogs excrete very little of a dose of this compound as metabolites 
possessing a free amino, gro-up. In the one human liver preparation studied 
the rate of deacetylation of 2-acetamidonaphthalene was as high as that of 
the experimental animals examined, indicating that man exposed to this 
compound may be at a similar risk to those exposed to 2-naphthylamine. 
In other experiments, not recorded here, it was found that 2-acetamido- 
fluorene was deacetylated at a rate slower than any of the other acetamido 
compounds tested, whereas acetanilide was hydrolysed at a faster rate. 
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It shouid be noted however that this comparison of species and substrates 
is not strictly validas differences in solubility precluded working at a common 
saturating substrate concentration. The concentration used was saturating 
for 4-acetamidobiphenyl and the figures shown in Table 3.3.8 are- indicative 
of the true potential of the hepatic microsomes to hydrolyse this substrate. 
In the case of 2-acetamidobiphenyl and 2-acetamidonaphthalene, this is 
not the situation and, as can be seen from Figure 3.3.4. exposure of the tissue 
preparations to higher concentrations of these substrates would have produced 
a higher rate of hydrolysis. As the actual concentration of the substrates in 
the hepatic endoplasmic reticulum in vivo is not known, it is difficult to 
extrapolate from the in vitro to the in vivo situation. In a study of the 
metabolism of 2-aminobiphenyl in rats, Gorrod and Carey (1970) failed to 
find any urinary metabolites in which the amino group was acetylated. The 
high in vitro deacetylase activity found in these experiments suggest that even 
if 2-aminobiphenyl had been acetylated, the product would have been 
subjected to extensive hydrolysis. 
3.3.9 Partition coefficients of some arylacetamido compounds 
The octanol-water partition coefficients were determined as described in 
3.2.6 and are presented in Table 3.3.9. It can be seen that comparison of the 
isomeric pairs of either acetamidobiphenyls or acetarnidonaphthyls, reveals 
large differences in the partition coefficients. In both the cases studied, the 
amide having an ortho substituent had the smaller partition coefficient. 
Conversely, those with a blocked para position were more lipid soluble. 
This 
partition coefficient appears to be further increased when rigidity is 
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introduced into the molecule; e. g. the introduction of a methylene bridge into 
4-acetamidobiphenyl to give 2-acetamidofluorene doubled the partition co- 
efficient. 
Table 3.3.9 The octanol-water partition coefficients of some arylacetamides 
Compound Partition coefficient 
I- acetamidonaphthalene 55 ±2 
2- acetamidonaphthalene 414 ± 50 
2- acetamidobiphenyl 125 ± 25 
4- acetamidobiphenyl 1250 ± 100 
2- acetamidofluorene 2660 ± 30 
The results presented in this section clearly show that there is present in 
animal hepatic tissues an enzyme which can deacetylate aromatic acetamido 
compounds. This enzyme activity is shown to be associated with the microsornal 
fraction of liver cells and is able to hydrolyse I- and 2-acetamidonaphthalene, 
2- and 4-acetamidobiphenyl, 2-acetamidofluorene and acetanilide to the 
parent aromatic amines. This system was not able to hydrolyse the thioacetyl 
compound studied. 
The studies carried out with the inhibitors indicate that this enzyme is 
probably the same as that solubilised and purified by Krisch and his coille-agjes. 
Bernhammer and Krisch (1965) consider that this enzyme is probably 
identical 
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to ali-esterase. If this is the case then it is of interest that in addition to the 
very high hydrolytic activity shown towards esters of carboxylic acids and 
amino acids the enzyme also possesses a low deacetylase activity. Whether 
the same active centre is involved in all these activities is not at present 
known; however, similarities in response to inhibitors suggest that only one 
centre is involved. Contrary evidence comes from the work of Bray, James, 
Raffan, Ryman & Thorpe (1949), and Bray, James, Thorpe and Wads, el 1 (1950), 
where they showed differences in the stability towards heat of the enzymes 
which deacetylate acetanilide and N-acetylglycine. Further, differentiation 
in regard to pH optima (Nimmo-Smith, 1960), inhibition by SKF 525A 
(Hollinger, 1960) or manganese stimulation (Franklin, Bridges & Williams, 1971) 
indicate that several different enzymic deacetylating systems must be present. 
The substrate specificity, tissue location and subcellular distribution of these 
various enzyme activities requires further study. 
The present work shows that even when a limited number of structurally 
similar substrates are examined a considerable difference in their rates of 
hydrolysis by a given species is found. The situation becomes even more 
complicated when the substrates are hydrolysed by hepatic microsomes 
derived from different species. At the present time certain generalisctions 
have become apparent which are helpful in understanding the role of 
deacetylation in the total metabolism of a foreign compound. 
When a pair of isomeric arylacetamides are hydrolysed by the microsomal 
system it seems that the arylacetamide having an ortho substituent 
is more 
rapidly hydrolysed than the corresponding para substituted isomer. 
This is 
exemplified by a comparison of the rates of hydrolysis of 
2- and 4-acetamido- 
biphenyl. 
- 173- 
In this case it can be seen that the first compound of the pair is usually 
hydrolysed at a greater rate than the second compound. This concept gains 
support from a consideration of earlier in vitro studies of substituted aryl- 
acetamides. Bray, James, Thorpe and Wasdell (1950) examined the influence 
of various nuclear substituents on the rates of deacetylation by a rat liver 
preparation. In every case the presence of an ortho substituent (these authors 
examined -CO 2 H, -CONH 2, -Cl and -NO 2) enhanced the amount of de- 
acetylation compared to the unsubstituted acetanilide, whereas the corresponding 
para substituent decreased it compared to acetanilide. 
Using the purified enzyme derived from beef liver, Benohr and Krisch (1967b) 
showed that orthoý-fluoracetanilicle was hydrolysed slightly faster than acetanilide 
whereas para-fluoracetanilide was hydrolysed considerably slower than either 
6 
acetanilide or the ortho-fluoro compound. These authors also showed that phenacetin 
(para-ethoxyacetanilide), para-nitroacetanilide and para-methoxyacetanilide were 
poor substrates for the enzyme compared to acetanilide. Results for the pig liver 
enzyme did not show such a marked effect as that observed for the rat and cow 
enzymes, and in these species the ortho-methoxy compound was a poor substrate 
compared to the para-isomer. 
Bernhammer and Krisch (1965) compared the rate of hydrolysis of the para- 
carboxyacetanilide with the rates of para-ethoxyacetanilide and acetanilide, 
and showed that the acidic compound was an extremely poor substrate, 
being 
hydrolysed about one thousand times slower than the unsubstituted compound. 
These authors attributed this resistance to hydrolysis as being due to either 
the high water solubility of the substrate, or its possession of an 
ionisable group, 
thus preventing interaction with the enzyme. The results 
in this section indicate 
quite a good correlation between partition coefficient and 
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degree of hydrolysis by the microsomal enzyme. The compounds having the 
lowest partition coefficient (and hence the highest water solubility) were 
the compounds most rapidly hydrolysed. However, the complexities involved 
in studies of deacetylating systems are exemplified by the recent results of 
Jarvinen, Santfi and Hopsu-Havu (1971). These authors isolated two de- 
acetylating enzymes from guinea pig liver microsomes, and showed that both 
enzymes deacetylated p-nitroacetanilide and p-carboxyacetanilide faster 
than acetanilide, and whilst one enzyme hydrolysed p-ethoxyacetanilide the 
other did not. One enzyme also hydrolysed 2-acetamidonaphthalene at twice 
the rate of the one isomer, whereas the other enzyme hydrolysed the I -isomer 
five times faster than the 2 -isomer. 
These authors were also able to demonstrate th%-4t the two enzymes differed 
in their ability to deacetylate 2-acetamidofluorene and the corresponding 
N-hydroxylated derivative. One enzyme hydrolysed the N-hydroxy compound 
two hundred and sixty times faster than the amide, whereas the other hydrolysed 
the amide twice as fast as the hydroxamic acid. The high rate of deacetylation 
of N-hydroxy-2-acetamidofluoreiie compared to the amide had previously been 
reported by Irving (1966). In view of the complexities reported in this section 
it is difficult to assess the total role of deacetylation in the overall metabolism 
of aromatic amines. As the introduction of a hydroxyl group into the aromatic 
nucleus usually occurs ortho or para to the amine, or acetamide, it would be 
expected that these substituents could affect the rates of hydrolysis. However/ 
as hydroxylated compounds are often conjugated at a rate much higher than 
their formation (Booth & Boyland, 1957) and these conjugates are higYy ionised, 
it may be that they are effectively removed from the environment of the 
deacetylating systems. 
,, 5- 
SECTION 4 THE "IN VITRO" HEPATIC ACETYLATION OF AROMATIC 
AMINES 
- 176- 
4.1 INTRODUCTION 
Whilst the acetylation of aromatic amines was recognised early as a metabolic 
pathway (Hensel, 1915; Ellinger & Hensel, 1914; Muenzen, Cerecedo & Sherwii, 
1926), it was not until the introduction of the sulphonamides and subsequent 
metabolic studies that the importance of this reaction began to be appreciated. 
Marshall, Cutting and Emerson (1937), and Fuller (1937), showed that the 
aromatic amino group (N 
4) 
of'sulphanilamide was acetylated in vivo by a variety 
of animal species including man. Klein & Harris (1938), utilising rabbit tissue 
- slices in vitro, showed that the liver was the major site of this metabolic reaction. 
Thereafter followed a period of investigation of the biochemical mechanisms 
involved in acetylation reaction. These studies culminated in the implication 
of coenzyme A (Lipmann, 1945; Kaplan & Lipmann, 1948) and ultimately in the 
isolation of acetyl coenzyme A (Fig. 4.1 .1 a) as the acetyl 
donor in the majority 
of enzymic acetylation processes (Stadtman, Novelli & Lipmann 1951; Lynen & 
Reichert 1951; Lynen, Reichert & Rueff, 1951). 
The aromatic amine acetylating system was at first shown to require both 
adenosine triphosphate and magnesium in addition to coenzyme A and acetate. 
Later it was realised that the function of the former components was in the bio- 
synthesis of acetyl coenzyme A (Chou & Lipmann, 1952), and that acety', co- 
enzyme A: arylamine N-acetyl transferase required only the acetylated coenzyme 
for active transfer to an acceptor molecule (Tabor, Mehler & Stadtman, 
1953). 
Acetylco. Bnzyme A: arylamine N-acetyl transferase was extensively studied 
using pigeon liver fractions and sulphanilamide as the acceptor molecule. 
In vitro studies were later extended to other acceptors, notably para-nitrooni 
line 
and para-amino benzoic acid, by Tabor et al (1953), and to other species. 
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Weber and Cohen (1967) showed that in rabbit liver the acetylating enzyme 
was localised in the cell cytoplasm, and Govier (1965) found the activity to 
be unique to the cells of the reticuloendothelial system of rabbit liver, and 
not to be associated with the hepatic parenchymal cells. Govier. (1965) also 
demonstrated the presence of acetylcoenzyme A: arylamine N-acetyl transferase 
in other rabbit organs rich in reticuloe-ndothelial cells, particularly the lung 
and spleen. 
Parallel with these in vitro studies many investigations were carried out in 
vivo using many different species. Whilst the initial impetus for these studies 
was undoubtedly the clinical use of sulphonamides, the introduction of iso- 
niazid into human medicine for the therapy of tuberculosis, soon provided a 
further stimulus. In their first investigation of sulphanilimide metabolism, 
Marshall et al. (1937) showed that both man and rabbit were able to acetyiate 
this compound, whereas the dog was not able to carry out this reaction. 
Subsequently, Marshall (1938) demonstrated that many species, including fish, 
chicken, mouse, rat, guinea pig, cat, pig, cow, horse and monkey were all 
able to acetylate sulphanilamide, leaving the dog as an example of a species 
unable to acetylate aromatic amines. 
The acetylation and subsequent deacetylation of the N 
4_ 
amino group of 
sulphonamides was examined by Krebs, Sykes and Bartley (1947), who 
concluded that the dog was able to acetylate sulphonamides, but that due to 
a high deacetylase activity in this species, the equilibrium lies towards 
production of compounds with a free aromatic aminogroup. Therefore, 
metabolites excreted in dog urine had a higher proportion of the 
deacetylated 
amino group cornpored to other species. This view was not accepted 
in a later 
,; AN who emphasised that in his opinion the doa lacks poper by Marsha II (19 ,, 
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the acetylcoenzyme A acetyl transferase cap-able of acetylating either sulphonil- 
amide or sulphamethazine. A further paper on the lack of acetylcoenzyme 
arylamine N-acetyl transferase activity in the dog by Leibman and Anaclerio 
(1962) implicates the presence of an inhibitor of the enzyme in this. species. 
These authors failed to find any arylamine N-acetyl transferase activity in 
slices, minces, homogenates or acetone powder extracts of dog liver. These 
preparations were able to acetylate the aliphatic amino-group glucosamine 
suggesting the presence of a variety of acetylco-enzyme A: acetyi transferases 
whose specificity depends upon the nature of the amino substrate. The concept 
of multiple enzymes able to carry out acetyl transfer to different acceptor 
groups has been studied by Hease and Weber (1973) and reviewed by Weber 
(1973). 
At the present time the exact nature of the acetyl transferase inhibitor present 
in dog liver described by Leibman and Anaclerio (1962) is unknown. The 
inhibitor is thermolabile and is inactivated by either trichloracetic or perchloric 
acids, and is thought to be a protein. The inhibitor also inhibits the trans- 
acetylation reaction, first described by Bessman and Lipmann (1953) whereby an 
acetyl group is transferred from a donor acetamido-compound (4-acetamidoozobenzene- 
4' -sulphonic acid) to an acceptor amine. In view of the observation 
by Steinberg, 
Cohen and Weber (1971), that the enzyme forms an : icetylated intermediate 
(Fig. 4.1 
. 
2) which then transfers the acetyl-group to -an acceptor molecule, 
it is 
tempting to suggest that the inhibitor present in dog tissue is the acetyitransferase 
enzyme lacking a binding site for the aromatic amine acceptor molecule. 
As 4-aminobiphenyl produces tumours of the urinary bladder when given 
to 
dogs (Section 1), and as acetylation of this compoind alters the site of microsornal 
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hydroxylation of the aro.. -natic system, it was thought desirable to confirm that the 
dog lacks the ability to -acetylate 2- and 4-aminobiphenyl in vitro. 
Genetic polymorphic distribution of acetyl transferase towards isoniazid, 
sulphamethazine and hydrallazine has been observed in man (Price-Evans & 
White, 1964), rabbits (Frymoyer & Jacox, 1963) and rhesus monkeys (Goedde, 
Schloot Walesky, 1967). Because species and individual variation in suscept- 
ibility towards cancer induced by aromatic amines may be due to acetylation 
altering the site of oxidation, the acetylation of 2- and 4-aminobiphenyl in 
vitro by hepatic preparations from various species was examined. 
One serious criticism that can be made against the bulk of the work reported 
on the in vitro acetylation of aromatic amines is the lack of specificity of the 
methods. Most authors rely on the disappearance of substrate,, as measured by the 
Bratton -and Marshall (1939) diazotisation and coupling colorimetric method, and 
assume that this quantitatively reflects acetamido formation. In other cases the 
experimental procedure contains both acetylating and deacetylating systems and 
attempts to study the former without either removal or inhibition of the latter 
can lead to erroneous results. For these reasons it is proposed to develop specific 
assays based on gas- liquid chromatography for the acetam'do-compounds 
formed 
from both 2- and 4-aminobiphenyl. 
Because of the structural similarity between N, S-diacetylcysteamine and 
the terminal moiety of acetyl coenzyme A, Goe-dde, Schloot and Valesky 
(1967) 
(Fig. 4.1 
.1 b) used the 
former compound as an acetyl donor in their in vitro study 
of the acetylating systems of the rhesus monkey. Because of the ease of 
preparation of N, S-diacetylcysteamine and the high cost of acetyl coenzyme 
A 
some experiments were carried out in which N, S-diacetylcysteamine was used 
as a cofactor in studies on the acetylation of aromatic amines. 
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a) acetyl-coenzyme A. 
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Fig. 4.1 
.1. The structures of acetyl-coenzyme A and N, S-diacetykysteami ne 
AcCoA CoA ArNH 2 
(NAT-CoA-Ac) NAT-Ac 
NAT = N-acetyltransferase 
AcCoA = acetylcoenzyme A 
ArNH 2ý aromatic amine 
ArNHAc = acetylated amine 
ArNHAc 
T-ArNHAc) NAT 
Fig. 4.1.2. The proposed mechanism for the acetylation of aromatic amines 
(after Weber 1973). 
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4.2 EXPERIMENTAL 
4.2.1 Materials 
4.2.1 .1 Substrates and metabolites 
1- and 2-Naphthylamine, 1- and 2-acetamidonaphthalene, 2ý- and 4- 
aminobiphenyl and 2- and 4- acetamidobiphenyl were prepared and purified 
as described in the preceding section. 
4.2.1.2 Cofactors 
Coenzyme A, acetyl coenzyme A, acetylphosphate and adenosine triphosphate 
were obtained from Boehringer Ltd. N, S-Diacetylcysteamine (2-acetamidoethyl- 
thiolacetate) was prepared as described by Baddiley and Thain (1951); the product 
was purified by fractional distillation under reduced pressure, the fraction boiling 
at 123-1250 at 0.1 mm'being collected. This material solidified as long needles 
on cooling (m. p. 26 
0; I it. 26- 28 0 ). 
4.2.1.3 Animals Animals used were the same species and strain as described 
in 2.2.1.4. 
4.2.2 Methods 
4.2.2.1 Tissue preparations. Cell fractions were obtained as described in 
2.2.2.1. 
4.2.2.2 Incubation rocedures Incubations were carried out in 25 ml conical 
f lasks at 37 ± 10 as descri bed in2.2.2.2. Incubates contained aromatic 
amines as substrate, usua IIy5 pi mol ef an acetyl donati ng system and a tissue 
fraction as a source of acetyl transferase. Variation of components of the 
incubate was carried out in order to determine optimum conditions 
for biological 
acetylation of aromatic amines. Incubates also contained sodium 
fluoride (100 11mole) 
to inhibit decetylase (see Section 3). In some experimentslincubation time was 
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also varied. 
Typical incubates contained: 
Volume (ml) 
Acceptor aromatic amine(. Sýimle) in Cellosolve 0.2 
Donor acetyl molecule (1 to 5 ; imole)in water 0.1 
Sodium fluoride (100 gmol) in water 0.2 
Tissue preparation in tris/KCI buffer, pH 7.4 0.1 M 1.0 
Phosphate buffer, pH 7.4.0.1 M 2.0 
total volume 3.5 ml 
4.2.2.3 Qualitative experiments. Certain experiments were performed in 
order to examine the feasibility of the biological acetylation of aromatic 
amines being carried out in vitro. These experiments were terminated by the 
addition of diethyl ether, which was then used to extract the substrate and the 
metabolites from the aqueous phase. The ether extracts were evaporated to 
about 100 pil at 450 and examined for the presence of metabolites by chroma- 
tographic techniques. 
4.2.2.4 Thin layer chromato Thin layer chromatography of the ether 
extracts were obtained using chromatography plates spread with Silica Gel G 
and various solvents. The chromatographic properties of the aromatic amines 
used as potential substrates and their acetylated derivatives were also determined 
using these chromatographic systems. The chromatographic properties of certain 
amines and their acetylated derivatives are recorded in Table 4.3-1. 
4.2.2.5 Gas liquid chromatograpýy. The ether extracts from incubates were 
examined by gas liquid chromatography using a Perkin Elmer F1 1 or F33 chroma- 
tograph fitted with glass columns and an F,, I. D. The column used for routine 
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work, and for the quantitative determination of the acetamido compounds 
formed, utilised OV17 (3%) on Chromosorb GI (80-100 mesh). The column 
was two metres in length with a z'" o. d. In order to obtain good symmetrical 
peaks the oven temperature was maintained at 240 0 or 250 0 depending upon 
the compound of specific interest. During chromatographic analysis nitrogen 
carrier gas pressure was kept at 25 p. s. i. , whi Ist the air pressure was 20 p. s. 
and hydrogen pressure was 17 p. s. i. The injection, port temperature was 
0 
maintained at 325 
In order to check the properties of the acetamido compounds formed, the 
extracts of the incubates were also examined using a2 metre column containing 
OW (3%) on Gas-chrom. Q (60-80 mesh), with the same gas pressures as above. 
The columns were conditioned at 300 0 for 72 h prior to use and were silanised 
0 
with hexamethyldisilazane (2 x 10 111), leaving thirty minutes between each 
injection Of this compound. 
4.2.2.6 Quantitative assay for acetamido compounds. Enzymic activity 
was stopped by the addition of diethyl ether (4 ml) and internal standard (2- 
acetamidonaphthalene (1,9molb in I ml phosphate buffer pH 7.4 containing 
10% methanol). The flasks and contents were vigorously shaken and the 
contents transferred to Soviril screw-capped glass tubes which were then placed 
on a rocking device for five minutes. The ether phase was collected and placed 
in an evaporating tube. it was usually necessary to centrifuge the mixtures 
prior to this step in order to break any emulsion which had formed. 
The 
ether extractions were repeated with a further 3x4 ml of ether and the total 
ether extract collected, bulked and evaporated at 45 
0 until about 100 41 
remained. An aliquot of this concentrate (usually 2 41) was chromatographed 
using a gas chromatograph fitted with a2 metre glass column packed 
with 
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OV17 (3%) on Chromosorb G at an oven temperature of 240 0 for the deter- 
mination of 2-acetamidobiphenyl and 2500 for the determination of 4- 
acetamidobiphenyl - The other conditions were as described in 4.2.2.5. 
4.3 RESULTS AND DISCUSSION 
4.3.1 Chromatographic methods 
The RF and RT values for the aromatic amines and the corresponding 
acetamido derivatives are recorded in Table 4.3,1 Both T LCI and GLC gave 
good separation of the substrate from the acetamiclo, derivative, allowing 
easy detection of the acetamido compounds if they were formed. No inter- 
fering substances were observed when "blank" incubates were examined in 
which the reaction had been stopped at zero time or in which the aromatic 
amine had been omitted. It was observed that the inhibitor SKF 525A had 
very similar chromatographic properties to those of 4-acetamidobiphenyl 
when examined using GLC and therefore it was not used in this work. Some 
spontaneous formation of acetamido compounds was observed when N, S-diacetyl- 
cysteamine was used in some experiments. This will be discussed later. 
For routine purposes TLC plates were examined using UV light as the 
detecting agent. Additional confirmation of identity was obtained by spraying 
the plates with acidic p-dimethylaminobenzaidehyde or p-dimethyl amino- 
cinnamaldehyde (see Section 2) and allowing them to stand at room temperature 
overnight. On respraying with either dilute hydrochloric acid or acidic 
ferric 
chloride the acetamido compounds then gave the same response as the parent 
amines to these reagents. 
In order to carry out routine analysis of 2- and 4-acetamidobiphenyl the 
oven temperature was maintained at 240 
0 for the assay of 2-acetamidobiphenyl 
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Table 4.3.1, Chromatoqrargh]jýcroperties of somt. cimmatic amines and 
their corresponding acetamido co 
Compound RIR2 (mins) FT 
A c OV17(3%) OV1 (3%) 
1-naphthylamine 0.42 0.85 0.49 2.0 1.0 
I -acetamidonaphtholene 0.08 0.31 0.14 5.5 2.25 
2-naphthylamine 0.31 0.80 0.44 2.25 1.1 
2-acetamidonaphthalene 0.16 0.38 0.22 7.0 3.25 
2-aminobiphenyl 0.68 0.95 0.63 2.0 1.0 
2-acetamidobiphenyl 0.18 0.70 0.33 4.75 2.25 
4-aminobiphenyl 0.31 0.81 0.46 3.5 1.75 
4-acetamidobiphenyl 0.08 0.38 0.19 14.0 5.5 
1. Using silica gel G uv 254 at room temperature and allowing the solvent to 
ascend between II and 13 cm past the origin. 
2. Using the gas pressures described in 4.2.2.5. 
OV17 column used at 240 0 with an inlet temperature of 300 
0 
0 OVI column used at 2000 with an inlet temperature of 275 . 
A= Petroleum Ether (40-60), Acetone 9: 1 v/v; B= Benzene, Methanol 9: 1 Y/v 
'I- = Toluene/methanol 95: 5 v/v. 
Table 4.3.2 Retention times 
1 
of 2- and 4-aminobiphenyl, 2- and 4-acetamido- 
biphenyl and the internal standard for the quantitative a 
the acetamido compounds 
Compound R2 (min) Compound R3 (min) TT 
2-cminobiphenyl 1.5 4-aminobiphenyl 2.5 
2-cicetami donaphtha I ene 4.5 2-acetami donaphtha I en e 
5.3 
2-acetamidobiphenyl 3.0 4-acetamidobiphenyl 9.3 
1. Using OV17 (3%) as described in 4.2.2.5 and 4.2.2.6 
2.240 0 3.250 
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0 
or 25 for te assay of 4-acetamidobiphenyl. This allowed a fairly rapid 
elution of the amide from the column. The retention times are recorded in 
Table 4.3-2.2-Acetamidonaphtholene was chosen as the internal standard 
as it had suitable similar physicochemical properties to the compounds being 
assayed, was stable in solution for several months and had a suitable retention 
time for the analysis of both isomers of acetamidobiphenyl. 
The quantitative assay developed gave a straight line relationship, using 
the peak height ratio method, up to 3.0 j4mole 2- or 4-acetamidobiphenyl 
formed per incubate. Using this method 0.01 jumole of acetamido compound 
could easily be assayed. 
4.3.2. Specificity of acetyl donor 
Using a whole homogenate preparation from rabbit liver as potential 
acetyl transferase source and I- and 2-naphthylamine and 2- and 4-amino- 
biphenyl as potential acceptor amines a variety of systems were investigated 
as to their usefulness as acetyl donor. Incubates were prepared containing 
either acetylphosphate (10 gmole), coenzyme A (I pmole), coenzyme A (I "mole) 
plus acetyl phosphate (10 pmole), coenzyme A (I pimole) plus ATP (5 Amole) or 
acetyl conenzyme A (I pmole). After incubating at 37 
0 for thirty minutes, any 
acetamido compounds present were extracted as described in 4.2.2.3 and 
the ether extracts examined by TLC and GLC. None of the potential acetylating 
systems investigated appeared to be able to acetylate either 1-naphthylamine 
or 2-aminobiphenyl. 
Positive evidence for the conversion of 2-ncphthylamine and 4-amino- 
biphenyl to the corresponding acetamido compounds was found when coenzyme 
A 
was supplemented with either acetyl phosphate or 
ATP; no evi3ence for acetyla- 
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tion was obtained using only coenzyme A. Coenzyme A plus ATP appeared 
to produce more 2-acetamidonaphthalene and 4-acetamidobiphenyl than when 
acetyl phosphate was used in conjunction with coenzyme A. ATP in the 
presence of the tissue was unable to support acetylation of the substrates used. 
Strong evidence, i.. e. large peaks at the correct retention time on the gas 
chromatograph using either column and strong discrete spots at the correct Rf 
in three solvent systems, was obtained for biological acetylation using 2- 
naphthylamine or 4-aminobiphenyl as acceptor amines. 
Under the conditions used 1-acetamidonaphthalene and 2-acetamido- 
biphenyl could not be detected as metabolites of the respective amines. In 
these experiments the incubates did not contain fluoride ions, as it was thought 
that fluoride may inhibit either the formation of an active form of acetate or 
the transfer of acetate from the donor to an acceptor. In the light of the results 
from the previous section it is clear that any 1-acetamidonaphthalene or 2- 
acetamidobiphenyl formed could have been rapidly hydrolysed by the microsomal 
cleacetylase as these were very good substrates for this enzyme. It was therefore 
concluded that future work would need to be carried out using acetyl coenzyme A 
as the acetyl donor. 
4.3.3 Subcellular location of acetyý coenzyme A: arylamine- 
transferase 
Using various subcellular fractions prepared from rabbit liver as potential 
sources of the acetyl transferase, acetyl coenzyme A (1 Amole) as the acetyl 
donor and 4-aminobiphenyl as the acceptor molecule, activity was determined 
after incubation for twenty minutes. The results which are presented in 
Table 4.3.3 show that the total activity of the homogenate can 
be found in 
the supernatant preparation of the cell. The supernatant which 
is derived from 
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Table 4.3.3. Sub-cellular distribution ie A- arylamine 
N-acetyl tronsferase 
Tissue Preparation 4-acetamidobiphenýl 
forned Ok moles) 
whole homogenate 0.21 
lysosomes and mitochondria 0.06 
microsomes 0.022 
washed microsomes 0.010 
soluble supernatant 0.25 
1. during twenty minutes at 37o 
Table 4.3.4. The effect of acetyl coenzyme A concentration on the 
acetylation of 4-aminobi 
acetyl CoA 
(9 mol es) 
4-acetamidobiphenýl 
formed (u moles) 
0 0.04 
1 1.15 
2 1.96 
5 2.57 
10 3.07 
I- during twenty minutes at 370 
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the cell cytoplasm, was used in all later experiments. 
4.3.4 The effect of variation in acetyl coenzyme A concentration 
The effect of varying the concentration of acetyl coenzyme A was 
investigated using a soluble enzyme preparation from rabbit liver. The 
enzyme preparation was equivalent to 0.5 g of original liver, and 4-amino- 
biphenyl (5 ginol e-) was used as acceptor molecule. 
The results which are shown in Fig. 4.3.1 and tabulated in Table 4.3.4 
indicate that high levels of acetyl coenzyme A are needed to saturate the 
acetylating system. It was decided that 5 Amole of this cofactor per flask 
would be used in later experiments on species differences in arylamine 
acetylation. 
4.3.5 The effect of variation in enzyme concentration 
Using 4-aminobiphenyl and 2-aminobiphenyl (5 Amole) as acceptor molecules 
and enzyme prepared from guinea pig liver the effect of variation in enzyme 
concentration was studied. The acetyl coenzyme A concentration was 2 ýnole 
per flask and the incubation time was twenty minutes. The results are shown 
in Fig. 4.3.2 and Table 4.3-5. 
Under the condiiions used, the acetylation of 4-aminobiphenyl showed a 
linear relationship with the concentration of enzyme present up to the equivalent 
of 250 mg of original tissue per incubation. Doubling the enzyme concentration 
failed to produce a further increase. In agreement with the results of the 
qualitative experiments (reported in 4.3.2) only a trace amount of 2-acetamido- 
biphenyl was detected. It was decided that when comparing the potential of 
various species to acetylate aromatic amines tissue equivalent to 250 mg of 
original liver would be used per incubation flask. 
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Fig. 4.3.1 The effect of acetyl__coenzyme on the acetylation of 4-aminobiphenyl 
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Fig. 4.3.2. The effect of tissue concentration on acetylation of 2- and 4-aminobiphenyl 
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Table 4.3.5 The effect of variation in enzyme concentration on the 
acetylation of 2- and 4-aminobiphenyl 
Tissue t 4-acetamidobiphenyl 2-acetal*dobiphenyl 
mg of original formedl (pmol e) formed (jimole) 
liver 
25 0.029 ND 
50 0.058 ND 
100 0.127 0.004 
250 0.342 0.005 
500 0.337 0.012 
1. during twenty minutes at 370 
ND = none detected. 
a 
Table 4.3.6 Species variation in the acetylation of 4-aminobiphenyl 
Speci es 4-acetamidobiphenýl 
formed (; Imole) 
Rat 0.46 
Mouse 0.73 
Hamster 1.77 
Guinea Pig 1.85 
Rabbit 2.57 
I- in the presence of supernatant fraction equivalent to 
250 mg wet weight 
of liver during forty minutes at 370. 
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4.3.6 cies differences in the ace lotion of 4-aminobiphenyi 
4-Aminobi phenyl (5 ; imol e) was incubated with tissue soluble. fraction 
(equivalent to 250 mg of original liver) from various species in the presence 
of acetyl coenzyme A (5 pmole) for twenty minutes. The results, which are 
shown in Table 4.3.6, show that some differences in the ability of the liver 
from various species to acetylate 4-aminobiphenyl exist. The results are in 
general agreement with those of Lower and Bryan (1973) who examined the 
in vitro acetylation of 2-amino fluorene, and 2-aminonaphthalene as well as 
4-aminobiphenyl. The results obtained in the present work and those of 
Lower and Bryan (1973) indicate that the guinea pig is one of the most active 
spe ci es in its abi I ity to acetylate aromatic amines. The present resu Its show 
that the rabbit and thb hamster are also very good in this respect. Also in 
agreement with Lower and Bryan (1973) the lesser ability of the rat to acetylate 
4-aminobiphenyl was confirmed. These authors were able to show that the 
dog was unable to acetylate 2-aminofluorene, 2-aminoncphthalene and 4- 
aminobiphenyl. Unfortunately dog liver was not available during the course 
of the experiments reported herein. 
It is interesting that the two species which did not develop urinary tract 
tumours after exposure to 4-aminobiphenyl, i. e. rat and mouse, were the 
species with the lowest ability to acetylate 4-aminobiphenyl, whereas the 
species usually considered refactory to amine carcinogenesis was amongst 
the 
most active species in acetylating ability. However, it must be concluded 
that 
acetylation per se is unlikely to be related to amine carcinogenicity as 
the 
species with the highest demonstrable acetylating activity 
(the rabbit) and a 
species lacking in this activity (the dog) both contract bladder tumours after 
exposure to 4-aminobiphenyl. 
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When these results are examined in conjunction with those of Section 3 
it can be seen that certain species are likely to excrete more of the free 
amine than the acetylated compound irrespective of whether 4-aminobiphenyl 
or 4-acetamidobiphenyl is administered. Thus it appears that the mouse has a 
high deacetylase activity plus a low acetylase activity. A similar situation 
obtains in the dog. The converse situation appears to occur in the rabbit 
and guinea pig which seem to have high levels of the 4-aminobiphenyl 
acetylating system with lower levels of the 4-acetamidobiphenyl deacetylating 
system. In these species 4-aminobiphenyl might be expected to be excreted 
predominantly as acetylated derivatives. As there is a difference in the sites 
of hydroxylation of 4-aminobiphenyl compared to 4-acetamidobiphenyl 
(Section 2) it is clear that these acetylating and deacetylating systems will 6 
play some role in determining the nature of the hydroxylated products 
excreted. It must be emphasised that this is only a very superficial study of 
the aromatic amine acetylating system. 
It is known that the purified acetylating system exhibits rather complex 
enzyme kinetics (Hersch and Jenks, 1967; Jenne and Boyer, 1962; Steinberg, 
Cohen and Weber, 1971 ) and it may be that further studies wi II be needed 
to establish the complete picture of species differences. 
It is also recognised that the ability to acetylate hydrazines and aromatic 
amines exhibits genetically controlled polymorphism, in humans (Price-Evans, 
Manley and McCusick,, 1960). A similar situation appears to operate in 
rabbits (Frymoyer and Jaycox, 1963a) and rhesus monkeys (Goedde, Schloot 
and Valesky, 1967), so that extension of these studies to a larger number of 
animals may have given rather different results. Incidentally, the some 
orgument applies to carcinogenesis studies of aromatic amines 
in these species. 
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In the experiments reported in this section the acetylation occurred at 
only very low rates using 2-aminobiphenyl as the acceptor amine and either 
rabbit or guinea-pig tissue as acetyl transferase source. This observation, 
coupled with the observation of high deacetylase activity towards 2-acetamido- 
biphenyl exhibited by most species (section 3), would indicate that 2-aminobiphenyl 
is unlikely to be excreted as an acetylated metabolite. This is in agreement 
with the failure of Gorrod and Carey (1970) to find an acetylated metabolite 
of 2-aminobiphenyl when the amine was administered to rats. It has been 
suggested that the acetylation of aromatic amines is related to the electronic 
charge on the amino nitrogen (Perault and Pullman, 1963). It is true that both 
the electronic charge and the free valence of the 2-isomer is lower than that 
. of 
the 4-isomer; however, both compounds have lower values than the values 
recorded for ortho-toluidine which is acetylated and higher than those recorded 
for ortho-nitroani line which is not acetylated (Table 4.2.7) 
Table 4.2.7. The eiectronic indices of some aromatic amines 
Compound Electronic Free Valence Reference 
charge on N of N atom 
ortho-toluidine 1.852 1.027 Perau It& Pu II man (1963) 
4-aminobiphenyl 1.842 1.014 Kibby ) 
) see appendix 
2-aminobiphenyl 1.838 1.008 Kibby ) 
ortho-nitroaniline 1.824 0.991 Percult & Pullman 
(1963 
It would seem unlikely that such small differences involved could 
be the 
factor controlling whether acetylation can or cannot occur in 
biological 
systems. These results indicate that further work on this reaction 
is needed to 
establish the relationship between structure and susceptibility 
towards acetylation. 
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Because of the high cost of acetyl coenzyme A and the need to have a 
readily available pure acetyl donor in this and related work, N, S-di- 
acetylcysteamine was prepared and examined as a potential acetyl source 
in the biological acetylation of aromatic amines. This compound was 
suggested by comparison of its structure with the terminal moiety of acetyl 
coenzyme A. (Fig. 4.1 . 1) and had been previously used by Goedde, Schloot 
and Valesky (1967) in a study of the acetylation of both aliphatic and 
aromatic amines. 
Following experiments in which 4-aminobiphenyl was used as an 
acceptor molecule and N, S-diacetylcysteamine was used as a potential 
acetyl donor, 4-acetamidobiphenyl was extracted and assayed according to 
the method described earlier (4.2.2.6). Irrespective of the time of incubation 
it appeared that a constant amount of 4-acetamidobiphenyl was formed. This 
phenomenon was further investigated by varying the amount of tissue present 
and keeping the time of incubation constant at twenty minutes. The assay 
again indicated that a constant amount of 4-acetamidobiphenyl was formed, 
even in the complete absence of tissue. These results suggested that NS- 
diacetylcysteamine was able to act as a chemical acylating agent. Further 
work esiab I ished that the acetylation of 4-aminobiphenyl by N, S-diacetyl- 
cysteamine occurred predominantly during gas liquid chromatography of the 
ether extracts., presumably due to the high temperatures needed for the 
chromatographic analysis of 4-acetamidobiphenyl. This "on-column" 
acetylation could be minimised by treating incubates with sodium hydroxide 
(2N, 4 ml) (McQuillin & Stewart, 1955) and allowing the mixture to stand 
at room temperature overnight before ether extraction and assay. Alkali 
- 196- 
treatment did not appear to affect the concentration of 4-acetamidobiphenyl 
but did appear to destroy any surplus N, S-diacetylcysteamine. Because of 
these results it was decided that N, S-diacetylcysteamine could not be easily 
used as an acetyl donor in this work and its use was not continued with. These 
findings suggest that any study using N, S-diacetyicysteamine as an acetyl donor 
in which the resulting reaction mixture is exposed to changes of temperature 
may inadvertently be measuring non-enzymic acetylation as well as enzymic 
acetylation (if it occurs). The observation that N, S-diacetylcysteamine is 
able to react "on column" to produce acetamido compounds from I- and 2- 
naphthylamine, 2-aminofluorene and 2-aminobiphenyl as well as 4-amino- 
biphenyl suggests that this compound may be developed into a reagent for 
producing derivatives for use in gas chromatographic analysis. Such a 
reagent may be useful where anhydrous conditions are difficult to achieve 
and would be free from the disadvantage of producing strongly acidic by- 
products which could damage alkaline treated column material. 
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SECTION 5 THE SYNTHESIS AND BIOSYNTHESIS OF 4-AMINO-3- 
BIPHENYLYL-g-D-GLUCOSIDURONIC ACID 
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5.1 INTRODUCTION 
The metabolism of 4-aminobiphenyl studied by Bradshaw (1959) showed that 
hydroxylation occurs at the three position of the biphenyl nucleus. This hydroxyl- 
ated metabolite was conjugated with either sulphuric or giucuronic acid prior to 
excretion in the urine. Further, the bladder implantation experiments of Bonser, 
Clayson and Jull (1956,1958) and Allen, Boyland, Dukes, Horning and Watson 
(1957) implicated ortho-aminophenols, and hence this metabolite, as being the 
active carcinogen derived from 4-aminobiphenyl. As the corresponding sulphate 
conjugates were found to be inactive in bladder implantation tests, and resistant 
to enzymic hydrolysis, Boyland (1956) suggested that the glucuronic acid conju- 
gates were the precursors giving rise to the carcinogenic ortho-aminophenols 
after hydrolysis by g-glucuronidase present in either. urine or blood epithelial 
cel Is. 0 
It was therefore of some interest to synthesise 4-amino-3-biphenylyi-o-D- 
glucosiduronic acid and to examine animal species variation in their ability to 
form this conjugate from its aglycone, as this may correlate with the suscep- 
tibility of the species towards bladder cancer produced by exposure to aromatic 
amines. 
The reactions involved in the biosynthesis of various types of glucuronides 
have been reviewed by Dutton (1966). The enzyme responsible for the 
final 
step of the biosynthesis is located in the endoplasmic reticulum of cells, the 
highest activity being found in liver tissue preparations. This enzyme catalyses 
the transfer of glucuronic acid from uridinediphosphoglucuronic acid 
(UDPGA) 
to suitable acceptor molecules. The enzyme requires the presence of magnesium 
ions for optimal activity. 
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As animal species variations in the biosynthesis and the hydrolysis of 4- 
amino-3-biphenylylglucosiduronate may occur, some in vivo experiments to 
detect the presence of this compound were carried out. 
The widespread use of an assay for glucuronyl transferase based on the 
conjugation of ortho-aminophenol (Dutton & Storey, 1962), suggested its 
use for the para- substituted ortho-aminophenol of interest in this study. 
5.2 EXPERIMENTAL 
5.2.1 Synthesis of Methyl(4-nitro-3-biphenylyi-tri -0-acetyi-o-D- 
qlucosiSýronate (1) 
4-Nitro-3-hydroxybiphenyl potassium salt (3.29) was refluxed in absolute 
ethanol (200 mi ) for two hours with methyl(tri-O-acetyl-a-D-glucopyranosylbromide) 
uronate (5g), prepared as described by Bollenback, Long, Benjamin and Lindquist 
(1955). The reaction mixture was evaporated to dryness using a rotary film evapora- 
tor at 40 0, and the solid material obtained extracted with ether, 
(3 x 500 ml). The 
ethereal extract was washed with 1N potassium hydroxide (total 900 ml) , water, 
and then dried over anhydrous sodium sulphate. The material obtained on evaporating 
the ether solution to dryness was recrystallised from absolute ethanol to yield methyl 
(4-nitro-3-biphenylyi-tri-O-acetyl-g-D-glucosid)urOnate; yield 1.2 g; m. pt. 1390 ; 
as pale yellow needles. 
(Found: C, 57.1 ; H, 4.8; N, 2.8%; C 25 H 25 0 12 
N requires C, 56.5; H, 4.7; 
N, 2.6%) 
. The product gave a strong positive 
test with the Tol lens naphtho- 
resorcinol (see 5.2.8) reagent for glucuronides. After hydrolysis with either acid 
or alkali 4- nitro- 3-hydroxybi pheny I was -detected by thin layer chromatography. 
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5.2.2 Synthesis of Met 1(4-amino-3-bi IYI-tri- 0-acetyl-ß- D-qlucosi 
uronate (11) 
Methyl-(4-nitro-3-biphenylyi-tri-O-acetyl-A-D-glucosid)uronate (2.5g) 
in ethanol was treated with hydrogen in the presence of Adam; platinum oxide 
catalyst until no further uptake of hydrogen could be detected. The reaction 
mixture was filtered and evaporated to dryness using a rotary film evaporator at 
0 
40 . The yellow product was recrystallised once from acetone and once from 
methanol to give nearly white needles of methyi-(4-amino-3-biphenyiyi-tri-o- 
acetyl-g-D-glucosid)uronate, m. pt. 164 0; yield 1 9. (Found, C., 60.5; H, 5.3; 
N, 3.2%. C 25 H 27 0 10 N requires C, 59.9; H, 5.4; N, 2.8%). This compound 
gave a positive Tollen s reaction (see 5.2.8) and 4-amino-3-hydroxybiphenyl 
on acid hydrolysis and gave coloured materials when acidified solutions were 
treated with sodium nitrite followed by alkaline g-naphthol. 
5.2.3 Synthesis of 4-Amino-3-biphenylyi-o-D-glucosiduronic acid (111) 
The product obtained after the reduction of 1 .1g of methyi(4-nitro-3-biphenylyi- 
A-D-glucosid)uronate as described above was dissolved in methanol (300 ml) and 
0 
treated with sodium methoxide (59) and left for 15 h- at 0. The reaction mixture 
was evaporated to about 50 mI at 40 0 in a rotary film evaporator and the residue 
applied as streaks across the origin of several sheets of Whatman 3MM chromatography 
paper. The papers were developed for 18 h, 
by volume, as solvent. 
using butanol, propanol, 2N ammonia, 
The area from Rf 0.24 to Rf 0.33 was cut out and the product was eluted with 
methanol. Concentration of this eluate at 40 
0 in a rotary filrn evaporator afforded 
4-amino-3-biphenylyi-g-D-glucosiduronic acid yield 75 mg as a pale 
buff- 
Coloured powder. (Found, C. 48.3; H, 5.1; N, 3.3%. C18H 18 
07N Na. 2H 20 
requires C. 51.6; H, 5.3; N, 3.3%). 
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The infrared spectrum of this material was compared with that of ortho-amino- 
phenol ý-D-glucosijduronic acid (Sigma Chemical Co. Ltd., ) in a Nujol mull using 
a Unicam S. P. 200 Infrared Spectrophotometer. 
5.2.4. The biosynthesis of 4-amino-3-biphenylyiqlucosiduronic acid. 
A microsomal fraction prepared as described eadier (Section 2) from 17.5g of 
guinea pig liver was resuspended in isotonic KCI (17.541) and incubated for two 
hours at 37 0 with 50 mg UD PGA in0.1 M phosphate buffer (35 m 1) contai ni ng 
magnesium chloride (0.02M), and with 20 pmoles of 4-amino-3-hydroxybiphenyt 
dissolved in 17.5 A ascorbic acid (0.2%). 
The incubations were carried out in ten 50 ml conical flasks each containing 
seven ml of the incubation mixture. The reaction was stopped and the protein 
precipitated by the addition of absolute ethanol (15 ml) to each flask. After 
centrifuging at 10,000xg for 10 mins the supernatant was concentrated to about 
0 20 ml in a rotary film evaporator at 45 . 
5.2.5 Chromatographic Methods 
Paper chromatograms of the synthetic compound and material obtained in 
5.2.4 were run descending on Whatman No. 1 paper using the following solvent 
systems. 
A. Butan-l-ol saturated with 2N Ammonia. 
B. Butan-l-ol, Propan-l-ol, 2N Ammonia (2: 1: 1 by vol. ) 
Butan-l-ol, Acetic Acid, Water (12: 3: 5 by vol. ) 
The developed chromatograms were examined under ultra-violet 
light and with 
Some detecting reagents used in Section 2. In addition, potassium 
dichromate 
(0.1 M) in acetic acid (0.05M) fol lowed by si Iver nitrate (0.1 
M) as described by 
Knight and Young (1958) was used to detect easily oxidised materials, and 
naphthoresorcinol (0.1%) in trichloracetic acid (10%) followed by heating the 
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sprayed chromatogram between two glass plates at 1000 (Dutton, 1966) was used 
to detect glucuronic acid conjugates. 
5.2.6 Comparison of colour formed after diazotisation and coupling of synthet c 
and biosynthetic materials. 
The. synthetilc and biosynthetic 4-amino-3-biphenyiylgiucosiduronic acids were 
treated separately with nitrous acid, ammonium suiphamate and N-1-naphthylethyl- 
enediamine (as described in 5.3.4) and the visible absorption spectra obtained. 
5.2.7 Enzymic hydrolysis of 4-amino-3-biphenyiylglucosiduronic acid 
The synthetic and biosynthetic 4-amino-3-biphenylylglucosiduronic acids were 
separately treated with either beef liver glucuronidase (Ketodase, Warner Chilcot 
Eastleigh, Hants), or bacterial A-glucuronidase (Sigma Chemicai Co. ) at 37 0 for 
20 h at pH 4.8 in 5 ml stoppered tubes. Suitable controls without enzyme or in- 
cluding glucosaccharo-1: 4- lactone (gift from D. Manson) at a concentration of 
10- 3M were also carried through the procedure. After incubation, the tube 
contents were treated with I ml trichloracetic acid (7.5%) and after centrifuga- 
tion to remove protein were treated with the reagents described in 5.3.4. 
Separate incubates prepared as above (5.2.7) were also examined by paper 
chromatography using the solvent systems and detection reagents described in 
5.2.5. 
5.2.8 "Tollen s" reaction of synthetic and biosynthetic material 
Solutions of the synthetic and biosynthetic material (2 ml) were treated with 
concentrated hydrochloric acid (2 ml) and naphthoresorcinol (10 mg) 
in a boiling 
water-bath for 20 mins. The cooled reaction mixtures were extracted with ethyl 
acetate (I m 1) . 
5.2.9 Development of assay for 4-amino-3 uronic acid. 
The coloured product obtained when 4-amino-3-biphenylylglucosiduronate 
was diazotised and coupled with N-1-naphthylethylenediamine (N. 
E. D. ) was 
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examined to study the influence of time, temperature and pH by variation of 
one parameter. This was done to optimise conditions for an assay system for 
4-amino-3-biphenylylglucosiduronic acid. 
5.2.10 Development of enzyme assay. 
The influence of 4-amino-3-hydroxybiphenyl and UDPGA concentrations., 
and the time of incubation, on the subsequent biosynthesis of 4-amino-3- 
biphenylylglucosiduronic acid were investigated in order to determine optimum 
conditions for the assay of UDPGA: 4-amino-3-hydroxybiphenyl glucuronyi trans- 
ferase. 
5.2.11 Comparison of UDPGA: 4-Amino-3-hydroxybiphenyl. glucuronyl, fransferase 
in various anima 
Hepatic microsomal preparations from various species were assayed for UDPGA: 
4-Amino-3-hydroxybiphenyl glucuronyl transferase using the methods developed 
in 5.2.9 and 5.2.10. 
5.2.12 The excretion of 4-amino-3-biphenylylglucosiduronic acid by variou 
animal s0 
4-Amino-3-hydroxybiphenyl was administered (i. p. ) as a solution in arachis 
oil to a rat, cat and guinea-pig. The rat and cat were given 25 mg in 0.5 ml oil, 
the guinea-pig 50 mg in 1 ml oil. The animals were mature males weighing 
300 g (rat), 30OOg (cat) and 500 g (guinea-pig). They were housed in metabolism 
cages for eighteen hours following administration of the amine and urine collected. 
The urine was examined using the chromatographic solvents and detection re- 
agents described earlier (5.2.5). 
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5.3 RESULTS AND DISCUSSION 
5.3.1 Chemical Synthesis of 4-amino-3-bi ! yl-g-D-glucosiduronic acid 
The chemical synthesis of 4-amino-3-biphenylyi-g-D-glucosiduronic acid was 
attempted by the methods described by Bol lenback, Long, Benjamin and Lindquist 
(1955) via the tri-O-acetylmethylester derivative. Attempts at the direct con- 
densation of methyl tetra- 0-acetyl-g- D-gl ucopyran-osiduronate with 4-nitro-3- 
hydroxybiphenyl, in the presence of para-toluenesulphonic acid as catalyst, at 
00 
120 - 140 . under a reduced pressure of 12 mm for various times up to two hours, 
produced only traces of a product with the desired characteristics. 
The successful preparation of methyi-(4-nitro-3-biphenylyi-tri-O-acetyl-g- 
D-glucosid)uronate was accomplished using a modification of the reaction 
conditions described by Bollenback et al. (1955) for the synthesis of methyl-(O- 
ni, trophenyltri - 0-acetyl-g- D-g I ucopyranosid) uronate. 
This synthesis consisted of treating potassi um-4- nitro- 3- hydroxybi pheny late 
with methyl tri-O-acetyl-a-D-glucopyronosyl bromide in boiling ethcnol. The 
removal of the acetyl groups and hydrolysis of the methyl ester were unsuccessful 
when either sodium or barium methoxide were used as described by Bollenback 
et al . This finding was similar to that of 
Belman (1961) who observed that 
hydrolysis of the corresponding compound from 2- nitro- I -naphthol was also un- 
successful. This author decided that prior reduction of the nitro group was a pre- 
requisite for the removal of these protecting groups. 
The simple reductive procedure of generating hydrogen from 
hydrazine hydrate 
in the presence of a platinum on charcoal catalyst, in situ, in an ethanolic solu- 
tion of the nitro compound, gave only 4-amino-3-hydroxybiphenyl, 
indicating 
that complete hydrolytic cleavage of the carbohydrate moiety 
had occurred. 
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Reduction of methyi-(4-nitro-3-biphenylyi-tri-O-acetylglucosid)uronate 
was accomplished using hydrogen at two atmospheres pressure, at room temp- 
erature, in the presence of Adanýs platinum oxide catalyst. Treatment of 
methyl-(4-amino-3-biphenylylglucosicf)uronate with barium methoxide gave 
solutions which rapidly darkened, and did not yield a product with the re- 
quired properties. However, treatment with sodium methoxide in methanolic 
solution led to the formation of 4-amino-3-biphenylylglucosiduronic acid. 
The synthetic route used in the successful chemical synthesis is outlined 
in Fig. 5.3.1. 
5.3.2 Biosynthesis of 4-amino-3-biphenylyi-o-D-glucosiduronic acid 
Initially a large scale experiment was carried out using guinea-pig liver 
microsomes and 4-amino-3-hydroxybiphenyl as the acceptor molecule, in order 
to confirm that the synthetic and biosynthetic glucuronides had identical 
properties. This led to the observation that when chromatograms of the bio- 
synthetic products were developed two compounds were detected which gave 
positive reactions for an aromatic amino group and glucuronic acid. Many 
experiments were performed, some of which are described, to try to establish 
the identity of the minor component, but eventually all the evidence 
indicated that the minor component was the same as the major component, and 
that splitting during chromatography had been due to inorganic salts present 
in 
the concentrate. 
Chromatography of the biosynthetic concentrate using solvent systems 
or B showed the presence of a major component which 
had the same Rf values 
and colour reaction towards spray reagents as the synthetic material. 
The 
chromatographic properties are described in Table 5.3.1 . 
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In addition, a minor component was present when developing solvents A 
or B were used which had identical reactions with the detecting reagents as those of 
the major component; this trace component was not present when the concen- 
trate was examined using solvent 
In view of the fact that the presence of a second compound could invalidate 
any investigation of the species difference in the formation of 4-amino-3- 
biphenyiyiglucosiduronic acid, some further experiments were carried out in 
the hope of gaining further information as to the nature of the minor component. 
That only one substance was detected using solvent system C suggested that a 
labile complex with some constituent of the incubation medium was formed, or 
possibly an N-glucuronide. However, the addition of some synthetic 4-amino-3- 
biphenylylglucosiduronic acid to either the incubation medium, a solution of 
glucuronic acid or a solution of ascorbic acid failed to produce a complex with 
the properties of the trace component. 
Two further possibilities were then examined, the first that a glucoside had 
been formed due to the presence of uridine diphosphoglucose (UDPG) as an 
impurity in the UDPGA, and the second that the uridine diphosphate (UDP) 
formed by the action of the glucuronyl transferase could act as a phosphorylating 
agent. 
In order to test these ideas, experiments were carried out as 
described 
in 5.2.4. except that either UDPG or UDP were substituted for UDPGA. 
Synthetic 4-amino-3-bipheitylylgluconiduronic acid was also examined as an 
acceptor molecule. All these experiments failed to produce evidence 
for the 
nature of the minor component. 
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The discovery of facile migration reactions as intermediates in metabolism 
suggested a remote possibility that migration of the hydroxyl group either before 
or after conjugation with glucuronic acid could occur. Further experiments were 
then performed in which 4-amino-4'-hydroxybiphenyl was used as'an acceptor 
molecule in place of 4-amino-3-hydroxybiphenyl in the system described in 
5.2.4. 
A conjugate with properties suggesting that it was the C-glucosiduronic acid 
was formed, the chromatographic properties of this compound being different from 
those-of the "minor" component. 
A further experiment in which phosphate was completely eliminated from 
the reaction mixture by replacing the phosphate buffer with 0.1 M tris pH 7.4 
indicated that the presence of traces of inorganic material could significantly 
alter the Rf of 4-amino-3-biphenyiýiglucosiduronic acid. The addition of 
various salts to samples of synthetic 4-amino-3-biphenylylglucosiduronic acid, 
followed by chromatographic examination, showed that the minor component 
was formed due to the presence of certain salts. This was particularly pronounced 
in the case of ammonium acetate, but occurred also in the presence of disodium 
hydrogen phosphate. 
Elution of the minor component from sheets of 3MM chromatography paper 
with water or methanol containing ammonia, followed by concentration using a 
0 
rotary film evaporator at 40, gave only a substance having the properties of the 
major component when re-examined by chromatography using solvent systems 
or 
From the foregoing it has to be concluded that when 4-amino-3-hydroxy- 
biphenyl is incubated in the presence of microsomes and UDPGA only one 
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substance is formed, although due to the presence of certain salts complexes 
may be formed with slightly different chromatographic properties. 
5.3.3 Comparison of the synthetic and biosynthetic 4-amino-3-biphenylyl- 
glucosiduronic acid. 
The synthetic and biosynthetic 4-amino-3-biphenylylglucosiduronic acids 
had identical chromatographic properties and response to detection reagents 
when examined by paper chromatography (Table 5.3.1). When treated with 
nitrous acid followed by NED, both synthetic and biosynthetic materials gave 
rise to azo-dyes having identical absorption spectra with a maximum at 572 nm 
(Fig. 5.3.2). Both synthetic and biosynthetic 4-amino-3-biphenylylglucosid- 
uronic acids gave a positive reaction with Tol len's naphthoresorcinol reagent, 
and were hydrolysed by bacterial and mammalian 9-glucuronidase. The enzymic 
hydrolysis was inhibited by the incorporation of glucosaccharo-1: 4-, lactone 
into the incubate. Chromatographic examination indicated the disappearance 
of the substance having the chromatographic properties of 4-amino-3-biphenylyi- 
glucosiduronic acid under the influence of A-glucuronidase. 
It is concluded that the synthetic and biosynthetic materials prepared have 
identical properties which are those expected of a glucuronic acid conjugate 
of an ortho-aminophenol . 
5.3.4 Development of assay and species variation of uridine diphosphoglucuronic 
acid : 4-amino-3-hydroxybiphenylglucuronyI transferase. 
The finding that 4-amino-3-hydroxybiphenyl gave rise to only one substance 
when incubated with UDPGA in the presence of guinea-pig hepatic microsomes, 
and that this substance was identical in all respects with 4-amino-3-biphenylyl 
91 ucosiduro note, allowed the development of an assay for the enzyme transferring 
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Table5.3.1. Chromatographic 2ro erties* and response to detectim 
shown by synthetic and bi 
glucosiduronate. 
Detecting Reagent Synthetic 
nitrous acid followed by alkaline 
(a) I-naphthol orange-pink 
(b) 2-naphthol red 
(c) hexylresorcinol ye I low 
p-dimethylaminobenzaldehyde yellow 
p-dimethylami nocinnama Idehyde magenta 
naphthoresorcinol in TCAýat 1000 pink 
potassium dichromate-silver nitrate yellow 
ultra-violet light blue 
Solvent 
Butan-l-ol satd. with 2N, ýmmonia 
Butan-l-ol, Propan-l-ol, 2NAmmonia 
2: 1 :1 v/v 
Butan-l-ol, Acetic acid, Water 
12: 3: 5 v/v 
0.2 
0.23 
0.62 
0.2 
0.23 
0.62 
ents 
nthetic 4-amino-3-biphenylyl- 
Synthetic 
Rf 
Response 
Biosynthetic 
orange-pink 
red 
yellow 
yel low 
magenta 
pink 
yellow 
blue 
Biosynthetic 
Rf 
* Descending on Whatman No. I paper at room temperature. 
+ Trichloracetic acid. 
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the glucuronic acid moiety from UDPGA to 4-amino-3-hydro; xybiphenyl. The 
failure of ortho-aminophenols to diazotise and couple, due to the formation 
of diazo-oxides, has previously been uti I ised by Dutton & Storey (1962) to 
allow the measurement of ortho-aminophenylglucuronide in the presence of 
ortho-aminophenol by a method involving diazotisation and coupling with NED. 
The resulting coloured azo :: ompound was measured and the intensity of colour 
shown to be proportional to the amount of ortho-aminophenylglucuronide formed. 
This method was adapted for the measurement of 4-amino-3-biphenylylglucuronide. 
5.3.4.1 Effect of Temperature and Time on Colour Deve 
Solutions of synthetic 4-amino-3-biphenylylglucosiduronate, (Ca. 4 gmoles/ 
m 1), were treated successively with 2N hydrochloric acid (1 mi), sodium nitrite 
0.05% (1 ml), ammonium sulphamate 0.5% (1 ml) and NED 0.1% (1 ml). The 
reaction mixtures were allowed to stand at room temperature for three minutes 
after the addition of sodium nitrite and again after the addition of the ammonium 
sulphamate. Immediately after the addition of the NED., the reaction mixtures 
00 
were placed in water-baths at either 37 or 65 
The absorbtion was measured at 572 nm in I cm glass cells at various time 
intervals and the results are shown in Fig-5.3.3. From these results 
it can be 
clearly seen that development of the colour at 65 
0 results in maximum absorbtion 
in 30 min, whereas at 37 
0 it takes at least 60 min to obtain the same colour 
intensity. It was decided that the colour would be developed at 
65 0 for 30 
min in all subsequent experiments. 
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5.3.4.2 Effect of Trichloracetic acid concentration on subsequent colour 
developmen 
Synthetic 4-amino-3-biphenylylglucuronide solution, ca. 4 pmoles in I ml 
of 0.2% ascorbic acid, was added to rabbit liver microsomes prepared from 0.5 g 
of liver resuspended in 2 ml of phosphate buffer pH 7.4. The microsomal sus- 
pension was treated with I ml of trichloracetic acid solution and centrifuged at 
10,000xg for 10 min. The experiment was repeated using concentrations of tri- 
chloracetic acid from 3.5% w/v to 10% w/v. Aliquots (3 ml) oF the supernatant 
were treated with sodium nitrite, ammonium sulphamate and NED as described 
in 5.3.4.1 . The absorbance was measured at 572 nm and the results are shown 
in Table 5.3.2. 
Table 5.3.2. Effect of trichloracetic acid concentration on subsequent colour 
development 
Absorbance (572 nm) 
It was decided that 7.5% trichloracetic acid would be used as a protein 
precipitant in the glucuronyl transferase assay. 
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5.3.4.3. Linearity of absorbance versus concentration lin the ass 
3-biphenylylglucosiduronic 
acid 
of 4-rim; nn- 
Various concentrations of synthetic 4-amino-3-biphenylylglucosiduronic 
acid 
were incorporated into mixtures of microsomal tissue plus UDPGA' .. treated with 
trichtoracetic acid (7.5%),, centrifuged, and aliquots of the supernatant treated 
with sodium nitrite, ammonium sulphamate and NED, as in 5.3.4.1 . The reaction 
is linear over the range 0.02-0.5 ; anoles/flask (Fig. 5.3.4). 
5.3.4.4. Effect of 4-amino-3-hydroxybiphenyl concentration on enzyme activity 
Guinea-pig liver microsomes from 0.5 g liver, resuspended in 0.5 ml isotonic 
potassium chloride, were incubated with UDPGA (fina! concentration 2 mM) in 
phosphate buffer pH 7.4 containing magnesium chloride 0.02M (0.5 ml) and 
4-amino-3-hydroxybiphenyl in 0.2% ascorbic acid (1 .0 ml). The effect of 4- 
amino-3-hydroxybiphenyl, ranging from 0.1 ji mole to 1 .2 jimole per 2 ml incubate,, 
on the amount of conjugate formed was examined. 
The colour development was carried out os described in 5.3.4.1 and 5.3.4.2. 
The results are shown in Fig. 5.3.5. From these results it was decided to use a 
final concentration of 0.3 mM (equivalent to 0.6 pmoles per flask) for all further 
experiments. 
5.3.4.5. Final assay procedure for 4-amino-3-hydroxybiphenyl_: UDPGA _ 
glucuronyl transferase. 
From the foregoing experiments described in this section the following assay 
for enzymic activity was developed. This assay was used in the subsequent 
investigation of the glucuronyl transferase activity present in the hepatic micro- 
somes of various animal species. 
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Fig. 5.3.4. Linearity of assay for 4-amino-3-biphenylylglucuronic acid 
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a) Incubation medium 
Microsomes from 0.5g of I iver resuspended in 1 . 15% KCI 0.5 mi. 
Uridine diphosphoglucuronic acid (10 mg)dissolved in 
phosphate buffer pH 7.4 containing 0.02M magnesium chloride 1.0 ml . 
4-Amino-3-hydroxybiphenyl (0.6 gmoles in 0.2% ascorbic 
acid)'. 0.5 mi. 
b) Incubation conditions 
The enzyme preparations were incubated at 37 0 in 25 ml narrow-necked 
conical flasks for 30 m, 
c) Colour deve 
unless otherwise stated. 
The reaction was terminated by the addition of trichloracetic acid 7.5% w/v 
(1 
.0 ml), and the protein sedimented by centrifugation at 10,000xg for 10 m 
Aliquots of the supernatants (2.0 ml) were transferred to 5 ml stoppered test tubes 
and successively treated with sodium nitrite solution 0.05% (1 .0 mi), ammonium 
sulphamate solution 0.5% (1 .0 ml), and NED 0.1% 
(1 .0 ml). The tubes were 
allowed to stand at room temperature for 3m- after the addition of the sodium 
nitrite, and again for 3 rn after the addition of the ammonium sulphamate. 
Immediately after the addition of the 
placed in a water-bath at 65 
0 for 30 m- 
NED the tubes were stoppered and 
After cooling to room temperature the absct-bancewas read against a blank, 
prepared exactly as described above 
the initial incubation mixture. 
but without the addition of UDPGA to 
5.3.4.6 Effect of time on the course of hesis of 
4-amino-3-biphenvlvl- 
glucosiduronic acid. 
Under the conditions of assay developed (5.3.4.5), the time course of 
the bio- 
synthesis of 4-amino-3-biphenylylglucosiduronic acid was determined 
for a rabbit 
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hepatic microsomal preparation. The results are shown in Fig. 5.3.6 where it 
can be seen that the biosynthesis is linear, at least up to thirty minutes. This 
incubation time was therefore used as the Standard incubation time for the species 
variation experiments. 
5.3.4.7. Species variation in the biosynthesis of 4-amino-3-biphenylylglucosid- 
uronic acid. 
The glucuronyl transferase activity towards 4-amino-3-hydroxybiphenyl was 
determined under the assay conditions described in 5.3.4.5 for hepatic microsomal 
preparations from various animal species, during the course of 30 m incubation. 
The results are presented in Table 5.3.3 and indicate that considerable species 
variation in the ability to form "glucuronides" does exist. It is well documented 
that the cat lacks the ability to form these conjugates (Dutton, 1966), and the 
finding that human foetal tissue also did not produce measurable amounts of con- 
jugate is in line with the low levels of glucuronyl transferase usually associated 
with the neonate (See Section 6). 
5.3.5. The urinary excretion of 4-ami- no:. 3-biphýnylylglucosiduronic achýb 
various anima 0 
Following the i. p. administration of 4-amino-3-hydroxybiphenyl to the rat, 
cat and guinea-pig, the urine collected from these species was examined by 
paper chromatography as described earlier. In all species studied only two 
substances were detected which had an aromatic arriinogroup, as shown 
by specific 
spray detection reagents, although many other compounds could be seen using 
ultra-violet light. In the case of the guinea-pig the principal substance 
detected 
was identical in every respect with 4-amino-3-biphenylylglucosiduronic acid. 
The minor metabolite had properties identical to those of an authentic sample of 
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Fig. 5.3.6 Linearity of rabbit microsomal 4-amino-3-hydroxybiphenyl: UDPGA 
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Table 5.3.3. Uridine diphosphoglucuronic acid : 4-amino-3-hydroxybiphenyi 
glucuronyl transferase in various species 
Species Activity * 
Expt. I Expt. 2 
Guinea-pig 0.44 0.38 
Rabbit 0.37 0.34 
Dog 0.37 0.31 
Hamster 0.30 0.28 
Mouse 0.25 0.30 
Rat 0.20 0.18 
Cat 0.05 0.02 
Human Foetus 0 0 
Results are expressed as pmoles 4ABPGA formed per 0.59 liver during 30 m 
0 incubation at 37 
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4-amino-3-biphenylyisulphate (gift from Dr. P. Sims) 
. The urine obtained from 
the rat contained 4-amino-3-biphenylyLsulphate as the principal detected 
metabolite, the glucosiduronic acid conjugate being present to a slightly 
smaller extent as judged from visual examination of the chromatograms. In 
the cat no evidence was found to indicate that this species could 
form a glucuronic acid metaboLite; the only substance detected with an 
aromatic amino group had properties identical tothose of 4-amino-3-biphenylyl 
sulphate. 
The results presented above are in line with the in vitro results shown in 
Table 5.3.3. The high level of this glucuronyl transferase in the guinea-pig is 
reflected in the finding of the glucuronide as the principal metabolite from 4- 
amino-3-hydroxybiphenyi. Conversely, the very low level of glucuronyi trans- 
ferase activity found in vitro in the cat hepatic preparations would indicate 
the caes relative inability to utilise this metabolic pathway. The findinr, of 
medium levels of the glucuronyl transferase in rat liver preparations is consistent 
with the detection of approximately equal amounts of both the sulphate and 
glucuronic acid conjugates. 
Clearly no direct correlation can be obtained between the UDPGA: 4-amino- 
3-hydroxybiphenyl glucuronyl transferase and carcinogenic activity of 4-amino- 
biphenyl in the species studied. It is of interest that the species usually con- 
sidered refractory to the carcinogenic effect of aromatic amines., i. e. the 
guinea-pig, possesses the highest glucuronyl transferase activity towards 
4- 
amino-3-hydroxybiphenyl of those species studied. In comparisonf the 
dog 
which is the species most susceptible to bladder carcinogenesis by aromatic 
amines, had only a slightly lower glucuronyltransferase activity. 
The low 
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activity of glucuronyl transferase demonstrated in the cat may, in part, play 
a roie in the high acute toxicity of aromatic amines associated with this species 
(Rohde, 1923). 
, 
it would seem that the other species examined do have sufficient 
levels of the glucuronyl transferase to allow conjugation of 4-amino-3-hydroxy- 
biphenyl if presented with it as substrate. The results in Section 2 indicate that 
the levels of ortho-hydroxylation of 4-aminobiphenyl in any species is likely to 
depend on the ability of that species to acetylate 4-aminobiphenyi and de- 
acetylate 4-acetamidobiphenyl. If the correct balance occurs and 4-amino-3- 
hydroxybiphenyl is formed, the results obtained indicate that sufficient glucuronyl 
transferase is present to allow the formation and excretion of the glucuronide 
conjugate. The finding that this conjugate is hydrolysed by ý-glucuronidase is 
in agreement with the original hypothesis proposed by Boyland (1956). The 
lack 
of a correlation between glucuronyl transferase activity and susceptibility towards 
amine carcinogenicity found in this study in no way invalidates 
Boyland's 
hypothesis. 
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SECTION 6 CARCINOGENICITY OF SOME HYDROXYLATED 
DERIVATIVES OF 4-AMINOBIPHENYL 
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6.1 INTRODUCTION 
4-Aminobiphenyl or compounds which are metabolised to this amine 'in vivo, 
e. g. 4-nitrobiphenyi and 4-acetamidobiphenyl are powerful carcinogens in a 
variety of species. In man (Melick et al. 1955), dog (Walpole et al. 1954) and 
rabbits (Bonser, 1962; Wood, 1970), 4-aminobiphenyl induces cancer of the 
urinary tract, whereas in rats (Walpole et al. 1952) it gives rise to both intestinal 
and liver tumours. After the administration of 4-aminobiphenyl by stomach tube 
to AB x IF mice, no alteration of spontaneous hepatoma incidence was found by 
Clqyson, Lawson, Santana & Bonser (1965); however, two carcinomas of the 
urinary bladder were found in twelve surviving animals. In a later paper, Clayson, 
Lawson & Pringle (1967) found that this compound produced a high yield of 
hepatomas in female C57 x IF mice, but no urinary bladder tumours. It appears 
that even in species which ard susceptible to the action of 4-aminobiphenyl, 
multiple daily dosing for long periods may be necessary to produce tumours. 
Deichmann & McDonald (1968) found that massive single doses of 4-aminobiphenyl 
given to dogs failed to produce any carcinogenic response. 
Because of its structural similarity to the known carcinogen 2-acetamido- 
fluorene, 4-acetamidobiphenyl was tested for carcinogenicity in rats by Miller, 
Sandin, Mi I ler & Rusch (1956) and was shown to be a mammary carcinogen with 
no effect on the urinary bladder. This compound, when fed to female dogs, 
however, produced tumours of the bladder with pulmonary metastases (Jabara, 
1963). 
Deichmann et al. (1958) showed that 4-nitrobi pienyl was carcinogenic to the 
dog urinary bladder, and Laham et al. (1964) showed that mammary tumours were 
produced with this compound when given to female rats. 
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However, despite the extensive studies on the metabolism of these compounds, 
as discussed in Section 2, the routes leading to the initiation of the carcinogenic 
response remain obscure. As a carcinogenic response to all three compounds has 
been found in the dog, and as interconversion to 4-aminobiphenyi-, but not to 4- 
acetamidobiphenyl or 4-nitrobiphenyl, would be expected, it is not inconceivable 
that a metabolite derived from 4-aminobiphenyl is the responsible agent. 
Three hydroxylated metabolites derived from 4-aminobiphenyl have been 
reported, viz., 4-amino-3-hydroxybiphenyl, 4-amino-4'-hydroxybiphenyl and 
I 
4-hydroxylaminobiphenyl. (Section 2). However, knowledge as to their carci n- 
ogenicity is poor and conflicting. When 4-amino-3-hydroxybiphenyi was 
incorporated into pellets and implanted into the urinary bladders of mice, it 
proved to be carcinogenic (Clayson et al. 1958). Using similar bladder implant- 
ation testing conditions, 4-aminobiphenyl, 4-amino-4'-hydroxybiphenyl and 4- 
hydroxylaminobiphenyl, were all shown to be inactive (Bonser et al. 1963; 
Clayson et al. 1958; Boyland et al. 1964). In the latter report 4-N-acetyl-N- 
hydroxylaminobiphenyl was also shown to be inactive in the mouse bladder 
implantation tests. 
When 4-amino-3-hydroxybiphenyl was incorporated into the diets of rats 
(Miller et al, 1956) it was inactive, whereas the N-acetyl derivative of 4- 
hydroxylaminobiphenyl was active in this test system (Miller, Wyatt, Miller 
Hartmann, 1961), producing high yields of mammary tumours. 
Because of the conflicting evidence as to the nature of the proximate 
carcinogen derived from 4-aminobiphenyl it seemed desirable to examine this 
compound and its metabolites in a further test system. 
Pietra, Spencer and Shubik (1959) showed that injection of mice with only 
30 Mg of 9,10-dimethyl-l. #2-benzanthracene during the 
first day of life, gave 
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rise to high yields of lung adenomas and malignant lymphomas. This method 
of testing substances for carcinogenic activity rapidly gained support and a 
large number of compounds which had previously required multiple dosing or 
life-span experiments gave positive results after one to three doses during the 
neonatal period. 
Roe, Rowsonand Salaman (1961) showed that tumours of many sites could 
be elicited using this test system, depending upon the nature of the toxic 
agent, and recognised that this was an extremely sensitive test for carcino- 
genesis studies. This sensitivity is probably duee to many factors including the 
possible role of viral infection, the lack of full immunological competence and 
the hormonal status of the test animal. These factors are known to modify the 
response to carcinogens in adult animals and may play some role in the neonate. 
It is known that young animals either lack or have decreased levels oF many 
microsomal drug-hydroxylating enzymes (Jondorf, Maickel & Brodie, 1958; 
Fouts & Adamson, 1959). In addition the ability to synthesise certain gluco- 
siduronates and other conjugates is slow to develop in animals and man (Dutton, 
1963; Vest, 1965; Vest & Salzberg, 1965). This would indicate that after 
injection of a substance to newborn mice, further biotransformation would be 
minimal, and exposure to the substance administered would be sustained. 
Evidence that this occurs has been obtained with the compound ethylcarbamate. 
With this compound, total elimination of a single dose of 0.5 mg/g took only 
eight hours in adult mice, whereas three days were required in newborn mice 
(Kaye, 1960; Mirvish, Cividalli 81 Berenblum, 1964). 
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Similarly, Domsky, Lijinsky, Spencer & Shubik (1963) showed that only 
10% of a dose of 7112-dimethylbenz (a) anthracene remained in the adult 
mouse four days after dosing; in the newborn mouse however, no decrease 
in the level of the compound administered was found even ten days after 
injection. 
It was therefore thought that the new-born mouse would be a suitable 
test system to indicate which, if any, of the known hydroxylated metabolites 
of 4-aminobiphenyl were likely proximate carcinogens. 
6.2 EXPERIMENTAL 
6.2.1 Chemicals 
4-Aminobiphenyl, 4- hydroxy lam inobiphenyl, 4-amino-3-hydroxybiphenyl 
and 4-amino-4'-hydroxybiphenyl were all prepared and purified as described 
in Section 2. 
7,, 12-Dimethylbenz (ý)anthracene (DMBA), which was used as a positive 
control, was obtained from Koch-Light Laboratories. 
6.2.2 Injection Media 
All the test compounds were suspended by ultrasonication in 3% aqueous 
gelatin for injection. 
6.2.3 Animals 
Four hundred and sixty newborn Swiss (Porton) strain mice were used. 
The 
animals were obtained from a caesarean-derived strain maintained under 
barrier conditions. The animals were randomised, within 24 hours of birth, 
into seven experimental groups. With the exception of a control group, each 
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group received one of the compounds or aqueous gelatine. After the first 
injection each mouse was returned to a mother, each of whom was given 
ten neonates. 
6.2.4 Administration of Test Substances. 
The mice were injected subcutaneously in the interscapular region on 
each of the first three days of life. They were treated as foilows: 
Group I: Three injections of 200 gg 4-aminobiphenyi in 0.02 ml 
3% aqueous gelatin 
Group II: Three injections of 200 gg 4-amino-3-hydroxybiphenyl 
in 0.02 ml 3% aqueous gelatin 
Group III: Three injections of 200 gg 4-hydroxylaminobiphenyl in 
0.02 ml 3% aqueous gelatin 
Group IV : Three injections of 200 Ag 4-amino-4'-hydroxybiphenyl 
in 0.02 A 3% aqueous gelatin 
Group V: Three injections of 0.02 ml aqueous gelatin 
Group VI : No iniections. 
Group VII : Three injections of 20 Mg DMBA in 0.02 ml 3% aqueous 
gelatin 
Groups I-IV constitute the test groups., groups V-VII being control groups . 
The latter group VII was included to demonstrate that the strain of mice used 
was sensitive to a known carcinogen. 
6.2.5 Conduct of experiment. 
The mice were weaned at four weeks and the sexes segregated - 
They were 
then housed in plastic cages, ten mice in each, fed an autoclaved cubed 
diet 
f 
(Small Animal Diet, Spillers Ltd. ), and given water ad libitum. Barrier 
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conditions were maintained and all bedding was sterilised. The mice were 
inspected daily and thoroughly examined daily. Sick animals were killed 
promptly and ail survivors were killed between forty-eight and fifty-two 
weeks after birth. 
6.2.6 Postmortem examinations 
Full postmortem examinations were carried out on all mice. The liveri 
kidneys and urinary bladder were removed routinely, together with other 
organs that showed any abnormal ities, and fixed in Bouin's solution. Paraffin 
sections were prepared at 5ju, stained with hematoxylin and eosin and where 
necessary with hematoxylin and van Gieson, Mason's trichrome, Gordon and 
Sweet's silver impregnation method for reticulin and periodic acid-Schiff. 
6.3 RESULTS AND DISCUSSION 
The numbers of mice treated in each group, the number alive at weaning, 
and the number of mice alive at forty-eight to fifty-two weeks are recorded 
in Table 6.3.1 . The distribution of the sexes in the groups 
is also shown. 
Survival rates in all groups was very good, always exceeding seventy per cent 
of those alive at weaning. In most cases over ninety per cent of the animals 
survived and there was no evidence to suggest that either sex was more sensitive 
to the treatments. The principal neoplasmsseen in these experimental animals 
were hepatomas and the distribution of these is shown in Fig. 6.3.1. The 
incidence of liver tumours which occurred in the untreated group VI was very I 
low and occurred exclusively in the male animals. The group treated with 
aqueous gelatin alone (Group V) had a slightly raised incidence of 
hepatomasr 
although this observation was of doubtful significance. 
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Table 6.3.1. Survival of mice in Groups I-VI I 
Experimental groups Number of micel Number of micel Number of mice Survivors at 4 
given injectionsi alive at wean- I alive at 48-52 52 weeks as % given injections alive at wean- alive at 48-52 52 weeks as % 
at < 24 hrs ing wee ks of those alive 
at weaning. 
Group 1: 
24 20 85.4 
4-Aminobiphenyi 52 51 43 
9 27 9 23 92.0 
e 23 e 19 82.6 Group 11: 
4-Amino-3- 55 55 48 
hydroxybiphenyl 932 1 9 29 
19 
90.6 
()ý 
20 19 95.0 
Group I 11: 
4-Hydroxylamino- 56 
. 
55 52 
biphenyl 9 35 9 33 9 94.3 
Group IV- e 22 ()ý 18 
81.8 
4- Am i no- 4'- 50 49 44 
hydroxybiphenyl 9 27 9 26 9 96.3 
48 
d, 
48 41 
04 
85.4 
Group V: 
Aqueous gelatin 100 98 98 87 
, 99-50 
9 
46 
9 
92.0 
Group Vl-. 
Untreated 98 
45 
96 
51 
Cx42 
42 
90 90 
9 48 
9, Cýa 93.3 
94.1 
Group VI I- 
7., 12-Dimethyl- 
benz(a)anthracene 
49 
26 
A 49 
923 
d 19 
39 39 
920 
d 73.1 i 
9 87.0 
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In the group treated with DMBA high levels of hepatomas were produced 
in male mice, whereas this compound was inactive in female mice. An almost 
identical result was obtained with mice treated with 4-amino-3-hydroxybiphenyl 
(Group 11). In the other groups as well, male mice were always the most sensi- 
tive to the carcinogenic stimuii. Surprisingly, the parent amine produced the 
highest percentage of hepatomas, with 4-hydroxylaminobiphenyl slightly less 
active and the isomeric aminophenols equipotent in the male mice. In most 
affected animals of groups I to IV and group VI I multiple liver tumours were 
present. In contrast, those mice affected in groups V and VI never had more 
than two hepatomas found in any one animal. In view of the low incidence of 
hepatomas found in the female mice of groups 11, V, VI and VII, it is probable 
that those found in groups 1,111 and IV were produced by the test compounds. 
As a high proportion of animals survived the full duration of the experiment 
it was not possible to determine the time of appearance of hepatomas in 
individual groups. 
A low incidence of other tumours was seen in groups - I-VI and, as expected, 
a high incidence of pulmonary adenoma was found in animals treated with DMBA. 
These incidences of tumours are recorded in Table 6.3.2 and show a surpris- 
ingly low occurrence of pulmonary adenoma in those animals treated with amines. 
A further surprising result was the complete absence of tumours of the urinary 
bladder in these animals. 
The histopathological examination carried out by Drs. Carter and 
Roe is 
reported as follows: - 
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"Liver: The macroscopic and microscopic appearances of the hepatomas 
were similar in all experimental groups. The lesions were usually multiple 
and showed no predilection for any particular zone of the liver. They varied 
in size, ranging from small nodules to large, protruding masses measuring up 
to 2.5-3.0 cm in diameter. The predominant cellular pattern was of well- 
differentiated cords, interspersed with large, blood-filled spaces. Hyaline 
cytoplasmic inclusions were seen in several tumours from all experimental 
groups. No bile-duct elements were identified. The turnours often showed 
patchy necrosis or fatty degeneration, and such changes were not necessarily 
accompanied by parallel abnormalities in the surrounding non-neoplastic pa- 
renchyma. Foci of haemorrhage and necrosis were sometimes prominent and 
some tumours showed extensive infarction. The surrounding parenchyma was 
often compressed but no extension of tumours into or beyond the hepatic cap- 
sule was evident. 
$I Livers from mice that did not develop hepatomas were either normal or 
showed nonspecific parenchymal abnormalities, such as margination of cytoplasm, 
hyaline, hydropic or fatty changes., ' and necrosis. Such changes were character- 
istically patchy and were not localized consistently to any structure in or around 
the hepatic lobule. No lesions regarded as preneoplastic were observed. 
Other tissues: Degenerative changes were seen in the renal tubules of 
several animals. Most bladders examined were normal: squamous metaplasia 
was observed in three mice and epithelial atypia in one. The vesical epithelium 
in this mouse showed some variation in size and shape of the component ceils 
and their normal regular polarity was somewhat disrupted. Nuclear structures 
were, however, largely normal, mitotic figures were rarely seen, and there 
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was no evidence of proliferation into the lumen of the bladder or downward 
through the basement membrane - the latter structure was intact. " 
These results clearly fail to implicate any of the known hydroxylated 
metabolites of 4-aminobiphenyl as the proximate carcinogen derived from 4- 
aminobiphenyl. Indeed the high ability to produce hepatomas shown by the 
parent amine is very surprising as it had always been assumed that metabolic 
activation was a prerequisite for initiation of the carcinogenic response. 
Similarly, the finding that 4-amino-4'-hydroxybiphenyl was at least as active 
as 4-amino-3-hydroxybiphenyl, suggests that hitherto unconsidered metabolites 
may be important under certain conditions. 
The activity of the hydroxylated derivatives and 4-aminobiphenyl is 
difficult to understand at present and it may be that metabolic activation is 
possible in this test system. If N-hydroxylation is thought to be necessary for 
carcinogenic activity, then one would have expected the 4-hydroxylamino- 
biphenyl to be more active than the parent amine. However, it may be that 
the physical properties of 4-aminobiphenyl allow it to be transported to the 
liver, converted to the hydroxylamine and, because of the lack of conjugating 
enzymes, the local concentration of the hydroxylamine in the liver increases. 
It has been demonstrated that ortho-amin6phenol: uridine diphosphoglucuronyl 
transferase is present in the newborn mouse at about twenty per cent of 
the level in adults (Dutton & Lawes, 1966). 
However, as the hydroxylamine does produce liver tumours, this compound 
or material derived from it must reach the target organ. Reduction of the 
hydroxylamine to the amine followed by re-oxidation in the liver, 
is a 
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possibility; such a system has been shown to operate in the newborn mouse 
during the conversion of urethane to N-hydroxyurethane and vice versa (Nery, 
1968; Boiato, Mirvish & Berenblum, 1966). This mechanism would also suppose 
that the other aminophenols are N-oxidised, but at present no real evidence 
is available to support this hypothesis. 
I 
In the light of the results cited earlier (Jondorf et al. 1958; Fouts et al. 
1959) there has been a tacit assumption that the newborn animal lacks drug 
metabolising enzymes; it is now apparent that this is not always the case, and 
certain processes may proceed at considerable rates. Beckett, Gorrod & Watson 
(1967) found that liver obtained from human foetuses had high levels of chlor- 
promazine N-oxidase activity, and Uehleke (1964) observed that the N-hydroxyl- 
ation of p-chloraniline occurs at approximately the same rate with hepatic micro- 
somes derived from either young or old rats, rabbits or cats. Kato, Takanaka 
& Onodo (1970) have shown that the young mouse, unlike the young rat, did 
not have an impaired ability to hydroxyiate hexobarbital, demethylate amino- 
pyrine or parahydroxylate aniline. In a study carried out in rats, Basu, Dickerson 
& Parke (1971) have shown that biphenyl-2-hydroxy lase activity is present early 
in life, but disappears when the animal reaches maturity. 
The exact mechanism controlling the depressed levels of certain enzymes in 
the newborn has not been elucidated. Feuer and Liscio (1969) 
have implicated 
the high level of gonadal steroids derived from the mother. 
If this is so, then 
the hormonal status of the mothers and/or the reactivity of the test compounds 
with factors controlling the levels of steroids in the neonate, may well 
be a factor 
in producing the results described in this section. 
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Another striking result of these experiments, is the much greater sensitivity 
to the compounds of the male animals. Similar results have been obtained in 
other studies when mice have been exposed to carcinogenic agents during the 
neonatal period (Klein,, 1959; Roe & Walters, 1967). The relative responses 
of the sexes seen when adult mice are treated with a compound,, appears to vary 
depending upon the amine. 2-Amino-5-azotoluene given to mice from the age 
of two months produced a higher incidence of hepatomas, in females (Andervort, 
Grady and Edwards, 1942), and in some strains of mice this amine was virtually 
inactive in males. When this compound was administered to newborn mice it 
gave rise to hepatomas in males but not in females (Nishizuka, Ito & Nakakuki, 
1965). 
When a related amide, 2-acetamidofluorene,, was given to five different 
strains of adult mice, no difference in sex susceptibility was apparent (Bonser 
& Armstrong, 1947). However, Leatham (1951) found that when this compound 
was given to adult Swiss mice, males were more susceptible than females. This 
result was also found for Strain A/He mice exposed to 2-acetamidofluorene 
(Klein, 1959). It is of interest that when the presumed active metabolite of 
2-acetamidofluorene,, i. e. N-hydroxy-2-acetamidofluorenewas tested in new- 
born mice by Klein & WeisbLrger (1966) a high incidence of hepatomas was 
again found in male mice, whereas this metabolite was inactive in females. 
The activity of 2-acetamidofluorene and its N-hydroxylated derivative 
in 
producing hepatomas in adult males after treatment of newborn mice, 
has 
re'cently been confirmed by Fujii & Takakashi (1974). 
As described in the introduction to this section, 4-aminobiphenyl itself 
produces higher yields of hepatomas in adult female mice of the 
C57 X IF strain 
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(Clayson et al. 1967) than in adult males. These results indicate that a 
genetic factor is of obvious importance in determining strain susceptibility 
to carcinogens. The results in this section also indicate that if metabolism 
of the amino compounds is a prerequisite for carcinogenesis, then a marked 
sex difference in either extent or nature of metabolic pathways exists. Such 
sex differences have been shown to exist in rats (Kato, Chiesara & Frontino, 
1962) and man (Beckett, Gorrod and Jenner, 1971), but have not previously 
been observed in mice (Quinn, Axelrod & Brodie, 1958; Novick, Stohler 
Swagzdis, 1966). 
Davies, Gigon & Gillette (1969) examined the rate of metabolic oxida- 
tion of ethylmorphine by male and female rats, and concluded that the differ- 
ence in oxidation rates was due to differences in the rieduction of the ethyl- 
morphine-cytochrome P-450 complex. However, ethylmorphine gives a Type I 
spectrum on combination with cytochrome P-450. (Remmer et al. 1966), whereas 
the compounds used in this section aII give Type 11 spectra (Gorro6 & Greim, 1968 
quoted by Temple, 1971). Gorrod. and Greim also showed that the Ks values 
for 4-aminobiphenyl, 4-amino-4'-hydroxybiphenyl and 4-amino-3-hydroxy- 
biphenyl were all very similar when determined with adult male or female mice 
cytochrome. No significant difference between the sexes was found in either 
control or phenobarbitone pretreated mice. When animals were pretreated with 
4-aminobiphenyl prior to determining the Ks values, a very marked decrease 
in Ks values was found with 4-aminobiphenyl and its 4'-hydroxylated 
derivative 
The Ks value of the, ortho-aminopbenol studied did not change in the male mice 
so treated and decreased 50% in female mice. As these compounds were equitoxic 
to 
male and female mice the results indicate that perhaps the relationship 
- 237- 
between Ks and Km is not as direct as sometimes supposed (Remmer et al. 1966). 
The results clearly confirm the newborn mouse as a sensitive test animal for 
examining the carcinogenic potential of chemical substances. In the above 
results the carcinogenicity of two substances has been confirmed and the carcino- 
genic activity of the other two substances has been revealed. 
At present, few aromatic amines or their metabolites have been tested by 
this method. Roe, Mitchley & Walters (1963) examined the bladder carcinogen 
2-naphthylamine and its N-hydroxylated derivative in newborn BALB/c mice, 
and found both produced a slight increase in lung tumours which was a "doubtful 
but probably positive" result. In a later paper, Walters, Roe, Mitchley & 
Walsh (1967) re-examined these two compounds at a higher dose level and with 
injections during the first five days of life. -Under these conditions 2-naphthyl- 
amine was inactive whilst 2-naphthylhydroxylamine was active in producing 
pulmonary tumours. No difference was reported in the distribution of these 
tumours between the sexes. 
I-And 2-naphthylamine, I-and 2-naphthylhydroxylamine and I-and 2-nitroso- 
naphthalene were tested by Radomski, Brill, Deichmann & Glass (1971) using 
newborn Swiss mice. In these tests the parent amines showed only very slight 
activity, the hydroxylamines produced lung adenomas in female mice and hepa- 
g adenomas in male tom. as in male mice, 'and I-nitrosonaphthalene produced lun, 
mice and was inactive in females, whereas 2-nitrosonaphthalene produced 
hepatomas in male mice but had low activity in the lungs of female mice. 
The 
results all indicated that N-oxidation produced more active compounds. 
In 
view of the known or suspected carcinogenicity of ring hydroxylated 
derivatives 
of the naphthylamines, it is a great pity that the authors did not 
include any of 
the ring- hydroxylated compounds in their experiments. 
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The tumour-inhibitory amine 6-aminochrysene, whi, ch is not carcinogenic in adult 
rats and mice, was highly carcinogenic when given to newborn male mice, 
both lung and liver tumours being produced , 
(Roe, Carter & Adamthwaite, 
1969; Carter & Roe, 1970). It seems that in this test system, aromatic amines 
and their derivatives which have -so far been examined only produce signi- 
ficant neoplasms in lung or liver, and no rule is available to predict which 
organ will be affected. It is noteworthy that the original interest in these 
compounds arose from their ability to produce bladder tumours in certain 
animal species, yet no bladder tumours have been observed following their 
administration to newborn mice. 
It is suggested that this test could be applied to more compounds and their 
metabolites in the hope that a better understanding of the role of the meta- 
bolites in carcinogenesis will evolve. 
However, this test system is not without its critics and Toth (1968) has 
examined all the data on the testing of urethane and N-hydroxyurethane by 
this method. A fuller survey of the potential of this system is indicated in 
the revi ew by Porta & Terrac ini (1969) - 
If, as discussed in this section, the neonate does have the ability to 
utilise certain metabolic pathways, then knowledge as to the situation 
in the 
human neonate is of obvious importance. Recently, more attention 
has been 
paid to this aspect of human drug metabolism. Serini, 
Morselli & Pardi 
(1972) have reviewed the situation in man and several routes of metabolism 
have been detected. 
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In order fully to exploit the newborn mouse testing technique, it would seem 
desirable to gain more knowledge of the drug metabolising potential of mice 
during development. As only very small amounts of test compounds are given to 
newborn mice this may have to await the development and application of highly 
0* 
sensitive analytical techniques. 
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SECTION 7 THE INFLUENCE OF AROMATIC AMINES AND CERTAIN 
OF THEIR HYDROXYLATED DERIVATIVES ON LYSOSOMAL 
STABILITY 
- 241 -, 
7.1 
_INTRODUCTION. 
In 1955 de Duve, Pressman, Gianetto, Wattiaux and Applemans reported on 
the cellular location of a number of hydrolytic enzymes in rat liver. The enzymes 
studied were characterised by all having acid pH optima. They could be sedi- 
mented by differential centrifugation methods, and all exhibited the property of 
latency- that is, the enzymes were unable to maximally hydrolyse their substrates f 
until the enzyme preparation had been subjected to certain treatments. The treat- 
ments used were - addition of detergents, changes in the osmolarity of the suspend- 
ing medium, repeated freezing and thawing of the preparation and exposure to 
ultrasonic waves. 
As these treatments were known to have the ability to damage biological lipo- 
protein membranes, de Duve et al. (1955) suggested that these hydrolytic enzymes 
were present in the cell sequestered within a membrane. The finding that these 
latent enzyme preparations had different properties, when examined by ultra- 
centrifugation, than the known cellular organelles, indicated that a new organelle 
had been recognised. As the original enzymes studied all had lytic properties 
de Duve et al. called the new cellular particles, lysosomes. The 
lysosome concept 
is indicated in Figure 7.1 .1., although only the original enzymes 
studied are 
indicated. Further studies using both light and electron microscopy 
have revealed 
the presence by histochemical techniques of particles within cells, 
having the 
properties of lysosomes (Dingle and Fell, 1969; Dingle, 
1972). These studies 
further showed that lysosomes; were not an homogeneous population, and 
that their 
size and number varied not only from organ to organ but also within 
different cells 
of any specific organ. It is now realised that the number of enzymes 
which can 
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be described as lysosomal far exceeds the five originally described by de Duve 
et al. 
Tappel (1969) and Barret (1972) showed that at least forty enzyme activities 
are associated with lysosomes from various tissues, and that they have the 
potential to degrade virtually every biological macromolecule. In addition, a 
multiplicity of smaller molecules can also act as substrates for these enzymes. 
The finding of lysosomal enzymes within an organelle, yet separated from 
their substrates by a phospholipid membrane, was something of a paradox. In 
view of the ability of these enzymes to degrade cellular constituents, it was 
suggested that the function of lysosomes was to release enzymes upon cell death 
which could then break down macromolecules, and allow the products to be re- 
utilised by the organ. It was soon realised that this was really an oversimplification 
of the situation, as following the administration of many inert compounds such as 
asbestos, silica or foreign Proteins (e. g. horseradish peroxidase or egg albumin), 
these "foreign" materials appeared within certain lyso6omes, particularly those of 
the kidney or liver tissue (Allison, 1967; Straus, 1967). From this it was con- 
cluded that lysosomes probably play some role in phagocytosis, but as this process 
involves invagination of the cell membrane it would be expected that the 
lysosomal 
membrane would have a similar composition to the cell membrane, whereas electron 
microscopy showed that this was not the case. 
Studies on the biosynthesis of the lysosomal enzymes indicated that whilst 
synthesis occurred on the rough endoplasmic reticulum, complete 
lysosomes 
appeared to originate in the region of the Golgi complex. 
Novikoff, Novikoff, 
Quintana and Haun (1971) have suggested that 
lysosomal enzymes are synthesised 
and transported to smooth endoplasmic reticulum (S. E. R. ) adjacent to 
the Golgi 
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complex; the S. E. R. is then used to encapsulate the enzymes. This system, 
known as G. E. R. L. (Golgi-endoplasmic reticulum- lysosome), is thought to 
produce primary lysosomes which can then become involved in a variety of 
cellular processes. Primary lysosomes have been shown to merge with phago- 
somes, pinocytic and autophagic vacuoles early after their formation by GERL 
to form secondary lysosomes. As each of these vacuoles may have a different 
composition it is easy to understand the heterogeneity of secondary lysosomes, 
and as secondary lysosomes may fuse with each other, or with another primary 
lysosome, the situation is extremely complex (Fig. 7.1.2). 
It is now known that the cellular function of lysosomes is far more intricate 
than the original ! 'suicide bag" concept, and that lysosomes are intimately 
connected with such processes as cell metamorpho-sis and cell differentiation. 
Lysosomes have been found to occur in all tissues of all animal species 
examined. More recently it has become obvious that lysosomes are not only 
involved in intracellular digestion via phagocytosis, pinocytosis and endocytosis, 
but also in extra-cellular digestion following the release of enzymes from the cell. 
Apart from their involvement in normal cellular physiology, lysosomes are 
implicated in a variety of pathological conditions such as diseases of connective 
tissue and rheumatoid arthritis, as well as a variety oF "storage" diseases. The 
details of these many facets of lysosome physiology and pathology are too 
numerous to elaborate herein, and excellent monographs are available by 
Dingle & Fell (1969) and Dingle (1973). 
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Allison (1967,1969) has proposed that lysosomes may be involved in the 
carcinogenic process. The evidence insupport of this concept is detailed by 
Allison (1969). 
Allison's theory requires that carcinogenic substances are localised within 
the cellular lysosomes of susceptible tissue, and thereby cause sufficient 
damage to the lysosomal membrane to allow the release of desoxyri bonuc I ease 
(DNA-ase) . It is suggested that DNA-ase has the ability to cross the nuclear 
membrane and hydrolyse desoxyribonucleic acid and cause chromosomal damage. 
In support of this theory, Allison & Mallucci (1964) demonstrated that car- 
cinogenic hydrocarbons were taken up by four different tissues in tissue culture, 
and that the hydrocarbons were localised within the lysosomes. In these experi- 
ments the non- carcinogenic hydrocarbon, anthracene, had the same tissue dis- 
tribution as the carcinogenic compounds studied. This suggested that localisation 
per se was not enough to account for the difference in specificity of activity 
exhibited by different hydrocarbons, and that perhaps better correlation could 
be obtained if the metabolism of the compounds was considered. 
In a study of rat adrenal necrosis produced by 7,12-dimethylbenzanthracene 
(DMBA), Allison and Dingle (1966) showed that one metabolite;, viz. 7-hydroxy- 
methyl-12-methylbenzanthracene (7-OHM-12-MBA)., had the ability to release 
acid phosphatase from adrenal lysosomes, the isomeric metabolite 12-hydroxy- 
methyl-7-methylbenzanthracene (12-OHM-7-MBA) being far less active. The 
activity of 7-OHM-12-MBA was much greater towards adrenal tissue than 
towards either kidney or liver tissue preparations. As adrenal necrosis can also 
be produced in vivo by administration of 7-OHM-12-MBA to rats, 
(Boyland, 
Sims and Huggins, 1965) but not by the isomeric compound, clearly a tissue- 
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specific, metabolite-specific cellular interaction had been demonstrated. 
In another study on the role of lysosomes in carcinogenesis, Allison and 
Paton (1965) showed that human diploid cells had the ability to concentrate 
a variety of photosensitizing agents within lysosomes. When these prepara- 
tions were further treated with light, of a suitable wavelength, chromosomal 
damage occurred. This damage to the chromosomes was not seen in prepara- 
tions not irradiated,, or not treated with the photosensitizing agent but 
irradiated. The authors conclude that it was the combined action of the local- 
isation of the material within lysosomes, plus the photosensitizing effect of 
light, producing damage to the lysosomal membrane and thus allowing leakage 
of DNA-ase into the cytoplasm. It has previously been shown that addition of 
DNA-ase to isolated nuclei caused the DNA-dependent RNA polymerase to 
stop (Widnell and Tata, 1964), indicating that DNA-ase can trcv-rse the nuclear 
membrane. It is interesting that lysosomal DNA-ase has different properties from 
pancreatic DNA-ase; the former, being double stranded, seems to be able to 
cleave both strands of the DNA simultaneously, whilst the latter breaks only one 
strand of the DNA helix. It is suggested that the double strand break may be an 
irrcw'parable process leading to excision of genetic material and ultimately to the 
neoplastic condition (Allison, 1967,1969). 
Despite the evidence presented above, knowledge regarding the involvement 
of lysosomes in carcinogenesis is still incomplete. For example., it 
is known 
that lysosomes are labilised as a result of exposure to a variety of toxic substances, 
and yet the tissue never develops into the neoplastic state. 
If the toxicant is 
indeed so toxic that cell death occurs, then it is obvious that carcinogenesis 
cannot proceed. However, Kerr (1973) has reviewed numerous changes which 
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occur in the lysosomes of liver cells as a result of sub-lethal injury where 
development to frank tumour could have occurred. It may be that in these 
cases either the toxicant has the additional ability to inhibit the activity 
of the lysosomal enzyme(s), so that only functionally inactive enzyme(s) 
is released from the organelle, or that a stabilising factor is present which 
selectively controls which enzymes are released. Many materials occurring 
in nature, particularly certain steroids, do have the ability to "protect" or 
stabilise lysosomal membranes under conditions where damage is normally 
expected (Weissmann, 1969). 
Despite the objections stated above, further evidence does indicate that 
lysosomal changes occur during the change from normal to cancer tissue. 
Maisin, MaIdgune and Deckers-Passau (1961) found an increase in cathepsin, 
acid DNA-ase and acid ribonuclease in the livers of rats fed diets containing 
either 2-acetamidofluorene or 4-dimethylaminoazobenzene. After feeding 
2-acetamidofluorene to rats at low but carcinogenic levels, Flaks (1970) found 
an increase in the number of lysosomes present in the liver cells at 3-4 weeks 
and 8-12 weeks of feeding. These lysosomes were present associated with auto- 
phagic vacuoles and dense residual bodies. On prolonged feeding of 2-acetamido- 
fluorene for 8-10 months the number of lysosomes and autophagic vacuoles decreased 
compared with the number present earlier, * however the abundance of these 
organelles was still sufficiently greater than normal to be well recognised (Flaks, 
1971). 
The publication by Flaks (1970,1971) using electron microscopy techniques 
extends and confirms the earlier work of Mikata and Luse (1964). 
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In addition many other hepatocarcinogens have been reported to increase 
the levels of lysosomal enzymes. Amongst the compounds studied are aflatoxin 
(Pokrovsky, Kravchenko & Tutelyan, 1972) and dimethyinitrosamine (Slater & 
Greenbaum, 1965). 
From the foregoing it seemed desirable to investigate the possible role of 
lysosomal damage in carcinogenesis induced by aromatic amines. In order 
to achieve meaningful results it is obvious that the target organ from a species 
susceptible to arnine carcinogenesis has to be used as a source of lysosomes. 
This is necessary as lysosomes vary both in enzyme content and membrane 
fragility depending upon both organ and species. 
if lysosomal damage is involved in amine carcinogenesis, then the damage 
should be caused by the metabolite of the amine responsible for initiating the 
carcinogenic process, and not by the parent amine or the non-carcinogenic 
hydroxylated metabolites. A similar approach has previously been used by 
Gorrod, Alifano, Papa and Quagliariello (1967) in a study of mitochondrial 
damage produced by aromatic amines and some hydroxylated derivatives. 
These 
authors showed that whilst aromatic amines were without effect on-mitochondrial 
architecture, certain aminonaphthols produced an immediate gross 
lytic effect, 
with concomitant inhibition of respiration and phosphorylation. 
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7.2 EXPERIMENTAL 
7.2.1 Materials 
Aniline, ortho-aminophenol, para-aminophenol, anthranilic acid and 
1- and 2-naphthylamines Yýere purchased from commercial sources. Hydroxylated 
derivatives of I- and 2-naphthylamines were a gift from Dr. D. Manson. Phenyi- 
hydroxylamine and ortho-carboxyphenylhydroxylamine were a gift from Dr. R. Nery. 
4-Aminobiphenyl and its hydroxyiated metabolites were prepared as described in 
Section 2.3-Hydroxyanthranilic acid was a gift from Dr. P. Grover and 5-hydroxy- 
anthranilic acid was synthesised according to published methods. All substances 
were purified by recrystallisation until chromatographic examination indicated 
the substance was pure. All melting points agreed with the literature values. 
Triton X-100 was a gift from Rhom & Hass Ltd. Tween 20, Span 20 and Brij 35 
were supplied by Honeywell-Atlas Ltd' Cetrimide by I. C. I. Pharmaceuticals Ltd.; 
and sodium lauryl sulphate by B. D. H. Ltd. 
7.2.2. Tissue Preparations 
Urinary bladders of dogs were obtained as soon after death as possible and 
rinsed with isotonic sucrose solution. The bladders were kept in ice-cold iso- 
tonic sucrose until use, which was always within an hour of the animal's death. 
The dogs were usually greyhound or alsatian strains, being primarily used as 
donors for organ transplant experiments. The donor animal was sacrificed 
by 
Nembutal overdose just prior to the excision of the urinary bladder. 
Histochemical examination of dog bladder tissue by Dr. E. Katchburian of 
the Department of Histopathology, The Royal Post-Graducite Medical 
School., 
revealed the presence of various lysosomal enzymes only in the epithelial cells 
(Gorrod, 1967). 
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The epithelial cells were removed from the muscle wall of the urinary 
bladder by gently scraping the exterior surface of the bladder with a scalpel, 
. 
he bladder being stretched on a dissection board during this procedure. The 
epithelial cells were harvested by suspending the scýapings in 0.25*M 
sucrose/tris 0.05M and centrifuging the suspension for 20m at 1000 xg. 
Homogenisation of the epithelial cells was carried out in isotonic sucrose 
media using a Teflon-glass Potter-Elveihem homogeniser (Arthur H. Thomas) 
size B. The glass mortar was held in a specially constructed perspex holder 
contained in an ice-bath. The teflon pestle was driven by an electric motor 
at 980 r. p. m., and passed through the cell suspension at least three times with 
pauses of at least 20 s between passes to ensure adequate cooling. 
The homogenate was centrifuged at 600 xg for 5 m. to sediment whole cells, 
cell debris and nuclei. The lysosome., -rich fraction was sedimented at 10,000xg 
for 20 m. the microsoma I fraction was sedimented at 140,000xg for 60 m. and 
the soluble fraction was that remaining in the supernatant. This technique was 
essentially as described by Dingle 0 961) for the preparation of lysosomes from 
liver tissue. 
The lysosomal sediment was carefully resuspended in 0.25M sucrose/tris 0.05M 
(pH 7.4), filtered using nylon sifting cloth grade 9N (Henry Simon Ltd. Stockport), 
and diluted with sucrose/fris (pH 7.4) so that the final suspension gave a 40% 
transmission reading when examined using an EEL nephelometer. This method of 
standardisation of biological particwles in suspension has previously been used by 
Hubscher (1966) in studies on the epithelial cel Is of rabbit intestinal tract. 
This lysosomal suspension was used for the experiments on the properties of dog 
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bladder epithelial cell lysosomes, and the effects of aromatic amines and some of 
their hydroxylated derivatives on lysosomal stability. 
7.2.3 Enzyme and Protein Assays 
7.2.3.1 g-Glucuronidase 
g-Glucuronidose activity was determined by measuring the amount of phenol- 
phthalein released from p henc, I phtha lei n-mono-g-9 I ucosiduroni c acid (Koch-Light 
Laboratories Ltd) at pH 4.6 and 37 0 as described by Talalay, Fishman and Huggins 
(1946). The reaction was stopped and the colour developed by the addition of gly- 
cine/NaOH buffer (0.3M, pH 10.6). The absorption was measured at 552 nm. 
one unit is that amount of enzyme which liberates Igg of phenolphthalein per 
hour under the assay conditions. 
7.2.3.2 Acid phosphatase 
The activity of acid phosphatase was determined by the method of Torriani 
(1960) using para- ni tropheny I phosphate (B. D. H. Ltd. ) as substrate at pH 5.0. 
The para-nitrophenol liberated was measured at 410 nm after the addition of 
glycine/NaOH buffer (0.3M, pH 10.6) to stop the reaction. A unit of acid 
phosphatase is that amount of enzyme which liberates I pg of para-nitrophenol 
per hour under the assay conditions. 
7.2.3.3 Aryl sulphatase 
Aryl sulphatase activity was measured using the method developed by Roy 
(1953) and modified by Boyland, Wallace and Williams (1955) using para- 
nitrocatechol sulphatesynthesised'according to Roy (1953), as substrate at pH 5.6. 
The para- nitrocatechol released was measured at 520 nm in the presence of 
alkaline hydroquinone. One unit of aryl sulphatase activity is that amount of 
enzyme which liberates Igg of para-nitrocatechol per hour under the assay 
conditions - 
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7.2.3.4. Protease (Cath 
Cathepsin activity was determined using the method of Anson (1939) utilising 
bovine haemoglobin (Armour Pharmaceutical Co. ), purified as described by Gianetto 
and de Duve (1955), as substrate at pH 3.6. After the protein had been precipitated 
with trichloracetic acid (6.7%) and removed by filtration, the liberated tyrosine was 
determined, on an aliquot of the filtrate, by the method of Miller (1959). 
A unit of cathepsin activity is defined as that amount of enzyme which liberates 
I lig of tyrosine per hour under the assay conditions. 
7.2.3.5. Protein determination 
Proteins were determined by the method of Lowry, Roseborough, Farr and Randall 
(1951), using the modification of Miller (1959). Folin-Ciocalteau reagent (B. D. H. 
Ltd. ) was used and the colour, measured at 730nm was compared with-those of standard 
solutions of bovine serum albumin (B. D. H. Ltd) subjected to the assay procedure. 
7.2.4 Properties oF lysosomal preparations from dog urinary bladder epithelial cells 
7.2.4.1 The distribution of lysosomal enzyme activity in cell fractions derived 
from dog-urinary bladder epithelial cells 
The specific activities of g-glucuronidase, arylsulphatase, acid phosphatase and 
cathepsin were determined using the assay procedures described in 7.2.3 on various 
cell fractions prepared as described in 7.2.2. All enzyme activities were determined 
in the presence of 0.1% Triton X-100 in order to release the enzymes from organelles 
(Wattiaux and de Duve, 1956). 
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7.2.4.2 The pH qptima of lysosomal enzymes derived from lysomes prepared 
from dog urinary bladder epithelial cells 
A lysosomal preparation, prepared as described in 7.2.2, was treated with 
Triton X-100 at a final concentration of 0.1%, and stored for one hour at 00. 
The suspension was centrifuged at 25,000xg for 10m and the supernatant was 
assayed for A-glucuronidase,, acid phosphatase, aryl sulphatase and cathepsin 
activities at various hydrogen ion concentrations between pH 2 and 7. 
7.2.4.3 The effect of detergents on the release of enzymes and protein from 
a lysosomal preparation 
Aliquots of a lysosomai preparation, prepared as described in 7.2.2, were 
treated with either sodium lauryl sulphate, Tween-20, Span-20, Triton X-100, 
Brij 35, or Cetrimide at a final concentration of 0.1%. The aliquots were 
incubated at 37 0 for 1 Om and then centrifuged at 25,000xg for 10m, Enzyme 
and protein assays were then carried out on the supernatant as described in 7.2.3. 
7.2.4.4 The effect of temperature on the release of enzy es from a lysosomal 
prepara ion 
Aliquots of a lysosomal preparation in 0.25M sucrose/tris (pH 7.4) were stored 
at either -10,0,20 or 37 
0 for I h, after which they were centrifuged at 25,000xg 
and the supernatant was assayed for protein and g-glucuronidase, aryl sulphatase, 
acid phosphatase and cathepsin activities. A further aliquot was centrifuged at zero 
time and another was treated with Triton X-100 for Ih at 37 
0 prior to centrifuging, 
and the supernatant assayed as above. 
7.2.4.5 The effect of incubation time on the release of enzymes from a 
lysosomal 
preparation 
A lysosomal preparation, prepared as in 7.2.2, was incubated at 37o. 
Aliquots 
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were removed at various time intervals and centrifuged at 25,000xg for 10m. 
The supernatant was assayed for A-glucuronidase, aryl sulphatase, acid phos- 
phatase and cathepsin activity and protein as described in 7.2.3. The total 
activities were determined after treatment with Triton X-100,0.1%, and 
centrifugation at 25., 000xg for 10m. 
7.2.4.6 The effect of pH on the release of enzymes from a lysosomal 
preparation 
A lysosomal preparation was recentrifuged at 10,000xg for 20 m and the 
sediment resuspended in 0.5M sucrose. Aliquots of this suspension were then 
diluted with equal volumes of either acetate buffer (0.1 M), pH 4.6,5.6 or 
6.6, or tris buffer (0.1 M) pH 7.6 or 8.6, and incubated at 37 0 for I h. The 
al iquots were then centrifuged at 25,000xg for 10 m and the enzyme and protei n 
level in the supernatant determined. The total activity was determined in the 
presence of Triton X- 100,0.1 
7.2.4.7 The effect of repeated freezing and thawing on the release of enzyme 
from a lysomal preparation 
A lysosomal preparation from dog urinary bladder epithelial cells was divided 
into equal portions, and one aliquot immediately centrifuged at 25,00xg for 10 m, 
and protein and enzyme assays carried out on the supernatant as described in 
7.2.3. The remaining aliquots were frozen in liquid nitrogen for 2 m, after which 
0 
they were allowed to thaw by placing in an ice-water bath at 0-4 . One aliquot 
was centrifuged as before, and the supernatant assayed as above. Freezing in 
liquid nitrogen for 2m and subsequent thawing was repeated on the remaining 
fractions., one aliquot being removed, centrifuged and the supernatant assayed at 
each successive thawing. The supernatant obtained in each case was analysed 
for 
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protein and enzyme activity. The total enzyme activity was determined in 
the presence of Triton X- 100,0.1%. Each aI iquot took approximately 5m 
to freeze and thaw. 
7.2.4.8 The effect of certain solvents on the release of enzymes from a 
lysosomal prepcratio 
A lysosomal preparation was separately treated with absolute ethanol, 
acetone or dimethylsulphoxide at a final concentration of 1%, and incubated 
at 37 0 for I h. Duplicate aliquots were treated with the solvent plus Triton 
X- 100,0.1 %. One aI iquot was centrif uged at 25,000xg for I Om at zero 
time, the remainder were centrifuged as above after incubation for I h. The 
supernatants were assayed for enzyme activity using the methods described in 
7.2.3. 
7.2.4.9 The determination of lysosomal fragility 
A lysosomal preparation, prepared as described in 7.2.2, was allowed to 
reach 37 
0, and an aliquot immediately removed and centrifuged at 25,000xg 
for I Om. Enzyme and protein assays were carried out on this supernatant as 
described in 7.2.3. The lysosomal preparation was maintained at 37 
0 for Ih 
and another aliquot removed and centrifuged at 25,000xg for 10 m. Enzyme 
and protein assays were carried out on this supernatant. The total enzyme 
activity of the preparation was determined in the presence of Triton X-100 at 
af inal concentration of 0.1 % as described by Wattiaux and da Duve (1956) . 
The "bound" activity is defined as the "total" activity minus the activity 
found in the supernatant at zero time. The lysosomal fragility can then be 
defined as that percentage of the "bound" activity which becomes non- 
sedimentable, under the centrifugation conditions used, after treatment at 
37 0 for Ih (Dingle, 1972). 
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7.2.5 The effect of aromatic amines and some of their hydroxyiated derivatives 
on the release of enzyme activity from lysosomes prepared from dog 
urinary bladder epithelial cells 
Lysosomal preparations, prepared as in 7.2.2, were treated with aromatic 
amines and certain of their hydroxylated derivatives at a final concentration of 
0.5mM (unless otherwise stated). The compounds were added as solutions in 
dimethylsuiphoxide, such that the final concentration of the soivent was 1%. 
Control experiments in which the test compounds were omitted, but the solvent 
included, were always run parallel to the test system. Duplicate experiments 
were carried out in which Triton X-100,0.1%, was included in the test system 
as well as the test compounds plus solvent. 
Aliquots of the lysosomal preparation obtained at zero time, and an aliquot 
treated with Triton X-100,0.1%, were centrifuged at 25,000xg for 
10m and 
the supernatants were assayed for enzyme activity as described in 7.2-3. 
The 
test system., with and without Triton X- 100,0.1 %, was incubated at 
37 0 for I hp 
then centrifuged at 25,000xg for 1 Om and the supernatants assayed 
for enzyme 
activity. 
In some experiments the concentration of the test compound was varied, 
the 
concentration of dimethylsulphoxide being 
kept constant at 1 %. 
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7.3 RESULTS AND DISCUSSION 
The experiments described in the previous section (7.2.4) were carried out 
to examine the possibility of obtaining a cell fraction from dog urinary bladder 
epithelial cells, which had the property of latency in respect to certain hydro- 
lytic enzymes. These enzymes are known to be associated with lysosomes 
derived from other organs. The subcellular distribution of enzymes and protein 
is shown in Table 7.3.1 . The results tabulated are from one specific tissue 
preparation derived from four separate dog urinary bladders. These results show 
that four hydrolytic enzymes, commonly used as markers for lysosomes in tissue 
distribution studies, are present in preparations from dog urinary bladder 
epithelial cells. The table also shows that the highest specific activity of the 
enzymes studied is always associated with the lysosomal fraction. However, 
the distribution of the enzymes shows wide variations, and in the case of both 
aryl sulphatase and acid phosphatase the bulk of the enzyme activity is 
present in the supernatant soluble fraction. Whether this is a true reflection 
of the in vivo situation, or whether produced by the homogenisation technique 
used, is not at present known. In other experiments using differing times of 
homogenisation, or using the Ultra-Turrax homogeniser, similar high levels of 
acid phosphatase and aryl sulphatase have been found in the supernatant 
fraction. This contrasts with the in vivo situation where Gorrod (1967) and 
Birkbeck and Grover (1965) reported the localisation of acid phosphatase 
within lysosomes in this tissue. 
As observed by others (see Dingle, 1973) considerable variation in enzyme 
localisation occurred in different preparations, even when the homogenisation 
technique was strictly controlled. Whilst the results presented in 
Table 7.3.1 
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are typical, the percentage of enzyme a. ctivity present. in the lysosomal fraction 
varied from 20-50% for A-glucuronidase, 30-50% for cathepsin, and 10-20% 
for aryl sulphatase and acid phosphatase. There was also a lack of consist- 
ency in the ratios of the enzyme activities in various preparations. However., 
this variation appears to be common in studies of this type, even with easily 
homogenised tissue such as liver. "Tough" tissue such as muscle, skin, or 
connective tissue invariably showed a greater variation. 
It has previously been reported that lysosomal enzymes may differ in regard 
to their pH optima 
, 
compared to the non-lysosomal enzyme (Mi I Is, Paul & 
Smith, 1953; Ganschow & Paigen, 1967; de Duve, Pressmann, Gianetto., 
Wattiaux & Appelmans, 1955). It was of interest to check the pH optima of 
the enzymes found associated with the lysosomal fraction in the dog bladder 
epithelial preparation. The pH activity curves are shown in Fig. 7.3.1 ; in 
each case the optimum pH of enzyme activity was in the acid region, a 
property of many lysosomal enzymes. The pH optimum for each enzyme corres- 
poncled to that of the lysosomal enzymes derived from other mammalian tissues. 
In order to see whether the fraction sedimenting at 10,000xg could really be 
termed a lysosomal fraction, it was necessary to confirm that it had the property 
of latency., that is, that certain treatments were able to enhance the level of 
enzyme activity. In his classic studies, de Duve found that treatment with 
detergents was able to liberate certain enzymes from a bound form. The 
results in Table 7.3.2 show that of the detergents studied Triton X-100 had the 
greatest ability to convert g-glucuronidose and acid phosphatase into a non- 
sedimentable form. The results also show that both sodium lauryl sulphate and 
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Cetrimide caused a marked inhibition of the 9-glucuronidase activity. 
Lauryi sulphate, which also inhibited acid phosphatase, had the greatest 
ability to convert the protein present in the preparation into a form non- 
sedimentable under the standard centrifugation conditions used. These 
results are in line with those obtained with preparations from other tissues 
(Dingle, 1973), and confirm the usefulness of Triton X-100 in releasing 
enzymes from cellular organelles (Wattiaux & de Duve, 1956; Glassman, 
1950; 
- 
Walker & Levvy 1951,1953), without causing enzyme inhibition. 
Triton X-100, a non-ionic detergent, was used in all further experiments to 
release enzymic activities from "bound" preparations. 
A further parameter often used to demonstrate enzyme latency is the 
variation in the release of the enzymes when the organelle is exposed to 
various temperatures. The results from one such experiment are tabulated 
in Table 7.3.3. Incubation oF the organelle preparation at 00 caused 
minimal release oF the bound enzymes; at this temperature g-glucuronidase, 
aryl sulphatase and cathepsin were all released to about the same extent., 
whereas acid phosphatase was much more labile. Decreasing or increasing 
the temperature of incubation increased the percentage of bound enzyme 
00. 
released in every case. Again, differences in sensitivity to temperature 
changes were seen with different enzymes. Increasing the incubation temper- 
ature from 00 to 37 0 trebled the activity of the aryl sulphatase released, the 
A-glucuroniduse being increased five-fold. Acid phosphatase release was 
increased only from 18 to 25% of the bound material. 
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Table 7.3.2 The effect of detergents on the release of some enzymes and 
protein from a dog urinary bladd, er preparation 
Detergent + A-Glucuronidase 
Units/ml 
Acid Phosphatase 
Units/ml 
Protein 
ýIg/ml 
Nil 1.0 12.8 40 
Sodium Lauryl Sulphate 0.2 2.3 132 
Tween 20 1.2 10.6 63 
Span 20 2.0 26.0 68 
Triton X-100 7.5 51.8 83 
Brij 35 2.4 18.6 59 
Cetrimide 0.4 20.6 50 
at afi na I concentrat ion of 0.1 %. 
Table 7.3.3 The effect of incubation temperature on the release of some 
enzymes and protein from a dog urinary bladder preparation 
% of Bound Material released during 1h incubation 
I 
Incubation temp. - Protein g-Glucuronidase Aryl Cathepsin Acid 
degrees Sulphatase Phosphatase 
-10 20 22 
20 10 24 
0 10 5 7 6 18 
20 15 15 15 8 20 
37 22 27 21 11 25 
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Table 7.3.4. The effect of incubation time on the release of 0-glucuronidase 
and acid phosphatase from a dog. urinary bladder preparation 
Time 
(m) 
Percentage of Bound Enzyme Released + 
A-glucuronidase Ac id phosphatase 
20 3 21 
40 8 29 
60 13 34 
90 18 41 
120 24 48 
150 29 53 
at 37 0 pH 7.4. 
6 
Table 7.3.5 The effect of pH on the release of enzymes from a do 
bladder preparation 
Percentage of Bound Enzyme Released during I hr 
incubation at 37 0 
pH O-Glucuronidase Aryl Sulphatase Acid Phosphatase Cathepsin 
4.6 49 81 21 11 
5.6 31 26 18 4 
6.6 22 21 21 4 
7.6 12 21 25 11 
8.6 19 31 32 24 
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When the incubation temperature was kept constant at 370, and the liberated 
A-glucuronidase or acid phosphatase was measured at different times, again a 
difference in sensitivity was observed (Tabie 7.3.4l Fig. 7.3.2). Whilst the g- 
glucuroniclase appeared to be released at a linear rate over the 150 m of incuba- 
tion, the acid phosphatase was rapidly released during the early period followed 
by a slow linear release as the incubation time increased. 
This variation in sensitivity was also seen when the tissue preparation was 
exposed to different hydrogen ion concentrations during the incubation. Whilst 
pH 7.6 seemed to favour the retention of g-glucuronidase within the organelle, 
a more acid environment (pH 5.6) provided more stability for acid phosphatase 
and cathepsin. Reducing the pH to 4.6 allowed the release of over eighty percent 
I 
of the aryl sulphatase activity and about half of the g-glucuronidase activity; in 
contrast only eleven percent of bound cathepsin was released (Table 7.3.5, Fig. 7.3.3). 
Following repeated freezing in liquid nitrogen and subsequent thawing at 001 
a gradual release of enzymes and protein was found. These results are shown in 
Table 7.3.6, and Fig. 7.3.4 confirms the results obtained earlier which indicate 
that several hydrolytic enzymes are present in dog urinary bladder epithelial cells. 
The finding that changes in the external environment of a subcellular fraction, 
by either incorporation of detergents, changes in pH or changes in temperature or 
freezing and thawing, - allow the release of enzyme and protein, all point to the 
conclusion that these enzymes are sequestered within a membrane . 
The properties exhibited by the subcellular fraction indicate that it is similar 
in many respects to fractions prepared in a similar manner from other organs and 
known to contain lysosomes. From the foregoing it must be concluded that a 
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[Aosome- rich fraction has been prepared from dog urinary bladder epithelial 
cells, and that experiments on the effects of amines and their derivatives are 
therefore possible. 
In order to carry out such studies it was necessary to add the. amines in a 
solvent which would not have a greater lytic effect on the organelles than that 
observed as spontaneous release during incubation under test conditions. The 
results obtained on the effects of several solvents are shown in Table 7.3.7. 
Table 7.3.7 
Addition 
final conci-n- 
tration I%) 
Nil 
Ethanol 
Acetone 
Di methylsulphoxid 
16 12 22 8 
22 20 30 15 
16 15 20 12 
16 12 20 9 
The solvents were chosen because of their demonstrated ability to dissolve the 
test compounds at the required concentration. Each of the enzymes studied was 
released to a greater extent in the presence of ethanol 0.1% than in control 
incubates. 
In view of the minimal effects observed with dimethylsulphoxide this solvent was used 
in subsequent experiments. 
During the course of these experiments, designed to verify the possibility of 
isolating a fraction containing "bound" enzymes within an organelle, 
it became 
The influence of solvents on the release of enzymes from a dog 
urinary bladder preparation after incubation at 370 for I h. 
Percentage of Bound Enzyme Released 
A-Glucuronidasel Aryl Sulphatasel Acid Phos. Phatasel Cathepsin 
apparent that considerable variation, both in the sub-cellular 
distribution and 
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the stability of the enzymes within the organelles during subsequent incubation 
at 37 0 existed. This variation could have resulted from the method of If 
preparation or could have occurred naturally depending upon the physiological 
status of the animal. As this variation in fragility could make difficult a compa- 
rison of effects of exogenous materials on lysosomal stability, it was decided to 
establish an arbitrary measure of fragility. This was done as described in 7.2.4.8, 
and fragility was defined as the percentage of bound P-glucuronidase which becomes 
non-sedimentable under the conditions used, after incubation for Ih at 37 0 in the 
presence of 1% dimethylsulphoxide. In practice most preparations had a "fragility" 
between 15 and 30%; any preparation failing outside this range was discarded and 
not used for further work in Section 7.2.5. 
In order to determine whether aromatic amines, or their hydroxylated deriva- 
tives., were able to interact with lysosomes and so release bound enzymes, experi- 
0 
ments were carried out in which the test compounds were incubated with lysosomal 
preparations at 37 
0 for I h. Because of the variations in the characteristics of 
the preparation, both in regard to enzyme content and to fragility, it was 
impossible to obtain an absolute measure of effect. Instead the effect was 
measured by a comparison of the enzyme activity released in the presence of the 
test compound compared to the amount of enzyme released spontaneously under 
the same test conditions. 
At the same time, it was important to measure the effect of the test compounds 
on the enzyme activity being measured. A situation could exist where 
the 
organelle was lysed yet because of the inhibitory action of the 
lysing agent on 
the enzyme measured no apparent lysis was observed. 
In order to test this 
possibility each test mixture was also run in the presence of 
Triton X-100. 
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The results obtained from a series of amines, and their hydroxylated 
derivatives, on the release of A-glucuronidase from a lysosomal preparation are 
tabulated in Table 7.3.8. From this table several interesting conclusions 
can be drawn. The first is that the majority of parent amines studied have 
little effect on lysosomal stability, as figures between 0.8 and 1 .1 indicate. 
However, 4-hydroxylaminobiphenyl does consistently release high levels of 
g-glucuronidase compared to lysosomal incubate without this addition, or 
compared with 4-aminobiphenyl, 4-amino-3-hydroxybiphenyl or 4-amino-4'- 
hydroxybiphenyl. In contrast, certain compounds appear to exert a protective 
effect on the lysosomal membrane preventing the release of 0-glucuronidase. 
This seems particularly true of the hydroxylated naphthylamines, yet when 
the effect of these compounds on g-glucuronidase activity was studied (Table 
7.3.8) it can be seen that it was these compounds which had the greatest 
inhibitory effect. As the relative concentration of these compounds would be 
correspondingly higher when acting only on spontaneously released enzyme, I 
inhibition rather than stabilisation may account for this phenomenon. Amino- 
naphthols are easily oxidised at pH 7.4 (Gorrod, Alifano, Papa & Quagliarello, 
1967) to yield a variety of products (Nagasawa, Gutmann & Morgan, 
1959). 
The parent substances or the oxidation products have the ability to covalently 
bind with proteins (Bellman & Troll, 1962; Nagasawa & Gutmann, 
1959). 
Visual examination of the sediment from lysosomal experiments in the presence 
of amino naphthols indicated that binding to a cellular constituent 
had occurred 
as the material was stained with a blue pigment. 
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Table 7.3.8. The effect of aromatic amines and their hydroxylated derivatives 
on the release of sedimentable ý-glucuronidase obtained from dog 
urinary bladder epithelial cells 
Compound + Effect on rel ease4b ,% Activity of enzyme 
x 
Aniline 0.9 98 
Pheny1hydroxylamine 0.9 94 
Ortho-aminophenoi 0.7 99 
Para-aminophenol 0.5 98 
Anthranilic acid 0.9 96 
Ortho-carboxyphenyihydroxylamine 0.9- 102 
3-Hydroxyanthranilic acid 0.7 99 
5-Hydroxyanthranilic acid 0.6 97 
1-Naphthylamine 0.8 99 
I-Naphthylhydroxylamine 0.9 98 
1 -Amino-2- naphthol o. 2 80 
1 -Amino-4- naphthol 0.1 76 
2-Naphthylamine 0.8 110 
2-Naphthylhydroxylamine 1.1 100 
2- Am i no- 1- naphtho 1 0.4 80 
2-Amino-5- naphthol 0.4 82 
4-Aminobiphenyl 1.4 105 
4- Hydroxy I am i nobi pheny 1 2.6 95 
4-Amino-3-hydroxybiphenyl 0.9 92 
4- Am i no-4- hyd roxybi pheny 1 0.9 100 
+ Compounds present at a concentration of 0.5 mM. 
* Effect = 
g-glucuronidase ity activ released sence of 
g-glucuronidase - activity released in absence of 
und 
compound. 
x g-C4ucuronidase activity measured in the presence of compounds 
(0.5mM) 
and Triton X- 100 (0.1 I/q) - 
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As 4-hydroxylaminobiphenyl had the greatest effect on release of ý- 
glucuronidase, further experiments were carried out with increasing concen- 
trations of certain ary1hydroxylamines. In each case the maximum measurable 
effect occurred at a concentration of I mM (Table 7.3.9). 
Table 7.3.9. The effect of increasing concentration of ary1hydroxylamines 
on the release of g-glucuronidase from dog urinary bladder 
. 
Iysosomes 
ompound Concentration 
(mm) 
Effect on en- 
zyme release 
henyl- 
hydroxylamine 
ýhocarboxyphenyl- 
hydroxylamine 
, -Naphthyl- hydroxy I am i ne 
HydýOxylamino- 
biphenyl 
0.5 
1.0 
2.0 
0.5 
1.0 
2.0 
0.5 
1.0 
2.0 
0.5 
1.0 
2.0 
1.1 
1.7 
1.3 
0.9 
1.1 
0.3 
1.1 
1.3 
0.8 
1.7 
1.8 
1.4 
98% 
82 
75 
100 
92 
73 
98 
82 
69 
98 
86 
62 
Effect = 
lucuronidase activity released in presence of compound 
0-glucuronidase activity released in absence o compound 
x 
Effect on en- 
zyme activity 
x g-Glucuronidase activity measured in the presence of compounds and 
Triton X-100 
(0-10/0) 
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Higher concentrations apparently had less effect. However, as the increased 
concentrations of the hydroxylamines all caused a greater inhibition of g- 
glucuronidase, this may have produced an erroneous picture of the situation. 
In a further experiment 4-aminobiphenyl and some related hydroxylated 
compounds were examined for a lytic effect with regard to the release of aryl 
sulphatase, and acid phosphatase from a dog urinary bladder lysosomal prepar- 
ation. A strong lytic activity_ with regard to aryi sulphatase was produced 
(Table 7.3.10) with 4-hydroxylaminobiphenyl, but not with regard to acid 
phosphatase. 
Table 7.3.10 The effect of 4-aminobiphenyl and some related hydroxylated 
derivatives on the release of acid phosphatase and aryl 
sulphatase from a dog urinary bladder lysosomal preparation 
0" 
Compound 
'0.5 mM) 
Acid Phosphatase 
Effect* Activity+ 
Aryl Sulphatase 
+ Effect* 1 Activity 
4-Aminobiphenyl 2.0 83 1.5 100 
4-Hydroxylaminobiphenyl 1.8 95 3.0 1 116 
4-Amino-3-hydroxy- 
biphenyl 1.6 102 1.0 120 
tAmino-4'-hydroxy- 
2 
I biphenyl 
72 0.3 6 
*Effect = 
Enzyme activity released ence of compound 
Enzyme activity released in absence of compound 
+ Enzyme activity measured in the presence of compounds 
(0.5mM) and Triton 
X-100 (0.1%). 
97A I" -T 
In these experiments it was found that 4-amino-4'-hydroxybiphenyi was 
an inhibitor of both acid phosphatase and aryl suiphatase, whereas an 
activating influence was seen on aryl sulphatase by both 4-hydroxylamino- 
biphenyl and 4-amino-3-hydroxybiphenyl. 
It is clear from these experiments that no conclusive correlation has been 
found between any structurally similar group of compounds and their effect on 
, 
&-glucuronidase release from dog bladder lysosomes. The finding that aryl- 
hydroxylamines released 0-glucuronidase, although not with the same efficiency, 
certainly supports Allison's theory of carýinogenesis by aromatic amines. 
However, when the release of aryl sulphatase and acid phosphatase was 
examined, only the former enzyme was released to an appreciable extent by 
4-hydroxylaminobiphenyl compared with the other compounds stud"Ied. Several 
reasons for this phenomenon can be postulated. 
It is now realised that the lysosome population within a cell is very hetero- 
geneous (Section 7.1), and in experiments of this type only those lysosomes 
which survive the isolation procedure are available for study. As considerable 
amounts of lysosomal enzymes were detected in the supernatant (Table 7.3-1), 
it may be that the lysosomes most sensitive to the carcinogenic (or indeed any 
other) stimuli, were already destroyed. Further, it is well documented (Tappel, 
1969), and supported by work in this thesis, that different enzymes do not 
become released from the lysosome matrix at the same rate. 
Extending the study to other enzymes,, therefore, may have afforded a 
better 
correlation between carcinogenic activity and lysosomal 
damage. Such a project 
is fraught with difficulty, even if sufficient tissue were to become available, 
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because many of the compounds of interest interfere with the assay methods 
used for determining enzymic activity. For example, hydroxylated compounds 
react with Folin-Ciocalteau reagent used in the assay of cathepsin, and the 
aromatic amines and their hydroxylated derivatives strongly absorb in the 
shorter wavelengths commonly used for the assay of both ribonuclease and 
desoxyri bon uc I ease. 
Another aspect of this problem is one of experimental design. Because of 
the practical problems in working with dog urinary bladder tissue, a system was 
developed which examined the release of enzymes from the lysosomes due to 
external stimuli. It is worth remembering that under the experimental conditions 
whereby bladder tumours are produced from aromatic amines, the amines and 
their metabolites are external to the epithelial cells, but these may be encap- 
sulated inside the organelle by pinocytosis. In order to carry out this type of 
experiment measurement of "fredand"bound" enzymes in susceptible cells 
during amine feeding experiments, would have to be carried out. Clearly this 
experiment was not feasible using dogs and aromatic amines as the test system. 
Whilst the test system developed herein is concerned with the leakage of enzymes 
out of the organelle, another aspect which was not explored was the possibility 
of the test compounds altering the permeability of the membranes, and allowing 
substrates to enter the organelle. This was not considered further as Allison's 
concept recognised that the nuclease had to get to nuclear nucleic acids rather 
than vice-versa. 
At present the mechanism by which 4-hydroxylaminobiphenyl allows excess 
leakage of 0-glucuronidose and aryl sulphatase from the organelle is not known. 
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It has been proposed that a peroxidation reaction involving the membrane is a 
prerequisite for enzyme release (Wills & Wilkinson, 1966). In experiments in 
which methyllinoleate was used as a model system, 4-hydroxylaminobiphenyl 
has failed to enhance the formation of malonaldehyde, indicating that lipid 
peroxidation is not affected by this compound. 
A similar release of g-glucuronidase from a rabbit liver lysosome prepara- 
tion has been reported with N-hydroxy-2-acetamidofluorene (ImM), the parent 
amide being inactive (Weissmann, Troll, van Duuren & Sessa, 1968). In a 
more recent paper., Berg and Christoffersen (1974) have shown that a considerable 
redistribution of hepatic lysosomal enzymes occurs after feeding 2-acetamido- 
fluorene to ratsthey suggest that larger lysosomes are formed indicative of 
increased cellular autophagy. This biochemical study is consistent with the 
findings of Flaks (1970) . referred to earlier. However, work by Takano, Kato, 
Miyata, Goto, Ohkuma, Mizuno, Kitigawa & Yokoyama (1971), on the 
distribution of hepatic lysosomal enzymes during carcinogenesis experiments with 
dimethy lam i noazobenzene, showed an increase in the amounts of g- 
glucuronidase and acid ribonuclease present in the cytoplasm - and 
less in the 
particulate form, indicating to the authors a change in lysosomal stability during 
carcinogenesis. 
The results in this section do not invalidate the possible role of lysosomal 
damage in carcinogenesis proposed by Allison (1967,1969). The results do show 
the extreme complexity of the present state of our knowledge on lysosomes, and 
the difficulties involved in working with experimental systems directly related 
to the disease induced in man. 
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SECTION 8 THE ACTIVATION OF g-GLUCURONIDASE 
BY CERTAIN AROMATIC AMINES. 
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8.1 INTRODUCTION 
The enzyme ý-glucuronidase is of considerable importance. Its localisation 
within the lysosome (see Section 7) has allowed its widespread use in tissue 
fractionation studies (De Duve, Pressman, Gianetto,, Wattiaux & Applemans, 
1955; Wattiaux, 1969; Dingle & Fell, 1969; Dingle, 1972) as a marker enzyme. 
Ganschow & Paigen (1967) have found differences in the properties of the en- 
zyme derived from different organelles within ceils, and have indicated that as 
these properties are under a genetic control mechanism, $-glucuronidase can 
be used as a suitable genetic marker. 
'n r"'I p-Gucuroniclase is present in plasma, milk, vaginal fluid and urine of 
mammals, and its activity is modified during many physiological processes, e. g. 
pregnancy, (Woessner, 1965), involution of the mammary gland and during the 
menstrual cycle (Helminen & Ericsson, 1968). Elevated levels of urinary 0- 
glucuronidase have been associated with cancer of the urinary tract in humans 
(Boyland, Wallace & Williams, 1955; Rappappert & Richterich, 1965; Mattea 
II 
& Pietra, 1959; Abul-Fadl, 1957), and its estimation in urine has been 
suggested to be of value for prognostic purposes in this disease. Bank & 
Bailine (1965) reported that urinary 0-glucuronidase was increased in patients 
with acute or chronic p>elonephritis compared with those patients having 
infections of the lower urinary tract. These latter conclusions have--recently been 
questioned by Roberts, Frampton, Karim and Beard (1967) who found elevated 
levels of the enzyme in a number of normal subjects with sterile urine. These 
latter authors also found elevated urinary ý-glucuronidase during gestation 
in 
humans. 
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Urinary 0-glucuroniclase has also been reported to be elevated in animals 
receiving either hepatotoxic or nephrotoxic agents (Soloimskaya, 1970), and 
it has been suggested that the increase in enzyme level may be used as an 
index of tissue damage (Slater, 1966). 
In view of the known excretion of metabolites of 2-naphthylamine as 
conjugates with glucuronic acid, Boyland (1956) implicated 0-glucuronidase 
in the etiology of bladder cancer. Boyland (1956) suggested that ý-glucuronidase 
present in urine was able to hydrolyse 2-amino-l-naphthyl-o-glucosiduronic acid 
to release 2-amino-I -naphthol as a locally-acting bladder carcinogen. Boyland 
and Williams (1960) showed that ý-glucuronidase from a variety of sources was 
able to hydrolyse 2-amino-l-naphthol-. ý-glucosiduronate, and suggested that 
inhibition of the enzyme may be of value in the treatment of cancer of the 
urinary tract. Attempts at chemotherapy using this approach have been carried 
out (Boyland, Kinder, Manson & Wallace, 1965; Boyland, Wallace & Williams, 
1957), but protection against bladder tumour formation has not been obtained. 
This may have been due to the rapid metabolism of the inhibitor glucosaccharo- 
I-i 4-lactone, resulting in a high level of residual enzyme activity present in 
the urine. 
However, Miyakawa, Yoshida, Harada & Kato (1973) did find apparent 
suppresiion of bladder tumour formation by treatment of rats receiving 2- 
acetamidofluorene., with the potent g-glucuronidase inhibitor 2,5 di-O-acetyl- 
D-glucosaccharo-I 44: 643- dilactone. 
During the course of the experiments described in section 7, a small 
but constant activation of R-glucuronidase was observed in the presence of 
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certain aromatic amines. This activation was not due to the release of the 
enzyme from an organelle, as activation was observed in preparations which 
had been treated with the non-ionic detergent Triton X-100, which is known 
to solubilise ß-glucuronidase (Wattiaux & De Duve, 1956). 
In view of the widespread measurement of 9-glucuronidase activity for 
monitoring purposes, it would seem that any factors altering the activity 
of this enzyme could produce misleading results unless they were taken into 
consideration. For these reasons some further experiments on the activation 
of 0-glucuronidase by aromatic amines have been undertaken. 
8.2 EXPERIMENTAL 
8.2.1 Chemicals 
Aniline, ortho-, meta- and para-toluidines, mesidine, anthranilic acid 
and para-aminobenzoic acid were obtained from Hopkins & Williamsý 4- 
aminobiphenyl, 2-naphthylamine, 2-aminochrysene, benzidine, 2,7-diamino- 
fluorene, 2-aminofluorene from Koch Light Laboratories, and 1-naphthylamine 
from British Drug Houses. 6-Aminochrysene and 3-aminopyrene were gifts from 
Dr. P. Sims, and 4'-fluoro-4-aminobiphenyl, 2-aminobiphenyiene oxide and 
glucuronic'acid were gifts from Dr. D. Manson, both of the Chester Beatty 
Research Institute. All chemicals were purified by recrystallisation or distilla- 
tion until only one substance was detected when examined by chromatographic 
methods. 
8.2.2 
Purified beef liver g-glucuronidase (Ketodase, Warner-Chilcot) was used 
throughout this section; dilutions of the enzyme were carried out using 0.2M 
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acetate buffer, pH 4.6, and compounds were incorporated as solutions in 
dimethylsulphoxide (DMSO) (B. D. H. ) (final concentration 1%). 
8.2.3 Assay Procedure 
g-Glucuronidase activity was assayed by the method of Talalay, Fish- 
man & Huggins (1946) by following the release of phenolphthalein from 
phenolphthalein mono-ý-D-glucuronide (I mM) as described in Section 7. 
8.2.4 Specificity of amine activation of 0-glucuronidase 
Aromatic amines were incorporated into the 
., 
8-glucuronidase substrate 
mixture at a final concentration of 0.25 mM. The enzyme was diluted to 
have an activity of between 0.5 and 0.7. Fishman units and was assayed 
by incubation in the presence of the amines for 15 h at 37 0 at pH 4.6. 
8.2.5 Effect of amine concentration on the activation of $-glucuronidase 
Aniline, 4-aminobiphenyl, 2-aminofluorene and 2-aminobiphenylene 
oxide were examined as above, except that the concentration of the amine 
was varied between 0.25 mM and 2.0 mM. The concentration of the solvent 
(DMSO) was kept constant at I%. 
8.2.6 The influence of D-glucuronic acid on the activation of 0-glucuronidase 
by aromatic amines 
Certain 
-aromatic amines., at a concentration of 
0.25 mMwere pretreated 
with D-glucuronic acid (0.5mM) at pH 4.6 for 20 h. at 370 prior to the 
addition of enzyme and substrate. The enzyme activity was then assayed as 
above. 
8.2.7 The influence of time after dilution on the activation of 0-glucuronidase 
by aromatic amines 
O-Glucuronidase was diluted as before to give a solution containing approx- 
imately 0.7 Fishman units. The solution was immediately divided and portions 
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treated with aromatic amines at a final concentration of 0.5 mM. One 
portion untreated with amine served as a control. All the experiments were 
carried out at 37 0 and pH 4.6. Aliquots were removed at various time inter- 
vals and assayed as before. 
8.2.8 Reactivation of 0-glucuronidase by aromatic amines 
A diluted (0.7 Fishman units) solution of the enzyme was stored at 0-30 
for 10 h, following which certain aromatic amines at a final concentration 
of 0.5 mM were added to portions of the enzyme, and the mixture again 
0 
stored for 10 h at 0-3 . The enzyme activity was then determined as before. 
In a further experiment aliquots of reaction mixture were removed at 0,1 , 
21 4,7 and 10 h after the addition of the amines to the diluted and stored 
enzyme and assayed as described before. 
8.3 RESULTS AND DISCUSSION 
The specificity of the activation of g-glucuronidase is indicated in Table 
8.3. J. In experiments at two enzyme concentrations no real evidence of 
activation can be seen after incorporation of the monocyclic aromatic amines 
used. Activation was observed with the bicyclic aromatic mono amines studied 
except I-naphthylamine, but the activation was lost when the amino group was 
associated with a larger polycyclic aromatic ring system. It is of interest that 
2-aminobiphenylene oxide, which contains a hetero-oxygen ring system, was 
the most potent activator found in the series studied. It may be that certain 
steric requirements are essential for activation, and it is tempting to suggest 
that substitution in the para-position is a prerequisite. Whilst this could account 
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Table 8.3.1 . The effect of various aromatic amines on the activity of a dilute beef 
river 0-glucuronidase preparation 
Amine present 
Phenolphthalein 
formed 
Expt. I% activity 
Phenolphthalein 
formed (pLg) Mean 
Expt. 2 % activity activity 
No addition 10.2 100 6.5 100 100.0 
Aniline 10.5 103 7.0 108 105.5 
Ortho-Toluidine 9.6 94 6.3 97 95.5 
Meta-Toluidine 10.2 100 6.8 104 102.0 
Para-Toluidine 10.0 98 6.4 98 98.0 
Mesidine 10.2 100 6.6 101 100.5 
Anthranilic Acid 9.8 96 6.4 98 97.0 
Para-Aminobenzoic Acid 10.4 102 6.8 104 103.0 
I-Naphthylamine 10.5 103 7.0 108 105.5 
2-Naphthylamine 11.8 116 8.5 130 123.0 
4-Aminobiphenyl, 11.4 112 8.0 123 117.5 
4'-Fluoro-4-aminobiphenyl 11.4 112 8.8 135 123.5 
2-Aminofluorene 11.2 110 8.0 123 116.5 
2-Aminobiphenylene oxide 13.0 127 10.1 155 141.0 
3-Aminopyrene 10.0 98 6.6 101 99.5 
2-Aminochrysene 10.5 103 6.8 104 103.5 
6-Aminochrysene 10.0 98 6.5 100 99.0 
4,4'-Diaminobiphenyl 6.0 59 4.5 69 64. o 
2,7-Diaminofluorene 6.2 61 4.5 69 65.0 
All amines were present at a concentration of 0.25 mM. 
During 15 h incubation at 37 
0 from phenolphthalein-A-D-glucuronide (1.0 mM). 
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for the lack of activity of 1-naphthylamine, compared to the 2-isomer and 
2-aminochrysene, it does not explain the inactivity of 6-aminochrysene, 2- 
aminopyrene, paro-toluidine or para-aminobenzoic acid, all of which have 
para substituents. 
Neither is there any correlation between ability to active g-glucuronidase 
and published pKa values for the amines studied. Aniline, pKa 4.59, was in- 
active, whereas 2-aminofluorene, pKa 4.64, was active. Additionally, the 
inactive amine 1-naphthylamine (pKa 3.92) is less basic than the active 2- 
isomer (pKa 4.11), whereas paro-toiuidine is more basic (pKa 5.12) and yet 
remains inactive. If, as discussed later, a surface effect is operating in this 
activation process, then the solubilities or partition coefficients may give the 
desired correlations. Both of the diamines studied showed marked inhibitory 
effects on the enzyme and were not studied further. The influence of amine 
concentration is shown in Table 8.3.2. 
In the case of the three active amines an increase in activating ability 
with increased concentration is shown. However, there seems to be a limiting 
value at about 0.5 to I mM, as doubling the concentration to 2 mM does not 
further enhance the amount of hydrolysis. These results also confirm the in- 
ability of aniline to activate 0-glucuronidase, even when the concentration 
is raised to 2 mM. 
The experiments where the aromatic amines were pretreated with D- 
glucuronic acid were performed to ascertain whether a spontaneous reaction 
between the amine and D-glucuronic acid, released from phenolphthalein-g- 
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Table 8.3.2. Influence of concentration on the activation of ý-glucuronidase 
by aromatic amines 
Amines Concentration Phenolphthalein 
mm 
I 
liberated (gg)* 
Activity 
No addition 114.2 11 100 
Aniline 0.25 4.2 100 
0.5 3.8 91 
1.0 4.0 95 
2.0 4.2 100 
4-Aminobiphenyl 0.25 5.0 119 
0.5 6.1 145 
11 1.0 7.2 171 
2.0 7.5 179 
2-Aminofluorene 0.25 6.2 148 
0.5 7.0 167 
1.0 8.2 1 195 
2.0 8.5 202 
2-Aminobiphenylene oxide 0.25 7.2 145 
11 0.5 8. o 190 
It 1.0 8.2 195 
of 2.0 8.5 202 
during 15 hrs incubation from phenol phthalei n-g- D- g lucuronide (1 .0 mM) 
at 37 o, pH 4.6. 
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D-glucuronide, could occur and cause a shift in the equilibrium., viz: 
Phenolphthalein-0- ý-glucuronidase Phenolphthalein + D-glucuronide D-glucuronic acid 
aromatic 
amine 
am ine- N-91 ucosiduronate 
Such reactions between aromatic amines and D-glucuronic acid are known 
to occur (Boyland, Manson & Orr, 1957; Bridges, 1964; Gorrod, 1960) and 
could account for'the activation observed. The results in Table 8.3.3 indicate 
that this is not the case, as active amines still show the same activation of 0- 
glucuronidase even after pretreatment with D-glucuronic acid. Under these 
conditions, D-glucuronic acid was without effect on the control enzyme activity 
in the presence or absence of aniline and did not affect the slight activation 
effect of I-naphthylamine seen in this experiment. 
During the course of the previous work in this section it became apparent 
that some differences in magnitude of activation under the influence of a fixed 
concentration of amine occurs. This is apparent from the two experiments shown 
in Table 8.3.1 where the same enzyme was used but different times elapsed 
bet . ween dilution of enzyme and its activation by amines. It was therefore, 
thought desirable to examine the influence of time after dilution of the enzyme 
on the subsequent effect of amines on enzyme activity. The results are shown 
in Fig. 8.3.1. With no addition of amine, and under the conditions employed, 
a loss of activity occurs which is rapid during the first few hours after enzyme 
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Table 8.3.3 The effect of pretreating aromatic amines with D-glucuronic 
acid on the activation of ý-glucuronidase 
Amine Present* Phenolphthalein liberated § (Ag) 
No pretreatment Pretreatment with 
Glucuronic acid+ 
No addition 6.9 6.7 
Aniline 6.7 6.5 
4-Aminobiphenyl 8.2 8.2 
4'-Fluoro-4-aminobiphenyl 8.8 8.4 
2-Aminofluorene 8.0 8.0 
2-Aminobiphenyleneoxide 10.2 10.2 
2-Naphthylamine 8.5 8.3 
1-Naphthylamine 7.2 7.2 
* Amines present at final concentration of 0.25 mM. 
Amines were treated with glucuronic acid 0.5 mM at pH 4.6 and 37 
0 
for 20 h prior to the addition of the enzyme and substrate. 
0 
During 15 h incubation at 37 from phenol phtha lei n-A- D-91 ucuronide 
(I mM) at pH 4.6. 
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dilution, but does not decrease appreciably after ten hours. In the presence 
of aniline the rapid decay is again observed, but, in this case, the plateau 
level of enzyme activity is maintained after four hours. The other aromatic 
amines studied completely prevent the loss of activity observed in their 
absence. In the case of both 2-aminofluorene and 2-aminobiphenylene oxide 
considerably higher levels of released phenolphthalein were obtained compared 
with the control preparations. This suggests that on dilution a very rapid 
dissociation of the enzyme occurs with a concomitant loss of enzyme activity. 
The aromatic amines could be producing their apparent activation effect by 
preventing this dissociation and the level of "activation" observed would then 
depend on their ability to prevent dissociation. If this is true,, then the rate 
of dissociation must either be very rapid during the first few minutes after 
dilution or certain amines must have the ability to enable the enzyme sub-units 
to reassociate to form more of the active species. 
In an attempt to see whether the latter postulate is tenable a solution of 
the di I uted enzyme was stored at 0-3 
0 for 10 h to allow inactivation 
(dissociation) to occur. After a further period of 10 h in the presence of amine, 
to allow reassociation, the enzyme activity was again measured and i, s shown in 
Table 8.3.4. In every case the activity of the stored diluted enzyme was enhanced, 
aniline having the smallest effect and 2-aminofluorene the greatest, with the 
other amines producing an intermediate effect. The reactivation of the diluted 
enzyme by amines appeared to be related to the protective effect shown in 
Fig. 8.3.1. An attempt to show a gradual reactivation of diluted stored enzyme 
by certain amines with time failed, as all the amines studied, except aniline, 
produced an activation of enzyme activity even when the enzyme assay was 
- 2go- 
4 
Table 8.3.4. The reactivation of ý-glucuronidase* by aromatic amines. 
Ami ne (0.5 mM) pig phenolphthalein § 
No addition 3.0 
aniline 3.9 
4-aminobiphenyl 5.0 
4'-fluoro-4-aminobiphenyL 6.9 
2-naphthylamine 5.0 
2-aminofluorene 8.5 
2-aminobiphenylene oxide 7.2 
* Enzyme diluted and stored at 0-3 
0 for 10 h prior to addition of 
amine, then stored for a further 10 h 
0 
Liberated during 15 h incubation at 37 
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initiated immediately after the addition of the amine. In this latter experiment 
it may have been that the long incubation period of the assay, due to the low 
concentration of the enzyme, masked the gradual reactivation hoped for' (Fig. 
8.3.2). In fact, the continual decrease in activity shown by the enzyme 
either in the presence or absence of aniline, clearly indicates that the enzyme 
activity had not plateaued at the ten hours chosen for storage in this experiment. 
The indication, found in Section 7, that certain aromatic amines caused an 
00 activation of 0-glucuronidase, has been confirmed in this wider study. It has 
also been confirmed that the activation., when carried out in the presence of 
concentrated, fresh enzyme preparations, is only slight. This activation can 
be highly significant if determined using aged diluted enzyme solutions. The 
results suggest that the apparent activation may be caused by preventing the 
inactivation produced by dilution and/or storage, rather than a true activation. 
The dissociation of 0-glucuronidase was first recognised by Bernfeld, 
Bernfeld, Nisselbaum and Fishman (1954). These authors indicated that A- 
glucuronidase formed inactive subunits upon dilution, but that the activity 
- could be retained in the presence of certain macromolecules, e. g. bovine 
serum albumin, desoxyribonucleic acid from various sources, gelatin, chymo- 
trypsin, ribonucleic acid and certain a, 4e-diaminomethylenes. Under the con- 
ditions used by these authors, at least two basic groups per molecule were 
required to produce an "activator". Although activating ability was found in 
all members of the series of diamines NH 2 (CHý) n 
NH 211 maximal activation 
was observed in 
. 
the diamine NH 2 (CH2), ON 
H 2' In contrast the results 
reported here show that the two aromatic amines studied 
benzidine and 2,7- 
diaminofluorene did not activate the enzyme but actually caused considerable 
inhibition of enzyme activity. 
'0 
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Bernfeld, Jacobson and Bernfeld (1957) confirmed the reversible nature 
of the dissociation occurring upon dilution of 0-glucuronidase, and its 
"activation" by macromolecular polycations. They also showed that this 
"activation "could be prevented by macromolecular polyanions, presumably 
by reaction with the polycation. In this paper a further slow inactivation of 
the dissociated sub-units is shown to occur if they are exposed to rough 
surfaces such as silica, sand or glass powder, after which reactivation by 
polyamines is unable to occur. A further type of activation of A-glucuronidase 
was reported in an "Urgent Bulletin on Bacterial O-Gucuronidase", issued by 
Sigma Chemical Co. (1958), in which chloroform, often used as a preservative 
in biological samples, had the ability to increase the activity of A-glucuronidase 
by up to seven hundred per cent. This activation was confirmed by Gautney, 
4 
Barker & Hill (1959) who showed that several aliphatic alcohols, as well as 
halogenated hydrocarbon solvents, also had this activation effect upon the 
enzyme derived from bacterial systems, but not on the mammalian enzyme. 
The degree of activation of the bacterial enzyme system by chloroform has 
been shown by Ryan and Mavrides (1960) to depend upon the area of the chloro- 
form/aqueous interface. It would seem unlikely that a surface phenomenon is 
occurring in the experiments described in this section. In the cases where it 
was seen that the amines were not wholly in solution, i. e. 3-aminopyrene 
or the aminochrysenes, activation was not observed (Table 8.3.1). It would 
seem fhat the prevention of dissociation of the enzyme by aromatic amines is 
more likely to be the mechanism involved. Recently it has been shown that 
lysosomal g-glucuronidase from rat liver is a tetramer having a molecular 
w'eight of approximately 280,0()0, which under certain conditions dissociates 
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into subunits of about 75,000 (Stahl & Toaster., 1971). In order to confirm the 
"protection" hypothesis it would be interesting to carry out experiments using 
either ultracentrifugation or gel electrophoretic techniques in the absence and 
presence of "activators". 
Since the completion of this work, my attention has been drawn to a report 
by Takanashi, Ohkubo, Takahashi, Ida, Okutomi & Kawada (1964) in which 
they perform some experiments on N-glucuronide formation. In these experi- 
ments 0-glucuronidase is used as a transferase to transfer the glucuronic acid from 
phenolphthalein -0-glucuronide to 2-naphthylamine. These authors found 
that the amount of phenolphthalein formed was increased with increasing 
concentration of 2-naphthylamine and concluded "that 9-glucuronidase is some- 
a 
what activated in the presence of 2-naphthylamine" . The results in this section 
confirm and extend their conclusions. 
In view of the known elevated concentrations of endogenous aromatic amines 
in certain pathological conditions (see Section 1), it is suggested that the raised 
levels of P-glucuronidase also found in some diseases may, at least in part, be 
due to changes in the enzyme environment rather than an actual increase in 
enzyme protei n. 
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The work presented in this thesis gives further support to the concept that 
the metabolism of xenobiotics may in some cases be an activating or toxication 
process. 
4-Aminobiphenyl and 4-acetamidobiphenyl were shown to be converted 
to N- and ring hydroxylated derivatives (Section 2), some of which were 
demonstrated to be more carcinogenic than the parent compound (Section 6 
and references cited therein). 
Unfortunately the N -acetylated compounds were not al I available at the 
time to allow them to be tested using the mouse neonate technique or to examine 
their effects on lysosomal membrcne stability (Section 7). It is clear that 
aromatic amine acetylation and the deacetylation of arylacetamido compounds 
are metabolic pathways which have to be considered togetherwhen studying 
the metabolism of aromatic amines. 
The evidence presented in Sections 4 and 5 shows that these reactions are 
far more specific than is perhaps generally thought. As the site of ring hydroxyl- 
ation is to some extent governed by whether the amine function is free or 
acetylated,, these conjugative and hydrolytic processes may play a role in the 
ultimate toxicity of an aromatic amine. 
Regarding the nature of the toxic agent derived from 4-aminobiphenyl or 
4-acetamidobiphenyl, no absolute correlation could be found between site of 
hydroxylation and species susceptibility to amine carcinogenesis (Section 2). 
The results indicate that 4-aminobiphenyl is converted into two known 
toxicants viz. 4-hydroxylaminobiphenyl and 4 -amino -3 -hydroxybipheny 1, 
whilst 4-acetamidobiphenyl is converted into the corresponding toxic hydroxamic 
acid, as well as to ring hydroxylated metabolites presently thought to be 
innocuous. 
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As the parent compounds tend to produce their carcinogenic effect at 
different sites, - i. e. 4-aminobiphenyl usually produces urinary tract tumours 
whereas 4-acetamidobiphenyl produces hepatic tumours (see Section 1), - 
there does not seem any a priori reason to assume the requirement for a 
common intermediate toxicant, despite the similarity of their chemical 
stru ctu re . 
In orderfor a toxicant to produce a deleterious effect on a biological 
system there has to be an interaction between the toxic stimulus and a biolo- 
gical receptor. 
The interaction can be a direct reaction, i. e. one leading to the pro- 
duction of the ultimate biochemical lesion, or an indirect reaction., for 
example one which allows the release of an enzyme from an organelle or 
upsets the oxido -reduction status quo within the cel I. 1ý these reactions the 
formation of a stable covalent bond between toxicant and receptor is not a 
prerequisite as formation of an easily dissociable enzyme-inhibitor complex 
could product similar results. This concept has been amplified elsewhere 
(Gorrod, 1979). 
In the case of carcinogenic substances, the insult which the susceptible 
cell receives has to be of a very special type: that is it has to be sufficiently 
great that the cellular repair mechanisms are unable to restore the cell to 
normality and yet sufficiently mild that cell death is not produced. It may be 
that the majority of cells attacked by a potential carcinogen do not receive 
such an insult and the tumour arises via the few (or even one) cells where just 
the correct conditions obtain. 
It is worth considering the nature of the site of subcellular 
damage required 
in order to allow tumour development. Tumours are, using the most simplistic 
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definition, cell masses characterised by a lack of coordinated differentiation 
and a rather unrestrained growth pattern. Therefore one has to consider with 
which biological receptor the carcinogen would have to react in order to 
produce this effect. Cell growth, as exemplified by protein synthesis, 
functions under control mechanisms which have the ability to either allow 
more of a specific protein to be produced or to virtually "close down" its 
production. The exact mechanism(s) by which these cellular controls are 
mediated are not fully understood and are outside the scope of this section. 
Suffice it to say that interference with these mechanisms could account for 
the unrestrained cell growth (Pitot & Cho, 1965), and if these controls 
utilised proteins or peptides as repressor substances then a reaction between 
one of these substances and an aromatic amine or a hydroxylated metabolite 
could easily be envisaged. Indeed the reaction between 2-amino-1 -naphthol 
and bovine serum albumin was reported by Nagasawa & Gutmann (1959) and 
confirmed by Belman & Troll (1962), although the latter authors questioned 
the nature of the moiety attached to the protein. 
Bovine serum albumin is not typical of many of the proteins present in 
mammalian cells due to its high proportion of lysine (the amino acid where 
reaction with 2-amino-1 -naphthol takes place). However, this protein 
is similar in many respects to the basic nucleo-proteins, the histones (Johns, 
1971), and as histones interact with DNA it can be seen that any reaction 
which interferes with this interaction is likely to 
interfere with transcription 
of genetic information. 
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In view of the reaction of aminonaphthols with the r-amino group of lysine 
cited earlier, it would not be surprising if these carcinogens reacted with other 
polyamines. Polyamines may very well play an important role in control of 
nucleic acid synthesis (Stevens. 1970) and have been implicated in the teratogenic 
effect of thalidomide (Fabro, Schumacher, Smith, Stagg & Williams, 1965). 
if by the reaction of the carcinogen with the histoneor polyamine it caused 
dissociation of the nucleohi. stone complex the nucleic acid could very well 
become vulnerable to the degradative action of nucleases. 
Further evidence that aromatic amines or their metabolites could react with 
nucleophilic centres in proteins or peptides cane with the report by Boyland, 
Manson and Nery (1963) that aniline and 2-naphthylamine were excreted as 
mercapturic acids. It would seem that these metabolites are formed by reaction 
of the metabolically formed arylhýdroxylamine with glutathione, followed by 
the known degradative pathway of glutathione conjugates. 
An alternative mechanism involving a quinone-imine intermediate has been 
proposed (Boyland, Manson &N ery, 1963). In view of the fact that this reaction 
was observed with the non -carcinogenic amine, aniline, as well as with the 
carcinogenic 2-naphthylamine, it would seem unlikely that this reaction per se is 
involved in carcinogenesis, but it indicates that aromatic amine metabolites 
can react with nucleophilic centres. 
0 14 In a further study using C-labelled compounds, the binding of aniline and 
2-naphthylamine to cellular proteins in vivo was compared (Roberts & Warwick, 
1966). 
No evidence was produced to suggest that protein binding was related to 
0 carcinogenesis as both amines were bound to about the same extent, 2-naphthyl- 
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amine being more highly bound to liver proteins than aniline, whereas aniline 
was bound to a great extentto kidney proteins. 
More recently, Manson (1972) has shown that 2-amino-1 -naphthylsulphate, 
2-amino-1 -naphthylglucosiduronic acid and bis(2-amino-I -n aphthy 1) phosphate 
have the ability to arylate N-acetylcysteine and glutathione in vitro, to give 
the corresponding S-(2-amino-1 -naphthyl) derivatives. It is interesting that the 
related N -acetyl or N -formyl compounds were inactive as was 4-amino-3- 
biphenylyl sulphate,, showing that this was not a general reaction of orthol-maenino 
phenyl sulphates. 
It may be that the controlling repressor or activator molecules are smaller 
molecules and Szent-Gyo'rgyi, Egyud and McLaughlin (1967) have suggested 
that certain ketones and aldehydes may have this function . If this is the case 
then certainly amines arýd their hydroxylated metabolites could react with them 
to form Schiff's bases and related compounds (Boyland &N ery, 1963) but it is 
difficult to see any specificity of reaction occurring. 
Further, whilst such a reaction with a regulator may easily account for 
altered cell growth characteristics, it is unlikely that these would be passed on 
to daughter cells unless either residual amounts of carcinogen are also transferred 
or the genetic information of the cell is malfunctioning. 
In order to produce a cell line with permanently altered genetic characteristics 
it is not unreasonable to propose that an alteration has to be introduced into the 
nuclear DNA. This alteration could involve producing a change in the base 
composition by a reaction of the carcinogen with a base leading to mismatching 
of complementary base pairs, or binding followed by excission of the affected area. 
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If reaction with nucleic acid is a prerequisite for carcinogenesis it might be 
expected that binding to target tissue DNA would be greater with carcinogens 
than with structurally similar inactive compounds. In fact most carcinogens 
examined do bind to nucleic acids and to proteins (Miller & Miller, 1966), and 
whilst DNA binding appears greater in susceptible organs in sensitive species 
compared to resistant species (. Qutmcnn, Maleika-Giganti, Barry Rydell, 1972) 
few experiments have been performed to compare the binding of non -carcinogen ic 
isomers. Roberts and Warwick (1966) did compare the binding of 2-naphthylamine 
and aniline residues to DNA after feeding the amines to rats,, but did not show any 
difference between the carcinogenic and non-carcinogenc amine. The binding 
of 2-naphthylamine to cellular constituents was reinvestigated in mice of two 
strains by Hughes and Pilczyk (1969) who showed that the liverof the susceptible 
6 
strain (CBA) bound 2-naphthylamine to all cellular macromolecules to a greater 
extent than did the non-sensitive C57 strain. 
Following the discovery that 2-acetamidofluorene was excreted as the N- 
hydroxylated metabolite (Cramer, Miller & Miller, 1960) it was soon realised 
that this metabolite was unique in that, unlike the ring hydroxylated compounds, 
it possessed enhanced carcinogenic activity compared to the parent 
(Miller, Miller 
Hartmann, 1961). This metabolite, the excretion of which showed a good 
correlation with carcinogenic activity (Table 9.1), also produced a much 
higher level 
of binding to macromolecules when fed to experimental animals 
(Willard & Irving, 
1964; Marroquin& Farber, 1965; Miller,, Cooke, Lotlikar & Miller, 1964), 
evidence suggesting that N -hydroxyl ation gave the reactive 
form derived from the 
amide. This compound, however, was disappointingly unreactive towards protein 
or nuclei c acids when examined in vitro. 
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A similar lack of reactivity with nucleic acids by 2-naphthylhydroxylamine 
in vitro had been observed by Troll, Belman & Levine (1963) and Krick (1965); 
this latter author did, however, find a reaction between both 2 -hydroxyl amino- 
fluorene and 4-hydroxylaminobiphenyl and DNA at acid pH, and suggested 
that binding occurred via the C-8 position of guanine. 
During in vitro experiments using the acetic acid ester of N-hydroxy-2- 
acetamidofluorene,, Miller, Juhl and Miller (1966) observed a surprising 
reactivity with guanine present in DNA and RNA; this observation initiated the 
development of the concept that a second activating step was required in order 
to produce the ultimate carcinogenic agent. 
Support for this idea gained strength when Lotlikar, Scri bner, Miller and 
Mi I ler (1966) showed that N -acetoxy-2-acetamidof luoren e and N -benzoyloxy- 
N-methyl-4-aminoazobenzene reacted with methionine, whether free or as a 
peptide or when incorporated into protein. These reactions occurred under 
mild conditions where reaction with the N-hydroxy compound could not be 
detected. Treatment of the reaction mixtures with alkali produced the 
corresponding ortho-S-methyl compound and homoserine lactone. The proposed 
reaction mechanism is shown in Figure 9.1 . 
This mechanism raises two important points to consider,, viz. the nature of 
the biological esterifying group and the determinant receptor molecule. 
The first question has been studied in three wayý: one by manipulating 
biochemical in vitro systems to allow the production of esters from various 
cofactors acting as biological acylating agents; a second 
by determining 
60 
the carcinogenic or mutagenic activity of compounds under conditions 
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whereby one route of esterification is likely to be altered; and lastly by the 
chemical synthesis of potential conjugates of carcinogenic hydroxamic acids. 
The glucosiduronate conjugate was the first ester of a xenobiotic hydroxamic 
acid to be discovered (Cromer, Miller & Miller, 1960) so that this ester was a 
likely candidate as the reactive ester. However, difficulties in obtaining 
k 
reasonable quantities of this compound meant that considerable work was carried 
out using the acetoxy compound referred to earlier. This type of compound had 
not been found in vivo, and Lotl ikar and Luha (1971 a) investi gated the possi bl e 
formation of acetyl esters in biological systems. 
Surprisingly, these authors found that reaction of hydroxamic acids with 
acetyl CoA occurred spontaneously. This reaction, which has a pH optimum 
between 10 and 11 , was great Iy in fI uenced by the nature of the buffer used. No 
evidence was produced to show that this reaction was enhanced by the presence of tissue 
preparations,, so that the formation of acetyl esters of hydroxamic esters in 
vivo, whilst being conceivable, has not yet been demonstrated. 
Similar results were obtained using S-adenosyimethionine (Lotlikar, 1968), 
inorganic phosphate (Lotlikar & Wasserman, 1970), adenosine triphosphate (King 
& Phi II ips, 1968) and carbamy! phosphate (Lotl ikar & Luha, 1971). In al I cases, 
is 
except methylation., a reactive esteg/formed which has the ability to react with 
nucleophilic centres in nucleic acids or proteins and with methionine. 
Another ester of hydroxamic acids can be formed by the transfer of the sulphate 
moiety from phosphoadenosine phosphosulphate under the influence of a sulpho- 
trcnsferase (King & Phillips, 1968; De Baun,. Rowley, Miller & Miller , 1968). 
The proposed structures of these esters are shown in 
Figure 9.2. 
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Whilst considerable evidence has accumulated to support the idea that a 
reactive ester has to be formed, this is not universally accepted and other routes 
to a reactive molecule have been proposed. These are shown in Figure 9.3. 
Forrester, Ogily and Thomson (1970) and Bartsch, Traut and Hecker (1971) showed 
that N-hydroxy-2-acetamidofluorene was converted into a nitroxide radical 
under the influence of certain one-electron oxidants. The nitroxide radical 
undergoes a disproportionation reaction to produce N-acetoxy-2-acetamidofluorene 
and 2-nitrosofluorene, both of which are carcinogenic. This reaction can be 
0 carried out enzymically under the influence of peroxidase in the presence of 
hydrogen peroxide. (Figure 9.3, route A. Bartsch & Hecker, 1971; Floyd & 
Soong, 1977). Whilst this reaction undoubtedly produces reactive compounds, 
as measured by binding with nucleic acids, the nitroxide radical has been shown 
not to be an obligatory intermediate as neither cyanide or sulphite inhibit the 
peroxidase-induced binding to nucleic acids in vitro (King, Bednar & Linsmaier- 
Bednar, 1973). It was shown by Booth (1966) that hydroxamic acids could act 
as acetyl donors to a variety of amine acceptors and this observation was extended 
by Bartsch, Dworkin, Miller and Miller (1972,1973) who proposed that aryl- 
hydroxylamines could also act as acetyl acceptors from hydroxamic acids to form 
O-acetyl derivatives which are reactive towards nucleophilic centres (Fig. 9.3, 
route B). In order to get a suitable acceptor it would be necessary to hydrolyse 
one molecule of the parent hydroxamic acid (Fig. 9.3, route Q; this process is 
known to readily occur in tissue preparations (Irving, 1966). 
An alternative proposal was put forward by King (1974) who showed that an 
enzyme was present in animal tissues which could transfer the acetyl group from 
the nitrogen to the oxygen of hydroixamic acids, thereby producing a reactive 
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I 
acetoxyarnine (Fig. 9.3 route B) - Therefore, it can be seen that several 
processes are available which can produce a reactive species; of course the 
question as to which is the important route has been asked by many workers, 
yet the evidence is not unequivocal. 
As described earlier, King & Phillips (1968) and DeBaun et. al. (1968) 
proposed that the sulphuric acid esters of hydroxamic acids were involved in 
carcinogenesis. Support for this idea come from additional sources. The first 
was data gained from carcinogenicity tests on animals receiving acetanilide 
as well as either 2-acetamidofluorene or N-hydroxy-2-acetamidofluorene 
(Weisburger, Yamamoto, Williams, Grantham, Matsushima & Weisburger, 1972) 
where it was shown that acetanilide inhibited tumour formation by acetamidofluorene, 
Possibly by inhibiting N-hydroxylation (Grantham, Mohan, Yamamoto, 
Weisburger & Weisburger, 1968). The carcinogeni city, of acetamidofluorene 
was not restored by dietary sodium sulphate supplementation. A similar 
inhibition of tumour formation was produced by acetan ilide when N -hydroxy-2- 
acetamidofluorene was administered to rats; in this case the inhibition could 
be partially reversed by additional dietary sulphate (Table 9.2. ). This data 
was consistent with the Wea that p-hydroxyacetanilide, formed as the major 
metabolite of acetanilide, utilised the available sulphate in forming a conjugate 
(Buch, Rummel, Pfleger, Eschrich & Texter, 1968), thereby preventing or 
minimising the formation of the sulphate conjugate of N-hydroxy-2-acetamido- 
fluorene and carcinogenicity. Dietary sulphate was thought to restore the 
the sulphate conjugation of the hydroxamic acid and carcinogenicity. 
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Unfortunately, when the experiments were repeated using p-hydroxy- 
acetanilide in addition to the N-hydroxylated carcinogen only a weak 
inhibition of tumour formation was observed compared to the effect with 
acetanilide, and carcinogenicity was not restored by additional dietary 
sulphate (Yamamoto, Williams, Richardson, Weisburger & Weisburger, 1973). 
Later work by Mohan, Grantham, Weisburger, Weisberger, and Idoine (1976) 
showed that prhydroxyacetanilide increased hepaticglucuronyl transferase 
and suggested that shunting more of the N-hydroxy carcinogen through this 
pathway accounted for the protective effect and the failure of sulphate to 
restore carcinogenic activity. 
A further anomaly is apparent in that whereas the levels of hydroxamic 
acid su I photransf erase showed a very good correlation with various physiolo- 
gical conditions and cancer induction (DeBaun , Rowley, Miller & Miller, 
1968; De Baun, Miller & Miller, 1970), this enzyme did not appear to activate 
N-hydroxy-2-acetamidofluorene when examined in the Ames Salmonella test 
for mutagenicity (Moulder, Hinson, Nelson & Thorgeirsson, 1977; Andrews, 
Hinson & Gillette, 1978). This test usually gives a very high correlation with 
carcinogenic activity (McCann & Ames, 1976). Furthermore, whilst the 
sulphotransf erase activity may correlate very well with hepatic tumour induction, 
this enzyme is absent in Zymbals gland and mammary glands (Irving & Veazey, 
1971). 
Neither was there any correlation observed between su 
lphotransf erase 
activity and the activation of another group of N -oxygenated carcinogens 
derived by chemical N-oxidation of purines (McDonald, Stohrer & Brown, 
1973). 
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King (1974) and King & Olive (1975) studied the acyltransferase referred 
to earlier and showed that the distribution of this enzyme in species, strains 
and tissues corresponded well with tumour formation from 2-acetamidofluorene. 
These authors also proposed that inhibition of this enzyme by acetan i 11de. and 
p-hydroxyacetanilide could account for the inhibition of carcinogenesis 
observedwith them compounds. Surprisingly no similar study on the distribution 
of the enzyme catalysing the biosynthesis of glucosiduronic acid conjugcýes of 
hydroxamic acids has been published, although their reactivity with nucleic 
acids etc. is well documented. 
Following the isolation of the 0-glucuronide of N-hydroxy-2-acetamido- 
fluorene by Hill and Irving (1967), this compound was found to react with RNA 
and DNA in vitro (Irving, Veazey & Russell, 1969; Irving, Veazey & Hi!!, 1969). 
The latter authors also found that the glucuronide bound more extensively to RNA 
and DNA when given to rats in vivo than did 2-acetamidofluorene, although less 
than the hydroxylated amide. Obviously if this was the only route to a reactive 
species more binding would have been expected; nevertheless it was concluded 
that the glucuronide ester could account for some of the binding to nucleic acids 
observed during carcinogenesis by the parent amide. Despite the reactivity of 
this glucuronide, both in vivo and in vitro., this substance and its triacetyl methyl 
ester were not carcinogenic in rats under conditions where the hydroxamic acid 
was (Miller, Lotlikar, Miller,, Butler, Irving & Hill, 1968). 
An analogous glucuronide is formed from N-hydroxy-4-acetamidobiphenyl 
(Irving, Russel I& Kriek, 1972) and is also reactive towards nuclei c acids and 
guanosine; however, this reactivity is very low, occurring at only about 
3-4% 
of that observed from the glucuronide of N-hydroxy-2-acetamidofluorene. 
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From the above it can be seen that the nature of the reactive ester, if indeed 
one is required, is still a matter for conjecture. In studies on the related amides, 
phenacetin and paracetamol, it again appears that N-hydroxylation can give rise 
to a more toxic species (Nery, 1971; Hinson & Mitchell, 1976). 
In these cases, ester formation also enhances the reactivity with glutathione 
or protein (Hinson, Nelson & Mitchell, 1977; Mulder, Hinson & Gillette, 1977 
& 1978; Calder & Creek, 1976), but the reiative importance of the respective 
esters in vivo has not been established. It is of some interest that structurally 
similar hydroxamic acids had entirely different degrees of activation by ester 
formation, so that whilst N -hydroxy-phenacetin and N -hydroxy-2-acetamido- 
fluorene were greatly "activated" by esterification with sulphate, N-hydroxyacetanilide, 
N-hydroxy-p-chloroacetcnilide and N-hydroxy-2-acetamidonaphthalene were 
hardly affected by this process. 
More recently Andrews, Hinson and Gillette (1978) have shown that whereas 
sulphation of N -hydroxy-2-acetamidof luorene decreased mutagenesis towards 
Salmonella TA1538, a soluble enzyme present in rat liver greatly enhanced the 
mutagenic activity. These authors suggest that the enzyme hydrolyses the hydrox- 
amic acid to the hydroxylamine which is known to be a potent frameshift mutagen. 
Certainly there is some evidence that an acetyl group is not always retained in 
the carcinogen moiety bound to nucleic acids (see later) and this approach would 
lead to a unifying concept of the mechanism of tumour initiation of amines and 
amides. 
In the case of the dog any mechanism proposed could not involve an acetyl 
group, as this species lacks the ability to acetylate aromatic amines 
(see Sections 
2,3 and 4). As described in Section 2, evidence 
has accumulated to suggest that 
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excretion of N -hydroxy-4-aminobiphenyl occurs in this species and is related 
to bladder tumour formation; however, the instability of this compound suggested 
that it was unlikely to have survived synthesis in the liver,, transport via the 
blood, excretion by the kidney and reabsortion from urine, unless. it was present 
as a conjugate (Radomski., Roy & Brill, 1973). In 1977 Radomski, Hearn, 
Radomski, Moreno and Scott succeeded in isolating a glucuronide conjugate 
of 4-hydroxylaminobiphenyl from dogs fed 4-aminobiphenyl. This compound, 
which was probably the N-glucuronide (Moreno & Radomski, 1978), was an 
active mutagen in several Salmonella tester strains, although possessing a lower 
activity than the corresponding hydroxylamine or nitroso compounds. It would 
be interesting to know if the corresponding 0-glucuronide, which the authors 
claimed to have synthesised, was an active mutagen, as this would have a 
structure similar to the esters derived from hydro<amic acids discussed earlier. 
Kadlubar, Miller and Miller (1977) have also considered the possibility of 
aryl hydroxylamines being excreted as glucuronic acid conjugates and succeeded 
in preparing the N -glucuronides of the N -hydroxy derivatives of I& 2-naphthyl- 
amine, 4-aminobiphenyl and 2-aminofluorene, These reactions were carried 
out in vitro using hepatic microsomal preparationsfrom dogs, rats or humans. 
The finding that hydroxylamines (Kriek, 1965) and esters of hydroxamic 
acids (Miller, juhl & Miller, 1966 and references cited earlier in this Section) 
could react with nucleic acids, poses the question of the nature of the bound 
material and the base to which it is bound. Kriek (1965) and Miller, IhI and 
Miller (1965) presented evidence that the base guanine was the principal site 
of the reaction in vitro. Many carcinogens have been found to react with DNA 
(Irving, 1973; Brookes, 1977) but few studies have elucidated the 
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nature of the bound material during tumorigenesis: i. e. in the susceptible tissue. 
Such a study has been carried out by Kriek and co-workers (Kriek, 1969,1971 1 
1972,1974; Westra, Kriek & Hittenhausen. 1976). The resu Its from these 
elegant studies are summarised in Figure 9.4. It appears that attack on the C-9 
position of guanine is the major route to the formation of bound material in either 
DNAor RNA. This material may be present either in an acetylated or deacetylated 
form. This material seems to have a relatively short half life of seven days (in DNA) 
and is probably cleared from the nucleic acid by a repair mechanism. An analogous 
reaction product has been observed for 4-acetamidobiphenyl (Kriek, 1971), although 
occurring at much lower levels than with 2-acetamidofluorene. During their work 
with 2-acetamidofluorene a further component was found which wasbound only to 
DNA; this material, which accounted for about 20% of the initial bound material. 
had a much longer half life and could easily be detected . even eight weeks after 
the carcinogen had been given to rats. The structure of this material has been 
elucidated and it has been shown to arise via attack on the amino group of guanine 
(Fig. 9.4) to give 3-deoxyguanosin-N2_yi)-2-acetamidofluorene. It is clear that 
this type of persistent bound material can seriously affect the function of cellular 
DNA; thus it would be unlikely to successfully base pair with messenger RNA and 
would thereby affect protein synthesis, perhaps leading to deletion of a specific 
protein as was suggested many years ago to occur in carcinogenesis (Miller & 
Miller, 1947; cf. Potter, 1964). This binding could also account for alterations 
in Tm, buoyant density and RNA polymerase priming activity previously observed 
with ca., rcinogen -treated DNA (Troll, Rinde Day, 1969) and the 
loss of transforming 
activity (Maher, Miller, Miller & Szybalski, 1968; Maher, Miller, Miller & 
Summers, 1970). 
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It is interesting that the N -glucuronide of N -hydroxy-1 -naphthylamine also 
reacts with nucle*ic acids in vitro (Kadlubar, Miller & Miller, 1978). In this 
case the base attacked is still principally guanine, but binding occurs via the 
06 position of the base and either the N! -or 2-position of the carcinogen to give 
either N -(deoxyguanosin -0 
6_yl)_, 
-naphthylamine or 2-(deoxyguanosin -0 
6_ 
yl)-l -naphthylamine. 
In studies using the related compound N-hydroxy-2-acetamidophenanthrene, 
S cri bn er an dN ai my (1973,, 1975) showed that in th is case bin d in g to nu cl ei c 
acids occurred via attack on adenine as well as guanine, so that it is surprising 
that in the case of 2-acetamidofluorene binding appears to occur exclusively via 
guanine. It may be that binding to other bases does occur but at such a low 
level that they are not detectable by contemporary methods. Scribner and Naimy 
(1975) have developed an interesting concept to account for differences in 
00 reactivity observed between different N-acetoxy-acetamido compounds and purine 
bases. Firstly, they propose that the rate of reaction depends upon whether a 
compound hydrolyses to an N -hydroxyacetamido compound or to aN -acetyl -N - 
aryinitrenium ion, which they propose as the reactive species. Secondly, they 
claim that the site of reaction can be predicted from molecular orbital calculations 
carried out on the various nitrenium ions. High reactivity of the nitrogen leads 
to reaction via carbon C-8 of guanine; high reactivity of carbon leads to reaction 
via an amino group in either adenine or guanine. Further work using a range of 
compounds will be needed to explore these ideas. 
is perhaps unforrunate, from a unifying point of view, 
that this "persistent" 
material still contains an acetyl function, as such a situation cannot 
obtain with 
aromatic amines in the dog, which nevertheless 
is susceptible to aromatic amine- 
- 010- 
induced tumours. It may be that ortho-aminophenols such as 4-amino-3-hydroxy- 
biphenyl, are the active agents as discussed in Section 1 . 6; certainly they are 
carcinogenic when implanted into the bladders of mice and are formed at high 
levels in species susceptible to the carcinogenic effect of the parent amines. If 
this is the case, then an alternative method of binding with DNA and affecting 
genetic processes presents itself. It is known that 4 -amino -3-hydroxybi phen yI is 
oxidised to 1,7-diphenyl-4-amino-3H-isophenoxazine-3-one (Nagasawa, 
Gutmann & Morgan, 1959; Fig. 9.5), a substance which is carcinogenic in the mouse 
bladder implantation test (see references in Section 1 . 6). This substance is 
structurally related to the phenoxazone cinnabarinic acid, a compound formed by 
nuclear enzymes from 3-hydroxy-anthranilic acid (Subba-Rao, Jegannathan & 
Vaidyanathan, 1965), and to actinomycin D (Fig. 9.5). 
As actinomycin D binds very strongly with nucleic acids (Hamilton, Fuller & 
Rei ch, 1963) it may be that other isophenoxazon es derived from carcinogen ic 
ortho-aminophenols can react in the same way. 
Kiese & Lenk (1971) observed the formation of anew compound in rabbit 
urine following the administration of 4-chloroani line. This material was isolated 
after the urine had been treated with glucuronidase and sulphatose and was 
tentatively characterised as 3-amino-7-chlorophenoxazone-2, although by analogy 
with the product from 4 -amino -3-hydroxybiphen yl the present author would have 
thought it more likely to be 1,7-dichloro-4-amino-3H -isophenoxazone, unless 
chlorine can be eliminated during the condensation reaction. 
In respect to their similarity to actinomycin D it is interesting that 2-amino-I , 
4-naphthoquinone, a compound which is formed by oxidation of the carcinogenic 
2-amino-I -naphthol (Belman, Ferber & Troll, 1967), 
has been proposed as a model 
- 319- 
-0 
0 
E 
0 tn 
-0 
0 
C 
E 
4 
'4- 
0 
-6- 
0- 
C 4- 
E 
-c I- 
F-- 
X 
m 
0 1 -0 X. - XE 
00 4- 4- 
W 4) 
LO 
r- 
0 
r- 
Uj 
Z 
Ljj 
Z 
co 
O 
Uj 
Z C") 
co 
c) 
Co 
CN LLJ Z LU Z %0 cv) 0 0, Lo ()- Le) - L, LU LU Lo Lo UU SO C") CN . . . Z 
Z Z 
Z 
CL 
9- 
.0 0 
>, 0 
. XE 
0 Lo LO 
o, 
LU 
Z 
LU 
Z llqt 00 
Uj 
Z , -4 , 4 LU z LU z .t C-) 
LU Z , o 
%lo 
N 
co Lu Z 
LLJ 
Z Lu Z K o (>ý 
-C 
z 
0 
>1 >1 xc 0 (1) L- -C -0 CL 
UJ 
Z 
LLJ 
Z , N 
Lr) 
6, 
Co 
- 
C, 4 
,o 
LLI 
Z 
LLJ 
Z 
U-i 
Z 0 .. I- 00 m a) 0, (N m 
LLJ 
z 
LLJ 
z 
LLJ 
z N C N L 1.0 CY) - - lqt Y >,. - -14- ý 04 LO M ) CY) 
o 
CN 
C: > 
CN 
4 
ý 
C ) 
r- -C -0 
>1 c 4) 
-C a- 
.0 0 
C-0 N 
CY) 
U. 1 
z 
U. J 
z N co to c) to to 
LLJ 
Z 
Lij 
Z 
uj 
Z c Lo L0 "0 
>; 
t c" 0 Co 
uj 
Z 
Uj 
Z 
Uj 
Z 
LLJ 
Z "" 
CL 
0-,,, 
-4- 4) cU 
Da o c) 0 o to o C: ) c) o 0 C> LO c) o c) C) C> o If) - 0 
00 0 0 LO C> 0 0 to 0 q C> LO C> to P-- c) LO - 
c 
0 c 
0 
0 
2 
E 4- 
0 
0 
0 
z m 
c 0 :) E 
c 0 c 0 E u E u 
> -C Ln - 0 
D 0 
-0 
a- 
1 -C a- co 
4) 
-0 
44 (D -C 0- C: ) 0 
(D 
-0 
0- 
1 
V) LU 
u 
0 L 
W +- Cý, < 0 
E 
a 
X 
. 
I 
< 
L- 
'o 
IV 
V, a 
Lu - co 4 - 
. 4- 
C 
C 
L 
C 
C 
C 
C 
U 
C 
C) 
E 
C 
a) L 
C 
U, 
a) L 
C 
C 
E 
C 
x 
. 1- 
0 
z 
uj 
z 
- 320- 
2 
***ý C 02 H 
NH2 
OH 
2 
OH 
NH2 
Formation of isophenoxazones 
F L- N- Meva I I 
sar 
I 0 L- Pro I 
D-Val 
I 
L-Th 
Meva I 
ba r II 
i-aro 
I Va I 
I 
Thr 
I 
uu 
N ; Izzý 
0 
C02H CP H 
N m, 2 
IN4 He 
01 
L%-", 
0 
NH? 
- 
0 
CH3 C H, 3 
Actinomycin- D___ 
5 The oxidation of ortho-aminophenols to isophenoxazones 
and their structural relationship to Actino 
N 
0 0 
NH2 
wr 
- 321 - 
compound for the study of actinomycins (Martin, 1964). A structural analogue 
derived from 2-amino-I -fluorenol was very strongly bound to proteins under 
conditions where N -hydroxy 2-acetamidof luorene was not (Gutmann & King, 1962). 
It may be that the ideas discussed in this Section are pertinent not only to 
amine and amide carcinogenesis, but are also worth considering in relation to 
other areas of amine and amide toxicity. It has long been knoym that the N-hydroxy- 
derivatives of I- and 2-naphthylamine are mutagenic to certain strains of E. coli 
(Perez & Radomski, 1965; Belman, Troll, Teebor & Mukai, 1968). Recently, 
because of the high correlation between mutagenicity and carcinogenicity obtained 
by Ames and co-workers (see McCann, Choi, Yamasaki & Ames, 1975), there 
has been a great interest in this area. The mutagenicity of 4-aminobiphenyl, 
4-hydroxylaminobiphenyl, N -hydroxy-4-acetamidobiphenyl and N -acetoxy-4- 
acetamidobiphenyl in a number of bacteria[ test systems has been examined 
as part of a programme to assess the role of N -oxidation in mutagenesis caused 
by a variety of nitrogen -containing structures (Pai, Bloomfield, Jones & Gorrod, 
1978). 
The data presented in Table 9.4 is derived from some recent work by Miss 
Pai. In agreement with other workers she found that 4-aminobiphenyl was 
inactive as a mutagen in three test systems. These systems detect mutagens 
which act either by frameshift mutation or a base-pair substitution mechanism. 
In contrast the corresponding hydroxylamine was highly mutagenic and apparently 
could act by either mechanism. However, it may be that under the conditions 
of assay some of the hydroxylamine was oxidised to 4-nitrosobiphenyl, as 
Radomski et al. (1977) have shown that 4-nitrosobiphenyl is a potent frameshift 
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mutagen using TA98 as tester strain. 4-Nitrosobiphenyl and a number of other 
nitroso compounds have previously been shown to be powerful mutagens towards 
Salmonella typhimurium (Ames, Gurney, Miller & Bartsch, 1972). 
The corresponding N -acetyl derivative was again inactive., suggesting that 
some activating process was lacking; however, when the synthetic acetoxy ester 
was examined this was found to be a mutagen, although only at high concentration 
compared to the hydroxylamine. These results, which were obtained without the 
addition of any mammalian hepatic enzyme, support the idea that in order for a 
hydroxamic acid to be active a further metabolic step is required. Our experiments 
using the acetoxy compound did not indicate greatly enhanced activity at low 
concentrations, whereas removal of the N-acetyl group certainly did. This 
suggests that the acyltransferase or a hydrolytic, process as discussed earlier are 
required. In studies with N-hydroxy-2-acetamidofluorene support for the acyl- 
transferase (Weeks, Allaben, Louie, Lazear & King, 1978) and the hydrolase 
(Stoat, Baptist, Matney & Shaw, 1976; Andrews, Hinson & Gillette, 1978)mechanisms arq 
available, and presently it is not possible to distinguish between these two hypotheses. 
If deacetylation is a prerequisite for mutagenesis then the mechanism must 
lead to nucleic acid-bound products which are different from those found during 
carcinogenesis where the acetamido group remains intact. 
In a series of experiments designed to examine the mutagenicity of derivatives 
of 2-acetamidofluorene, Fahmy and Fahmy (1972) used Drosophila melanogaster 
as the test organism. This study showed that the highest mutagenic activity was 
again associated with esters of the hydroxamic acid. Some differentiation of effect 
was observed; the N-acetoxy compound produced a wide range of mutational 
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effects, whereas the N-sulphate produced rather specific effects. 
Nelson and Thorgeirsson (1972) examined the mutagenicity of a wide range 
of 2-acylaminofluorenes towards S. typhimurium. These authors concluded thct 
the mutageni city of these compounds correlated with the degree of N -hydroxyl - 
ation undergone by the substrate. 
The mechanism of the mutagenic action of hydroxylamines has recently been 
0 reviewed by Budowsky (1976). 
The results of mutagenicity testing of compounds containing nitrogen, 
together with their N -oxidised derivatives and conjugates, are obviously as 
difficult to interpret as those obtained during carcinogenicity studies. 
One's final conclusion has to be that despite the enormous amount of 
work which has been carried out since the recognition of amine-induced cancer 
in man and its reproduction in experimental animals, much still remains to be 
done in elucidating the mechanism of amine and amide carcinogenesis. Perhaps 
one of the most satisfying things to appear is the idea that many diverse structures 
may be activated via enzyme systems which had hitherto been considered as 
detoxifying systems (See Gorrod, 1979, and references cited therein). 
These enzymes have the ability to metabolise many natural ly-occurring 
substances, as well as xenobiotics, and as these enzymes vary from subject to 
subject they may be able to produce active carcinogens in one subject yet 
completely protect another. If this is true, then a knowledge of substrate 
specificity and route of metabolism may ultimately help to reduce the incidence 
of cancer caused by both endogenous and exogenous compounds. 
In this case we may truly be "at the beginning of the end" rather than, as 
stated by the late Sir Alexander Haddow in his address to the International 
Cancer Congress in London (1958) "at the end of the beginning". 
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ADDENDUM 
- 361 - 
The data contained in this addendum was obtained by Dr. M. R. Kibby, 
Department of Biochemistry, University of Strathclyde, Glasgow, Scotland 
using an ALGOL Mickel molecular orbital programme devised by KrýJger-Theimer 
and Hansen (1966). 
The numbering of the atoms within the molecules is in accordance with the 
diagrams shown and not the conventional system. This is necessary for the operation 
of the computer. 
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